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the  establishment  of  mutations.  8-­oxo-­G   is  an  abundant  and  highly  miscoding  oxidative  DNA  lesion  arising   from  a  
YDULHW\RIH[RJHQRXVDQGHQGRJHQRXVVRXUFHV ,WKDVEHHQVKRZQWKDW$R[R*PLVPDWFKHVZKLFKDUHFDXVHGE\








ZLWKR[R*OHVLRQV)XUWKHUPRUH LW LVGHPRQVWUDWHGWKDW WKHSKRVSKRU\ODWLRQRI3ROȜE\&GN&\FOLQ$LQWHUIHUHV
ZLWK0XOHPHGLDWHGGHJUDGDWLRQRI3ROȜ0HFKDQLVWLFDOO\SKRVSKRU\ODWLRQVWDELOL]HV3ROȜE\LQFUHDVLQJWKHDI¿QLW\







370VXELTXLWLQDWLRQDQGSKRVSKRU\ODWLRQWKDWDOORZVWKH¿QHWXQLQJRIWKHFHOOXODU3ROȜOHYHOVin  time  and  space
and  thus  contributes  to  the  maintenance  of  genetic  stability.
8German
EVLVWYRQlXVVHUVWHU:LFKWLJNHLWIUHLQH=HOOHGDVVGLHLQGHU'1$NRGLHUWHJHQHWLVFKH,QIRUPDWLRQP|JOLFKVWNRQVWDQWJHKDOWHQZLUGXPGLH(WDEOLHUXQJYHUKHHUHQGHU)ROJHQYRQ0XWDWLRQHQ]XYHUPHLGHQZHOFKH]XP%HLVSLHO ]XU .UHEVHQWVWHKXQJ IKUHQ N|QQHQ 'LH JHQHWLVFKH 6WDELOLWlW ZLUG GXUFK YLHOH YHUVFKLHGHQH '1$
5HSDUDWXUPHFKDQLVPHQJHZlKUOHLVWHWZHOFKHGXUFKLKUH.RUUHNWXUIXQNWLRQHQGDV*HQRPVWlQGLJJHJHQHLQH9LHO]DKO
YRQVFKlGOLFKHQ(LQÀVVHQYHUWHLGLJHQ'1$5HSDUDWXU3RO\PHUDVHQ3ROVZLH3ROh  und   die  sich  auf  das  Bearbeiten  





die  Oxidation  der  Base  Guanin  durch  Agenzien  aus  verschiedensten  endogenen  und  exogenen  Quellen  entsteht.  Wenn  
UHSOLNDWLYH3ROVEHUR[R*KLQZHJV\QWKHWLVLHUHQEDXHQVLHKlX¿JIDOVFKHV$GHQLQVWDWWGHVNRUUHNWHQ&\WRVLQHLQ
ZDV]X3XQNWPXWDWLRQHQIKUHQNDQQ(VLVWJH]HLJWZRUGHQGDVVVROFKH$R[R*)HKOSDDUXQJHQin  vitro  und  in  vivo  
durch  Zusammenarbeit  von  MutYH  und  Pol  hSUl]LVHNRUULJLHUWZHUGHQN|QQHQ3ROhZLUGGXUFK&GN&\FOLQ$LQ
GHUVSlWHQ6XQGGHU*3KDVHGHV=HOO]\NOXVSKRVSKRU\OLHUW'LHVH3KRVSKRU\OLHUXQJI|UGHUWGLH6WDELOLVDWLRQYRQ3RO
hGDGXUFKGDVV3ROh  weniger  ubiquitiniert  und  damit  weniger  durch  den  proteosomalen  Degradationsweg  abgebaut  
ZLUG%LVKHULVWHVMHGRFKQRFKDEVROXWXQNODUJHZHVHQZLHJHQDXGLHVH3KRVSKRU\OLHUXQJGLH6WDELOLVDWLRQYRQ3RO
hPHFKDQLVWLVFKEHZLUNW=XGHPLVWQLFKWEHNDQQWREHV.RIDNWRUHQJLEWGLHHLQH)HLQDEVWLPPXQJGLHVHU5HJXODWLRQ
bewirken  und  somit  zur  Stabilisation  von  Pol  hEHLWUDJHQ=XJXWHUOHW]WLVWGLH)UDJHZLHGLH5HNUXWLHUXQJYRQ3RO
h LQDNWLYH5HSDUDWXUNRPSOH[HYRQVWDWWHQJHKWQRFKJlQ]OLFKXQEHDQWZRUWHW ,QGHUYRUOLHJHQGHQ'LVVHUWDWLRQZLUG
JH]HLJW GDVV3ROh   durch   die  E3   ubiquitin   ligase  Mule   ubiquitiniert  wird.  Durch   diese  Ubiquitinierung  wird  Pol  h  
dem  Abbau  durch  das  Ubiquitin-­Proteasom-­System  zugeführt.  Diese  Regulation  des  zellulären  Gehalts  an  Pol  h  hat  
IXQNWLRQHOOH)ROJHQIUGLH)lKLJNHLWYRQ6lXJHWLHU]HOOHQPLWR[R*XP]XJHKHQ'HVZHLWHUHQZLUGJH]HLJWGDVVGLH





8-­oxo-­G  Schäden  miteinbezogen  wird  und  nicht  von  Mule  abgebaut  werden  kann.  Die  Fraktion  von  Pol  hKLQJHJHQGLH
QLFKWLQDNWLYH5HSDUDWXUNRPSOH[HDQV&KURPDWLQJHEXQGHQLVWLVWYHUPHKUWLP=\WRSODVPDORNDOLVLHUWXQGZLUGGHVKDOE
GXUFK0XOHGHUSURWHDVRPDOHQ'HJUDGDWLRQ]XJHIKUW=XVDPPHQIDVVHQGZLUGJH]HLJWGDVVGLHzeitliche  und  räumliche  














have  been  conserved  over   this  enormous  amount  of   time  by  being  meticulously   relayed  from  one  generation   to   the  



















by  massive  removal  of   the  parts  of   tissue  between  the   individual  digits.  This   is  accomplished  by   the  execution  of  a  
programmed  cell  death  termed  apoptosis.  Also  cells  that  line  the  intestine  or  build  the  skin  are  only  short-­lived  and  are  
VKHGDIWHUYHU\IHZGD\VRIOLIHDUHSHWLWLYHSURFHVVWKDWFRQVWDQWO\RFFXUUVGXULQJWKHHQWLUHOLIHVSDQRIDQLQGLYLGXDO
,QYLHZRIVXFKDKXJHPXOWLIDFHWHGDQGFRPSOLFDWHGV\PELRVLVLWEHFRPHVFOHDUWKDWWKHUHJXODWLRQRIHYHU\VLQJOH
component  is  of  pivotal  importance.  A  loss  of  the  ability  of  a  single  cell  to  act  as  part  of  the  collective  is  mostly  caused  by  
PXWDWLRQVLQ'1$HLWKHUEURXJKWDERXWE\HUURQHRXVUHSOLFDWLRQRUDIDLOXUHLQWKHUHSDLURI'1$GDPDJHDVRXWOLQHG
above.  Such  mutations  alter  the  genetic  information  and  can  lead  to  defective  functions  of  the  proteins  encoded  thereby.  
7KHVHDOWHUDWLRQVUHVXOWLQFKDQJHVRIDFHOO¶VEHKDYLRXUDQGFDQOHDGWRVHYHUHSUREOHPVDQGGLVRUGHUV&HOOVWKDWWKH
body  has  lost  complete  control  over  will  start  proliferating  uncontrolledly  and  can  ultimately  culminate  in  the  formation  
of  a  very  well  known  and  –  sadly  –  predominant  disease  to  humanity:  cancer.
The  distant  hope  to  one  day  be  able  to  cure  cancer  or  even  prevent  it  is  a  powerful  source  of  motivation  for  thousands  of  
SHRSOHLQYROYHGLQFDQFHUUHVHDUFK+RZHYHUDV%UXFH$OEHUWVWKHHGLWRULQFKLHIRIWKHPDJD]LQHµ6FLHQFH¶SKUDVHG
it  in  a  recent  editorial:  “The  remarkable  advances  in  our  knowledge  of  the  chemistry  of  life  achieved  in  the  past  few  
decades  […]  could  lead  non-­experts  to  assume  that  biologists  are  coming  close  to  a  real  understanding  of  cells.  On  
10
the  contrary,  as  scientists   learn  more  and  more,  we  have   increasingly  come  to  recognize  how  huge   the  challenge   is  
that  confronts  us”,QOLJKWRIWKHLPPHQVHFRPSOH[LW\RIHYHQDVLQJOHFHOOZKLFKZHDUHVWLOOIDUDZD\IURPHYHQ
JUDVSLQJ LQ DOO LWV DEXQGDQFH DQG LQWULFDF\ LWZLOO VWLOO WDNH HQRUPRXV VWUXJJOH HIIRUW FRRSHUDWLRQ LQQRYDWLRQ DQG
perseverance  to  achieve  the  remote  objective  of  conquering  cancer.  
The  attempt  of  the  work  presented  here  is  much  more  humble.  It  is  merely  to  shed  a  tiny  bit  of  light  onto  a  struggle  
that  is  as  old  as  life  itself:  a  cell’s  endless  endeavour  to  protect  the  integrity  of  its  genetic  information  against  the  daily  
challenges  that  it  is  facing.  
1HYHUWKHOHVVDVGLI¿FXOWDQG'DHGDOLDQWKHTXHVWRIXQGHUVWDQGLQJFKDOOHQJLQJDQGXOWLPDWHO\KRSHIXOO\GHIHDWLQJD
GLVHDVHDVFXQQLQJDVFDQFHUPLJKWVHHPWRTXRWH7KHRFULWXVDOZD\VUHPHPEHU
“While  there  is  life  there  is  hope,  and  only  the  dead  have  none”.
11











'1$IURPWKHPRGL¿HGEDVHV +RZHYHU WKH OHVLRQV WKDWJRXQGHWHFWHGE\ WKHUHSDLUV\VWHPVRU WKRVHIRUPLQJ
GXULQJWKH6SKDVHPLJKWUHPDLQXQGHWHFWHGDQGHYHQWXDOO\SRVHDFKDOOHQJHWRWKHUHSOLFDWLYH3ROVHQFRXQWHULQJWKHP






&*J$7WUDQVYHUVLRQVDUHRIWHQSUHVHQW$ODUJHSURSRUWLRQRIWKHVH&*JAT  transversions  might  be  attributed  to  
8-­oxo-­G  lesions.







IDFWRU3&1$DQG VLQJOH VWUDQGELQGLQJSURWHLQ53$FDQ LQÀXHQFH WKH WUDQVOHVLRQ V\QWKHVLV DELOLW\RI FHUWDLQ3ROV
)RUH[DPSOH WKHSURFHVVLYLW\ IDFWRU3&1$KDVEHHQ IRXQG WR LQÀXHQFHE\SDVVRIR[R* OHVLRQVE\3ROb   and   to  
LQFUHDVHWKHHI¿FLHQF\RIQXFOHRWLGHLQFRUSRUDWLRQERWKRQXQGDPDJHGWHPSODWHVDQGRSSRVLWHDOHVLRQE\3ROVdf  and  




8-­oxo-­G  coordinated  by  MutYH  glycosylase  and  Pol  h7DNHQWRJHWKHUWKHVHGDWDLQGLFDWHWKDWKXPDQFHOOVSRVVHVV
an  accurate  error-­free  bypass  mechanism  for  8-­oxo-­G  involving  Pol  h.  
12
DNA  polymerases,  the  key  enzymes  for  DNA  replication  and  DNA  repair
EYHUVLQFHGLVFRYHU\RIWKH'1$VWUXFWXUHE\:DWVRQDQG&ULFNLQLWTXLFNO\EHFDPHFOHDUWKDWWKHUHKDGWR EH VSHFLDOL]HG IXQFWLRQDO HQWLWLHV LQ WKH FHOO FDSDEOH RI UHDGLQJ DQG FRS\LQJ WKLV JHQHWLF PDWHULDO HYHQthough   the   authors   themselves  didn’t   exclude   a   spontaneous   assembly  of  nucleotides   as  possible  mechanism  
RI'1$UHSOLFDWLRQDW¿UVW6KRUWO\DIWHUWKDW0HVHOVRQDQG6WDKOGHPRQVWUDWHGWKHH[LVWHQFHRIDVRFDOOHG
‘semiconservative  mechanism  of  DNA  replication’  in  the  bacterium  Escherichia  coli  (E.coli)  6XEVHTXHQWZRUNE\
Kornberg  and  his  co-­workers  led  to  the  discovery  of  a  Pol  that  is  capable  of  synthesizing  DNA  chains  in  a  fashion  that  
DOORZVEDVHSDLULQJRI$RSSRVLWHWK\PLQH7DQG*RSSRVLWH&FUHDWLQJ$7DQG*&EDVHSDLUV7KLVHQ]\PH




enzyme.  Next  a  newly  incoming  nucleotide  is  attached  in  a  phosphoryl  transfer  reaction  to  the  3’-­OH  group  of  the  pre-­
existing  DNA  strand  that  is  the  ‘primer’  or  the  growing  DNA  strand.  The  repetition  of  this  cycle  will  ultimately  lead  to  
the  formation  of  DNA  chains  of  megabases  length.  
6RIDUDOONQRZQ3ROVKDYHEHHQJURXSHGLQWRWKHVHYHQGLIIHUHQWIDPLOLHV$%&';<DQG57EDVHGRQVHTXHQFH
homologies.  The  following  Table  1  tDNHQIURPLVLQWHQGHGWRVXPPDUL]HDQGLOOXVWUDWHWKHVHYHQ3ROIDPLOLHVDQG
WKHLUPHPEHUVWKDWDUHNQRZQWRGDWH3URNDU\RWHV$%&DQG;DUFKDHD%';DQG<DQGHXNDU\RWHV$%;
<DQG57DOOSRVVHVVDGLIIHUHQWDUUD\RIWKHVHIDPLOLHV7KHUHDVRQIRUWKHPXOWLWXGHRI3ROIDPLOLHVDQG3ROVLVWKH
YDULHW\RIIXQFWLRQVDQGVLWXDWLRQVWKDWWKH\KDYHWREHFDSDEOHRIGHDOLQJZLWK)RULQVWDQFHWKHWKUHH3ROV_b  and  ¡  
DUHUHTXLUHGGXULQJ'1$UHSOLFDWLRQ'1$UHSDLURQWKHRWKHUKDQGSRVHVDPXFKPRUHFRPSOH[WDVNDVWKHEDVHVWKDW
KDYHWREHE\SDVVHGKDQGOHGRUH[WHQGHGDUHGDPDJHGDQGWKXVDUHYHU\RIWHQPLVFRGLQJRUHYHQEORFNLQJ)RUHYHU\
kind  of  lesion  or  stress  situation  there  is  a  specialized  array  of  Pols  prepared  to  perform  what  they  are  best  at:  trying  to  
maintain  the  original  sequence  and  thus  protecting  the  genetic  integrity.
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Table  1:  An  overview  of  DNA  polymerase  families  and  their  members.
$GDSWHGIURP
Family Viral   Bacteria Archaea Eukaryotes
A T3  Pol Pol  I  E.  coli 3ROȖ
T5  Pol Pol  I  T.  aquaticus 3ROș
T4  Pol 3ROȞ
T7  Pol
B T6  Pol Pol  II  E.  coli Pol  BI 3ROĮ
RB69  Pol Pol  BII 3ROį




C Pol  III  E.  coli
Pol  III    B.  subtilis
Dna  E  B.  subtilis
Pol  III  T.  aquaticus
D Pol  D
















Y 3RO,9(FROL Dpo4  Pol  7 3ROȘ





2:  Herpes  simplex  virus
3:  African  swine  fever  virus
4:  Saccharomyces  cerevisiae
5:  Schizosaccaromyces  pombe
6:  Terminal  deoxyribonucleotidyl  transferase
7:  From  Sulfolobus  solfataricus
8:  Reverse  transcriptases  form  retroviruses  and  lentiviruses
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DNA  polymerase  han  enzyme  with  many  functions




structure  of  Pol  hFRQVLVWVRIWKHW\SLFDOSDOP¿QJHUVWKXPEDQGN'DG53O\DVHVXEGRPDLQVDPLQRDFLGV±
)XUWKHUPRUHWKH1WHUPFRPSULVHVWKHQXFOHDUORFDOLVDWLRQVHTXHQFH1/6DPLQRDFLGV±IROORZHGE\D%5&7
GRPDLQDPLQRDFLGV±DQGDSUROLQHVHULQHULFKGRPDLQDPLQRDFLGV±Figure  17KHVHTXHQFH





Figure  1:  Schematic  presentation  of  the  subdomains  of  DNA  polymerase  h.
:KHQ¿UVWLGHQWL¿HGLQGHSHQGHQWO\E\WZRJURXSVLQ3ROh  was  implicated  to  play  a  role  mainly  in  DNA  repair  
V\QWKHVLVDVVRFLDWHGZLWKPHLRVLV7KLVZDVGXHWRWKHIDFW WKDW1RUWKHUQEORWWLQJ LQVLWXK\EULGL]DWLRQDQDO\VLVDQG
immunostaining  in  mice  showed  Pol  hWREHKLJKO\DEXQGDQWLQWHVWLVDOWKRXJKEDVDOOHYHOVFRXOGEHGHWHFWHGLQDOO
WLVVXHVWKDWZHUHH[DPLQHG)XUWKHUPRUHWKHWUDQVFULSWOHYHOVRI3ROh  were  found  to  be  highest  during  the  
SHULRGLQZKLFKPHLRWLFUHFRPELQDWLRQRFFXUVDOVRLQWHVWHVRIDGXOWPLFHVXSSRUWLQJWKHK\SRWKHVLVRIDQLQYROYHPHQW
into  meiotic  DNA  repair.




that  the  targeting  approach  used  in  this  study  did  not  only  knock  out  Pol  hEXWDOVRVXUURXQGLQJSDUWVRI'1$ZKHUH
genomic  analysis  predicted  the  existence  of  a  transcribed  gene  that  is  strongly  conserved  throughout  evolution  on  the  
strand  opposite  of  Pol  h.  Thus  the  observed  phenotype  was  most  probably  not  only  due  to  a  lack  of  the  original  target  
Pol  hEXWUDWKHUDVLGHHIIHFWFUHDWHGE\WKHORVVRIWKHDGMDFHQW'1$VHTXHQFHHQFRGLQJIRUDQRWKHULPSRUWDQWSURWHLQ
7KHVHFRQGJURXSWKDWJHQHUDWHG3ROhNQRFNRXWPLFHXVLQJDPRUHWDUJHWHGDSSURDFKRQO\GHOHWLQJWKHFDWDO\WLF
domain  of  Pol  hUHSRUWHGWKRVHPLFHWREHYLDEOHDQGIHUWLOH$GGLWLRQDOO\DQRYHUDOOKLVWRORJLFDOH[DPLQDWLRQRI
YDULRXVWLVVXHVIURPWKHVHPLFHIDLOHGWRUHYHDODQ\GHIHFWWKXVFRQWUDGLFWLQJWKH¿QGLQJVE\.RED\DVKLet  al.  A  report  
by  Bertocci  et  al  stated  that  Pol  hWRJHWKHUZLWKLWVFORVHUHODWLYH3RO+VHHPHGWREHGLVSHQVDEOHIRULPPXQRJOREXOLQ
JHQHK\SHUPXWDWLRQDVDVVHVVHGE\DQDO\VLVRIKHDY\FKDLQVHTXHQFHVREWDLQHGIURP3H\HU¶VSDWFKGHULYHG%FHOOV
Follow-­up  work  provided  evidence  that  Pol  hLVLQYROYHGLQ9'-UHFRPELQDWLRQDV3ROh  knockout  mice  displayed  a  
VKRUWHQLQJRIWKHLPPXQRJOREXOLQKHDY\FKDLQ&'5E\¿YHEDVHSDLUVRQDYHUDJH$OVRWKHVWXG\VKRZHGWKDW
Polh  -­/-­0()VGLGQRWGLVSOD\VHQVLWLYLW\WRZDUGV;UD\VVXJJHVWLQJWKDW3ROh  does  not  appear  to  contribute  to  DNA  
UHSDLURI'6%V,QFRQWUDVWWRWKDWDVWULNLQJVHQVLWLYLW\RIPolh  -­/-­  primary  MEFs  towards  oxidative  stress  -­  as  induced  
E\FXOWXULQJWKHPDW22  -­  was  revealed.  This  sensitivity  manifested  itself  in  a  reduced  number  of  cells  entering  S  
SKDVHDQGDVXEVHTXHQWHQWU\LQDJURZWKDUUHVWHGVWDWHRUSUHPDWXUHFHOOXODUVHQHVFHQFHZKLFKZDVFRQ¿UPHGE\WKH
elevated  expression  of  senescence-­associated  `-­galactosidase.  This  senescence  could  be  avoided  by  growing  the  cells  at  
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22VXJJHVWLQJDQLQYROYHPHQWRI3ROh  in  the  protection  against  oxidative  DNA  damage.
Using   a   combination   of  Polh   and  Pol` VLQJOHNQRFNRXW0()V DQG QHXWUDOL]LQJ DQWLERGLHV VSHFL¿F IRU ERWK 3ROV
Braithwaite  et  al  showed  that  Pol  h  is  capable  of  mediating  a  back-­up  BER  activity  when  Pol  `  is  not  present.  This  
ZDVWKH¿UVWin  vivo  proof  that  Pol  hDFWVLQD%(5SDWKZD\)ROORZXSZRUNGHPRQVWUDWHGWKDWFHOOVGH¿FLHQWLQ
Pol  h  display  a  hypersensitivity   to  oxidative  stress   induced  by  H2O2  or   the  incorporation  of  5-­hydroxymethyluracil  
KPG8UGZKHUHDV WKH\EHKDYHGDVZLOGW\SHFHOOVZKHQH[SRVHG WR0HWK\OPHWKDQHVXOIRQDWH0067KRVH
¿QGLQJVSURYLGHGIXUWKHUHYLGHQFHWKDW3ROhFRXOGSRVVLEO\EHLQYROYHGLQWKHUHSDLURIVSHFL¿F'1$OHVLRQVin  vivo.  
$ORQJWKLVOLQHWKH%(5SDWKZD\IRUKPG8UDLQYROYLQJ3ROh  as  well  as  interaction  of  Pol  h  with  the  SMUG1  DNA  
glycosylase  could  be  reconstituted  in  vitroE\XVLQJSXUL¿HGSURWHLQV$OVRWKHUHTXLUHPHQWRIWKH1WHUPRI3ROh  for  the  
recruitment  of  Pol  hWRVLWHVRIODVHULQGXFHGR[LGDWLYH'1$GDPDJHWRJHWKHUZLWK608*ZDVGHPRQVWUDWHG)LQDOO\
the  authors  claimed  not  to  have  able  to  observe  recruitment  of  Pol  hWRVLWHVRI'1$GRXEOHVWUDQGEUHDNV'6%VLQ
DFFRUGDQFHZLWKSUHYLRXV¿QGLQJVWKRXJKWKHGDWDFRQFHUQLQJWKLVZHUHQRWVKRZQ
An  involvement  of  Pol  h  and  a  cooperation  of  Pol  h  with  Pol  `LQWKHUHSDLURIR[LGDWLYH'1$GDPDJHLQFKLFNHQ'7
cells  was  shown  by  Tano  et  al:KLOHPol`  -­/-­  or  Polh  -­/-­  single  knockout  cells  displayed  only  slight  hypersensitivity  
to  H2O2WUHDWPHQWDFRPELQHGNQRFNRXWVWURQJO\HQKDQFHGWKHVHQVLWLYLW\SKHQRW\SHPol`-­/-­  cells  displayed  a  slightly  
HOHYDWHGOHYHORI'1$VLQJOHVWUDQGEUHDNV66%VEXWWKH%(5FDSDFLW\RIPolh  -­/-­  cells  did  not  differ  from  wt  cells.  
+RZHYHUWKHUHZDVDFOHDULQFUHDVHLQ66%IURPPol`  -­/-­  to  Pol`  -­/-­  Polh  -­/-­GRXEOHGH¿FLHQWFHOOVVXJJHVWLQJWKDW3ROV`  
and  h  can  complement  for  one  another  in  the  protection  against  the  genotoxic  effects  of  H2O2  treatment.  In  vitro  BER  
experiments  fully  corroborated  the  in  vivo  GDWDDQGSURYLGHGIXUWKHUSURRIWKDWLQFRQWUDVWWR3RO`3ROh  is  not  involved  
in  the  repair  of  damage  mediated  by  alkylating  agents.
,Q  ZRUN IURP0DJD et   al.   found   that   Pol   h WRJHWKHU ZLWK LWV FRIDFWRUV 5HSOLFDWLRQ 3URWHLQ$ 53$ DQG
3UROLIHUDWLQJ FHOO QXFOHDU DQWLJHQ 3&1$ LV FDSDEOH RI LQVHUWLQJ WKH FRUUHFW & RSSRVLWH R[R* IROGPRUH
HI¿FLHQWO\ WKDQ WKH LQFRUUHFW$ in  vitro ([SHULPHQWVZLWKZKROHFHOO H[WUDFWV IURPZWDQGPolh-­/-­  MEFs   further  
underlined  Pol  h’s   role   in  coping  with  8-­oxo-­G   in  vivo.  The   idea  of  a   role   for  Pol  h   in  8-­oxo-­G   repair  was   further  
strengthened  when  a   study  Maga  et  al.   provided   insight   into   the   regulatory  mechanism  of  polymerase-­choice  at   an  
R[R*VLWH  ,WFRXOGEHVKRZQ WKDW3&1$DQG53$DFWDVPROHFXODUVZLWFKHV WRDOORZ WKH3ROh-­dependent  
KLJKO\HI¿FLHQWDQGIDLWKIXOUHSDLURI$R[R*PLVPDWFKHVin  vitroE\XVLQJSXUL¿HGHQ]\PHVDQGin  vivo  by  the  use  of  
Polh-­/-­  and  Pol`-­/-­NQRFNRXWFHOOH[WUDFWV)XUWKHUPRUHLWFRXOGEHGHPRQVWUDWHGWKDWWKHGLIIHUHQWLDOH[SUHVVLRQRI3ROV
h  and  `FRUUHODWHZLWKWKHGHYHORSPHQWRIDWXPRXUDOSKHQRW\SHRILPPRUWDOL]HGKXPDQ¿EUREODVWV5HFHQWO\SXEOLVKHG
data  further  demonstrate  that  MutYH  and  Pol  hDUHUHFUXLWHGVSHFL¿FDOO\WRVLWHVRI$R[R*PLVPDWFKHVEXWQRWWR
XQGDPDJHG'1$LQFHOOH[WUDFWV,PPXQRÀXRUHVFHQFHH[SHULPHQWVLQGLFDWHGWKDWWKRVHWZRSURWHLQVDUHLQYROYHGLQ
repair  of  oxidative  DNA  damage  in  vivo,QWKHVDPHVWXG\DIXOO\UHFRQVWLWXWHGin  vitro  SDWKZD\LQYROYLQJ0XW<+
$SXULQLFDS\ULPLGLQLFHQGRQXFOHDVH$3(3ROh3&1$53$)ODSHQGRQXFOHDVH)(1DQG'1$OLJDVH,ZDV
SUHVHQWHGVXJJHVWLQJWKHH[LVWHQFHRIDQRYHOFHOOXODUUHVSRQVHSDWKZD\WRUHSDLUR[R*DVVRFLDWHGGDPDJH
,QVXPPDU\3ROh  seems  to  be  a  multifunctional  enzyme  that  has  been  ascribed  a  variety  of  roles.  The  feature  of  Pol  h  
that  is  momentarily  in  the  main  focus  of  our  attention  and  also  the  main  point  investigated  in  the  work  presented  here  is  
LWVLQYROYHPHQWLQWKHUHSDLURIR[LGDWLYH'1$GDPDJH3UREDEO\WKLVLVRQHRIWKHPRVWGLI¿FXOWIHDWXUHVRI3ROh  to  be  
assessed  in  vivo  due  to  the  numerous  functional  redundancies  with  a  variety  of  other  repair  factors  all  working  together  
LPPDFXODWHO\ LQ WKHFHOO WRFRPEDW WKHPXWDWLRQDOSRWHQWLDORIR[LGDWLYH'1$GDPDJH WKRURXJKO\ UHYLHZHG LQRXU
UHYLHZVKRZQEHORZ7KHLQYHVWLJDWLRQDQGFODUL¿FDWLRQRIWKLVUROHRI3ROh  in  vivo  is  likely  to  present  still  quite  some  
surprises  and  confusions  in  the  years  to  come.
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MutYH  DNA  glycosylase  –  the  initiator  of  A:8-­oxo-­G  repair
AVGLVFXVVHGDERYH WKHSUREOHPRIR[R*LV WKDWIUHTXHQWO\DZURQJ$LV LQFRUSRUDWHGRSSRVLWHWKHOHVLRQThis  A:8-­oxo-­G  mispair   is   the   substrate   for  MutYH  and   it   is   the  DNA  glycosylase   activity  of  MutYH   that  catalyses  the  excision  of  the  wrongly  incorporated  A  opposite  an  8-­oxo-­G.  More  information  about  the  catalytic  
mechanism  and  the  role  of  MutYH  in  the  repair  of  oxidative  DNA  damage  can  be  found  in  an  own  review  attached  
EHORZS,QWKHIROORZLQJWKHFXUUHQWNQRZOHGJHDERXWWKHUROHRI0XW<+in  vivo  is  summarized.  
MutYH  Associated  Polyposis  
MutYH  dependent  repair  of  8-­oxo-­G  was  recognized  to  be  important  in  vivo  when  Al-­Tassan  et  alIRXQGLWWREH





8-­oxo-­G  mediated  mutagenesis.  This  observation  led  to  the  discovery  of  biallelic  germline  missense  mutations  in  the  









Al-­Tassan  et  al  have  been  tracked  down  so  far.  The  abundant  body  of  literature  investigating  different  single-­nucleotide  
SRO\PRUSKLVPV613VDQGWKHLUUHOHYDQFHWRFDQFHUGHYHORSPHQWKDVEHHQWKRURXJKO\UHYLHZHG,QWHUHVWLQJO\






LQJDVWURLQWHVWLQDODQGFXWDQHRXV WXPRXUV $QRWKHUJURXS UHSRUWHGDSRVVLEOHDVVRFLDWLRQRID0XW<+ELDOOHOLF
PXWDWLRQZLWKHQGRPHWULDOFDQFHUDQG0XLU7RUUpV\QGURPH,QWKHFDVHRIWZRVLEOLQJVKRPR]\JRXVIRUD0XW<+





unknown  13-­base-­pair  deletion  on  intron  six  of  MutYH  was  found  in  two  patients  suffering  from  a  relatively  severe  
form  of  MAP.
MutYH  germline  mutations  and  Mismatch  Repair
$QDVVRFLDWLRQRI0XW<+DQG0VKJHUPOLQHPXWDWLRQVLQFRORUHFWDOFDQFHUSDWLHQWVKDVEHHQGHVFULEHGVXJJHVWLQJ






It  has  been  reported  that  tumours  from  MAP  patients  show  similarities  to  microsatellite  instable  cancers  such  as  they  are  
VHHQLQFDQFHUVDULVLQJGXHWR005GH¿FLHQF\0LFURVDWHOOLWHLQVWDELOLW\ZDVDOVRIRXQGLQ%FHOOO\PSKREODVWLF
lymphomas  from  msh2-­/-­  mutyh-­/-­  PLFHGXULQJWXPRXUGHYHORSPHQW$VWXG\DGGUHVVLQJWKHKXPDQOHXNRF\WHDQWLJHQ
,H[SUHVVLRQSDWWHUQRQWXPRXUFHOOVGHULYHGIURP0$3SDWLHQWVVKRZHGWKDWWKHLWVH[SUHVVLRQSDWWHUQLVGHIHFWLYHLQ
RIWKHWHVWHGSULPDU\FDUFLQRPDVRIWHQRFFXUULQJFRQFRPLWDQWO\ZLWKORVVRIWKHH[SUHVVLRQRIEHWDPLFURJOREXOLQ
Those  are  features  usually  observed  in  MMR-­defective  tumours  and  are  generally  thought  to  represent  immune  evasion  
PHFKDQLVPVEHQH¿FLDO WR WKHFDQFHUFHOOV$QRWKHUVWXG\VKRZHGWKDW0$3FDUFLQRPDVRIWHQKDUERXUFKURPRVRPDO
regions  of  copy-­neutral  loss-­of  heterogeneity  and  claim  this  is  an  important  mechanism  in  the  tumourigenesis  of  MAP  

MutYH  and  age-­related  diseases
5HFHQWO\D&KLQHVHVWXG\UHSRUWHGDPXWDWLRQLQWKH0XW<+JHQHWREHDVVRFLDWHGZLWKLQFUHDVHGOHYHOVRI2+G*
LQWKHOHXNRF\WHVRIWKHFDUULHUVDQGLQFUHDVHGLQWHUOHXNLQOHYHOVVXJJHVWLQJLPSDLUHG'1$UHSDLUDQGLQÀDPPDWLRQ
SRVVLEO\ OHDGLQJ WR WKH GHYHORSPHQW RI DJHUHODWHG RU FKURQLF GLVHDVHV  6WULNLQJO\ WKH SUHYDOHQFH RI KHDOWK\
KRPR]\JRXVFDUULHUVGHFUHDVHGIURPLQWKHJURXSRI±\HDUVRIDJHWRLQWKHDJHJURXS±
\HDUVKLQWLQJWRZDUGWKHIDFWWKDWKRPR]\JRVLW\IRUWKLVPXWDWLRQPD\KDYHDVWURQJLQÀXHQFHRQWKHGHYHORSPHQWRI
age-­related  or  chronic  diseases  or  even  mortality.  
'HFUHDVHGOHYHOVRI0XW<+KDYHEHHQLPSOLFDWHGWREHDVXVFHSWLELOLW\IDFWRUDOVRLQDJHUHODWHGUHWLQDOGLVHDVHV
and  the  same  group  found  increased  mitochondrial  DNA  damage  in  rodent  retinal  pigment  epithelium  and  choroid  to  
FRLQFLGHZLWKWKHGRZQUHJXODWLRQRIH[SUHVVLRQRI0XW<+DPRQJRWKHU'1$UHSDLUHQ]\PHV
MutYH  -­/-­  cells  and  mice
The  data  on  cells  and  mice  with  biallelic  deletion  of  MutYH  are  somewhat  heterogeneous.  Hirano  et  al  reported  MutYH  
NQRFNRXWPRXVHHPEU\RQLFVWHPFHOOV(6FHOOVWRGLVSOD\DPXWDWRUSKHQRW\SHPDQLIHVWLQJLQDWZRIROGLQFUHDVHG
VSRQWDQHRXVPXWDWLRQUDWH LQDÀXFWXDWLRQDVVD\ZKLOH WKHFHOOVGLGQRWVKRZDQ\K\SHUVHQVLWLYLW\ WRZDUGV+2O2  or  
PHQDGLRQHD9LWDPLQ.DQDORJXH WKDWJHQHUDWHV UHDFWLYHR[\JHQVSHFLHV 526E\UHGR[F\FOLQJ:KHQ;LH





A   study   by  Russo   et   al   with  mutyh-­/-­  0()V IRXQG WKDW WKRVH FHOOV DFFXPXODWH  WLPHVPRUHPXWDWLRQV WKDQZLOG
type  cells  at  the  HPRTJHQHEXWWKH\VWLOOGLVSOD\HGDUDWKHUPLOGPXWDWRUSKHQRW\SHFRPSDUHGWRmsh2-­/-­  MEFs.  The  
combination  of  both  knockouts  to  mutyh-­/-­  msh2-­/-­  OHDGWRDPXWDWLRQUDWHWKDWGLGQRWGLIIHUVLJQL¿FDQWO\IURPWKHVLQJOH
msh2-­/-­  0()VVXJJHVWLQJWKDWERWKJHQHSURGXFWVDUHLQYROYHGLQWKHVDPHSDWKZD\DWOHDVWin  vitro
A  study  with  mutyh-­/-­NQRFNRXWPLFHE\;LHet  al UHYHDOHGQRVLJQL¿FDQWGLIIHUHQFH LQVXUYLYDORU WXPRXU LQFLGHQFH
between  wild-­type  and  mutyh-­/-­NQRFNRXWPLFHDIWHUPRQWKV OHDGLQJ WR WKHFRQFOXVLRQ WKDW0XW<+GH¿FLHQF\ LV
QRW VXI¿FLHQW WRFDXVHD WXPRXUSUHGLVSRVLWLRQ 7KLV VWXG\DOVR VKRZHG WKDWZKHQ0XW<+ZDVNQRFNHGGRZQ
VLPXOWDQHRXVO\ ZLWK 2JJ WKH VXUYLYDO DJH IRU GRXEOH NQRFNRXW PLFH ZDV VLJQL¿FDQWO\ UHGXFHG DQG WKH WXPRXU
LQFLGHQFHZDV VLJQL¿FDQWO\ LQFUHDVHG FRPSDUHG WRmutyh-­/-­   or   ogg1-­/-­   single   knockouts.   The  malignancies   found   in  
those  double-­knockouts  were  lung  and  ovarian  tumours  and  lymphoma  as  well  as  some  gastrointestinal  adenoma  and  




mutyh-­/-­  ogg1-­/-­EDFNJURXQG$FRPSOHWHNQRFNRXWRI0VKWRJHQHUDWH WULSOHNQRFNRXWPLFHmutyh-­/-­  ogg1-­/-­  msh2-­/-­
led  to  an  even  higher  tumuor  incidence  and  decreased  survival  time  but  did  not  differ  from  the  phenotype  displayed  by  
msh2-­/-­  single  knockouts.  This  might  be  due  to  the  fact  that  the  strong  mutator  phenotype  of  msh2-­/-­  mice  could  mask  any  
additional  difference  due  to  mutyh-­/-­  and  ogg1-­/-­.  
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Analysis  of  spontaneous  mutagenesis  in  the  small  intestine  of  ogg1-­/-­  and  mutyh-­/-­  ogg1-­/-­  GRXEOHGH¿FLHQWPLFHDWWKHDJH
RIIRXUWR¿YHZHHNVE\XVLQJDSURNDU\RWLFUSV/WUDQVJHQHDVDUHSRUWHUUHYHDOHGDQLQFUHDVHGPXWDWLRQDOIUHTXHQF\LQ
the  double-­knockouts  but  not  in  the  ogg1-­/-­PLFH)XUWKHUPRUHWKH&*J  AT  mutation  frequency  was  four-­fold  increased  
in  mutyh-­/-­VLQJOHNQRFNRXWV¿YHIROGLQFUHDVHGLQogg1-­/-­  and  a  41-­fold  increase  could  be  observed  in  mutyh-­/-­  ogg1-­/-­
suggesting  the  existence  of  a  cooperative  function  between  Ogg1  and  MutYH  to  prevent  8-­oxoG-­related  mutagenesis  
LQPDPPDOV$QRWKHUJURXSDOVRUHSRUWHGDQDGGLWLYHHIIHFWLQmutyh-­/-­  ogg1-­/-­  on  the  age-­dependent  increase  in  
R[R*OHYHOVVSHFL¿FDOO\LQOLYHUOXQJDQGVPDOOLQWHVWLQHFRPSDUHGWRWKHVLQJOHmutyh-­/-­NQRFNRXWVZKLFKVKRZHG
only  an  age-­dependent  accumulation  of  8-­oxo-­G  in  their  livers  comparable  to  ogg1-­/-­  mice  6WULNLQJO\WKHWLVVXHV
that  accumulated  8-­oxo-­G  in  mutyh-­/-­  ogg1-­/-­  mice  were  the  same  ones  that  showed  increased  cancer  incidence  in  the  
VWXG\E\;LHet  al
0XW<+GH¿FLHQF\LQDEDFNJURXQGRI$3&min/+  mice  has  also  been  shown  to  enhance  the  occurrence  of  stop-­codons  
LQ WKH$3& JHQH E\ LQGXFWLRQ RI&*J$7 WUDQVYHUVLRQPXWDWLRQV DQG WKXV WR SURPRWH LQWHVWLQDO WXPRXULJHQHVLV
XQGHUOLQLQJWKHUROHRI0XW<+LQSUHYHQWLRQRI&*J  AT  transversions  and  carcinogenesis  in  vivoDVLWLVDOVRVXJJHVWHG
WRKDSSHQGXULQJSDWKRJHQHVLVRI0$3
,QDVWXG\LQYHVWLJDWLQJDODUJHFRKRUWRIPLFHNHSWIRUPRQWKVUHSRUWHGDQLQFUHDVHGVXVFHSWLELOLW\WRVSRQWDQHRXV
as  well  as  stress-­induced  intestinal  tumourigenesis  in  mutyh-­/-­  PLFHZKLOHWKHLUPRUWDOLW\ZDVQRWLQFUHDVHGLQFRPSDULVRQ
WRWKHZLOGW\SHPLFH7KHVHUHVXOWVVWURQJO\FRQWUDGLFWHGWKHGDWDRQmutyh-­/-­  obtained  by  different  groups  thus  
far.  Those  mutyh-­/-­  PLFHGLVSOD\HG¿YHWLPHVPRUHRIWHQLQWHVWLQDOWXPRXUVWKDQZLOGW\SHOLWWHUPDWHVVXJJHVWLQJWKDW
SUHVHQFHRID0XW<+GH¿FLHQF\LVLQGHHGVXI¿FLHQWWRSUHGLVSRVHPLFHWRGHYHORSPDOLJQDQFLHVRIWKHLQWHVWLQDOWUDFW
VXFKDV O\PSKRPDDQGDGHQRPD0RUH LPSUHVVLYHO\VWLOOmutyh-­/-­  PLFHGLVSOD\HGDGUDPDWLF LQFUHDVH LQ&*J  AT  
transversion  mutations  and  small  intestinal  tumours  when  treated  orally  for  four  weeks  with  KBrO3DNQRZQLQGXFHURI
oxidative  stress  and  particularly  of  8-­oxo-­G.  The  authors  claimed  that  the  tumour-­prone  phenotype  of  the  mutyh-­/-­  mice  
might  have  been  missed  that  far  due  to  differences  in  the  genetic  background  of  the  mouse  strains  and  the  older  age  at  
which  the  tumour  burden  was  evaluated  in  their  study.  This  is  in  line  with  the  fact  that  many  of  the  studies  with  mutyh-­/-­  
mice  have  been  reporting  a  strong  tendency  towards  age-­dependent  accumulation  of  8-­oxo-­G  in  tissues.
$V QRWHG DERYH WKH FRPELQDWLRQ RI WKH WZR NQRFNRXWVmutyh-­/-­   and  msh2-­/-­  GLG QRW VLJQL¿FDQWO\ DOWHU WKHPXWDWLRQ
rate   compared   to   the   single  msh2-­/-­  0()V VXJJHVWLQJ WKDWERWKJHQHSURGXFWV DUH LQYROYHG LQ WKH VDPHSDWKZD\DW
least   in   vitro +RZHYHUZKHQ WKH DPRXQW RI R[LGDWLYH'1$GDPDJHZDV H[DPLQHG LQmutyh-­/-­  msh2-­/-­   double  
NQRFNRXWPLFH WKH ORVVRImutyh-­/-­ FRQWULEXWHG WRD VLJQL¿FDQW LQFUHDVH LQ VHYHUDORI WKH WHVWHGRUJDQVFRPSDUHG WR  
msh2-­/-­  VLQJOHNQRFNRXWPLFHVXJJHVWLQJDQLQGHSHQGHQWFRQWULEXWLRQRIERWKJHQHVWRWKHPDLQWHQDQFHRIORZOHYHOVRI
R[LGDWLYH'1$GDPDJHZLWKLQDPDPPDOLDQRUJDQLVP6XUSULVLQJO\ERWKWKHGHYHORSPHQWRIPHWDVWDVL]LQJO\PSKRPD
DQG WKH WLPH RI GHDWKZHUH VLJQL¿FDQWO\ GHOD\HG LQ WKHmutyh-­/-­  msh2-­/-­  mice   compared   to  msh2-­/-­   VLQJOH NQRFNRXWV
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a b s t r a c t
The maintenance of genetic stability is of crucial importance for any form of life. Prior to cell division
in each mammalian cell, the process of DNA replication must faithfully duplicate the three billion bases
with an absolute minimum of mistakes. Various environmental and endogenous agents, such as reactive
oxygen species (ROS), canmodify the structural properties of DNA bases and thus damage the DNA. Upon
exposureof cells tooxidative stress, anoftengeneratedandhighlymutagenicDNAdamage is7,8-dihydro-
8-oxo-guanine (8-oxo-G). The estimated steady-state level of 8-oxo-G lesions is about 103 per cell/per day
in normal tissues and up to 105 lesions per cell/per day in cancer tissues. The presence of 8-oxo-G on the
replicating strand leads to frequent (10–75%)misincorporationsof adenineopposite the lesion (formation
of A:8-oxo-Gmispairs), subsequently resulting in C:G to A:T transversionmutations. Thesemutations are
among the most predominant somatic mutations in lung, breast, ovarian, gastric and colorectal cancers.
Thus, in order to reduce the mutational burden of ROS, human cells have evolved base excision repair
(BER) pathways ensuring (i) the correct and efficient repair of A:8-oxo-Gmispairs and (ii) the removal of
8-oxo-G lesions fromthegenome.Very recently itwas shown thatMutYglycosylasehomologue (MUTYH)
and DNA polymerase ! play a crucial role in the accurate repair of A:8-oxo-G mispairs. Here we review
the importance of accurate BER of 8-oxo-G damage and its regulation in prevention of cancer.
© 2010 Elsevier B.V. All rights reserved.
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1. Functional consequences after oxidative stress
DNA is a dynamic structure, constantly subjected to changes.
Some of these changes are alterations in the chemistry of nor-
mal bases, sugar moieties and the backbone of DNA, thus leading
1568-7864/$ – see front matter © 2010 Elsevier B.V. All rights reserved.
doi:10.1016/j.dnarep.2010.03.004
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to DNA damage. Depending on the source, DNA can be damaged
by (i) spontaneous reactions, mostly by hydrolysis; (ii) products
of our metabolism, such as reactive oxygen and nitrogen species
(ROS; NOS); and (iii) exogenous physical and chemical agents [1].
Exogenous sources of DNA damage include environmental agents
such as ultraviolet (UV) light, ionizing radiation (IR), toxins, chem-
icals and pollutants [2–4]. Types of DNA damage that are produced
include double-strand breaks (DSB), single-strand breaks (SSB),
mismatches, inter- or intrastrand cross-links as well as chemical
modifications of the bases or sugar moieties [5,6].
Besides deamination, spontaneous hydrolysis and nonenzy-
matic methylation, exposure to ROS is considered to be a major
source of spontaneous DNAdamage. ROS are constantly generated:
in living organisms as byproducts of oxidative respiration in mito-
chondria, through redox-cycling events involving Fenton reactions
mediated by heavy metals, as a consequence of IR, chemother-
apeutic drugs and environmental exposure to transition metals
and chemical oxidants [7–9]. In addition ROS are also produced by
macrophages and neutrophils at the sites of infections and inflam-
mations [10]. During oxidative metabolism in mitochondria, the
majority of oxygen is converted to water (H2O) and only 0.2–2% to
ROS, due to leakage of the electrons directly to oxygen leading to
formation of superoxide anions (•O2−) [11]. Superoxide anions can
be further converted to hydrogen peroxide (H2O2), either sponta-
neously or through catalysis by superoxide dismutases. H2O2 can
be next reduced to H2O or partially reduced to a very strong oxi-
dant, the hydroxyl radical (•OH). Despite being less reactive than
someother ROS, H2O2 has an important role in generation of oxida-
tive damage and carcinogenesis due to its ability to easily diffuse
through biological membranes. This enables H2O2 to reach fast
other cellular compartments, such as nuclear DNA [12].
ROS damage vital cellular macromolecules such as proteins,
lipids andDNA [13]. The first actors in the defense against the dam-
aging effects of ROS are various antioxidants. Upon oxidative stress
the ratio of oxidants to antioxidants increases. One of the most
dramatic consequences of oxidative stress is the formation of DNA
lesions, which might result in genomic instability and can lead to
various diseases [6,14,15]. The cellular response to oxidative dam-
age involves several processes, such as DNA repair, cell cycle arrest
and apoptosis [16–18], while irreversible mutations contribute to
oncogenesis [19].
1.1. 8-oxo-guanine is the best-studied oxidative DNA damage
DNA damage caused by ROS includes a large variety of
lesions, such as base and sugar damages, DNA breaks and DNA-
protein cross-links. There are more than 100 different types
of oxidative base modifications identified in the mammalian
genome and the most important ones are documented in Fig. 1
[20,21]. The low redox potential of guanine (G) makes this base
especially vulnerable to oxidation [22]. Two main products of
G oxidation are 7,8-dihydro-8-oxo-guanine (8-oxo-G) and 2,6-
diamino-4-hydroxy-5-formamidopyrimidine (faPy-G). Eventually,
8-oxo-G can be further oxidized to produce guanidinohydan-
tion and spiroiminodihydantion. Primary products formed from
adenine (A) oxidation are 7,8-dihydro-8-oxo-adenine (8-oxo-A),
4,6-diamino-5-formamidopyrimidine (faPy-A) and ethenoadenine
(!A). Oxidation of pyrimidines leads mostly to the formation of
thymine glycol, 5-hydroxycytosine and dihydrouracil (for more
details see ref. [24]).
Among all the lesions created by ROS, 8-oxo-G is one of the
most abundant and best characterized. 8-oxo-G arises by the intro-
duction of an oxo group on the carbon at position 8 (C8) and a
hydrogen atom to the nitrogen at the position 7 (N7). The estimated
steady-state level of 8-oxo-G lesions is about 103 per cell/per day
in normal tissues and up to 105 lesions per cell/per day in cancer
Table 1
Endogenous levels of different oxidative DNA damages per human cell per day.






Lipid peroxidation products (etheno-A, etheno-C) 1000
Ring saturated pyrimidines (thymine glycol) 2000
a Data adopted from references [21,23,24].
b Estimates are for 3× 109 bp genomes.
tissues [23,24] (Table 1). The presence of 8-oxo-G is often used as a
cellular biomarker to indicate the extent of oxidative stress [9]. 8-
oxo-G in syn conformation is particularly mutagenic because of its
strong ability to functionallymimic T.When present in the genome
during DNA replication, 8-oxo-G represents a direct source of C:G
to A:T transversion mutations (Fig. 3).
1.2. Many cancers arise due to C:G to A:T transversion mutations
Somatic mutations include rearrangements and copy number
alterations, small insertions and deletions, base substitutions, as
well as epigenetic changes. These mutations occur in the genomes
of all dividing cells, both normal and neoplastic. Driver mutations
represent a class of somatic mutations that render clonal growth
advantage and are often implicated in cancer development. These
mutations are considered to be in ‘cancer genes’. Mutations that
do not contribute to the cancer development are called passenger
mutations. So far there has been limiting information about the
prevalence of somatic point mutations in human cancer genomes.
Greenman et al. [25] analyzed somatic mutations in coding exons
of 518 protein kinase genes in 210 diverse human cancers and
reported different mutational signatures between different can-
cer types. C:G to A:T transversion mutations were identified to be
among the most predominant somatic mutations in lung, breast,
ovarian, gastric and colorectal cancers.
Cigarette smoke consists of a complex mixture of over 7000
compounds, including high levels of oxidants and ROS [26]. Among
those compounds are more than 60 mutagens that can bind and
chemically modify DNA [27]. It is suggested that cigarette smoke
causes oxidative stress as well as a pro-inflammatory response in
lung cells [28]. This can significantly contribute to the develop-
ment of lung diseases, such as cancer. Lung cancer is a leading
cause of cancer-related deaths world wide, with more than a mil-
lion new patient cases identified each year [29]. Using massively
parallel sequencing technology, 22,910 somatic substitutions were
detected in a small-cell lung cancer cell line [30]. Among those C:G
to A:T transversion mutations were observed in one third (34%) of
all identified somatic substitutions. In addition, the first compre-
hensive catalogue of somatic mutations from an individual cancer
genome identified C:G to A:T mutations as second most prevalent
mutational signature in melanoma cells [31].
These very recent extensive studies of the patterns of somatic
mutations in genomes of different cancer types shed light on the
abundance of C:G to A:T transversion mutations and stress the
importance of DNA repair systems that counteract accumulation
of such events, thus preserving genome stability and integrity.
2. Base excision repair of 8-oxo-guanine
In order to repair DNA, cells have evolved differentmechanisms.
The base excision repair (BER) (Fig. 2) pathway is the primary and
essential repair system involved in the removal of damaged DNA
bases. The BER pathway is generally initiated by damage specific
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Fig. 1. The most common oxidative DNA lesions. 7,8-dihydro-8-oxo-guanine (8-oxo-G); 7,8-dihydro-8-oxo-adenine (8-oxo-A); uracil glycol; thymine glycol;
5-hydroxycytosine (5-hydroxy-C); 5-hydroxyuracil (5-hydroxy-U); ethenoadenine (etheno-A); 2,6-diamino-4-hydroxy-5-formamidopyrimidine (faPy-G) and 4,6-diamino-
5-formamidopyrimidine (faPy-A).
DNA glycosylases that recognize nucleotide lesions and excise the
damaged DNA bases by cleaving of the N-glycosylic bond between
the 2′-deoxyribose and the damaged base [32–34]. All organisms
possess several DNA glycosylases that can recognize and remove
different DNAdamages. The specificity of the BERpathway is deter-
mined by the type of the glycosylase that initiates it [32]. Based on
their reactionmechanismDNA glycosylases are classified asmono-
or bifunctional.
The monofunctional DNA glycosylases attack the anomeric car-
bonof the damagedbasewith an activatedwatermolecule, thereby
creating a free base and an apurinic/apyrimidinic (AP) site. The
major 5′ AP endonuclease, apurinic/apyrimidinic endonuclease 1
(APE1) utilizes the AP site and generates a DNA repair intermedi-
ate that contains a single-strand (ss) break with 3′-hydroxyl and
5′-deoxyribose-5′-phosphate (5′dRp) termini [35]. The 5′dRp ter-
minus is next excised by the dRp lyase activity of DNA polymerase
(pol) ! and a one nucleotide gap is created. The bifunctional DNA
glycosylases, upon recognition and excision of the damaged base,
incise by an associated AP lyase activity (! elimination activity) the
strand 3′ of the AP site. The remaining unsaturated 3′ abasic frag-
ment becomes a substrate for the APE1 and thus a one nucleotide
gap is produced.
Further DNA repair is achieved through at least two distinct
BER subpathways (Fig. 2): (i) short-patch BER (SP-BER) and (ii)
long-patch BER (LP-BER). The feature distinguishing these two sub-
pathways is the size of the repair patch synthesized by the repair
DNApol: (i) onenucleotide in the case of SP-BER [36], and (ii) two to
12 nucleotides in the case of LP-BER [37,38]. DNA pol! is themajor
repair polymerase in the SP-BER. In the LP-BER DNA pols with a
capacitiy to perform strand displacement synthesis are required,
a property that DNA pol ! and the lagging strand replicase DNA
pol " possess. Moreover DNA pol ! has been described to most
likely incorporate the first nucleotide [39], while the subsequent
elongation step is carried out by the replicative DNA pols " or #.
Additional players in LP-BER are (i) replication factor C (RF-C) that
is required to load proliferating cell nuclear antigen (PCNA) onto
the DNA, (ii) PCNA, which is the sliding clamp for DNA pols and
(iii) flap endonuclease 1 (FEN1), a structure specific nuclease that
excises the displaced oligonucleotide [40]. The final ligation step
in SP-BER is coordinated by DNA ligase III/X-ray repair cross com-
plementing 1 protein (XRCC1) complex [41] and in LP-BER by DNA
ligase I [42]. Recently an APE1-independent BER pathway has been
described [43]. Upon base excision, the endonuclease VIII (Nei)-like
proteins, NEIL1 and NEIL2, cleave DNA at the AP site by!" elimina-
tion leaving at 3′ phosphate that is then removed by polynucleotide
kinase (PNK).
To reduce the mutagenic effect of 8-oxo-G, many organisms
have developed a three-component enzyme system (termed the
‘GO system’ after 8-oxo-G). In humans this systemconsists of the (i)
8-oxo-dGTPase (MTH1), and the two BER proteins (ii) 8-oxo-GDNA
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Fig. 2. Short-patch (SP) and long-patch (LP) base excision repair (BER) pathways. For further details, see text.
glycosylase (OGG1) and (iii)MutYglycosylasehomologue (MUTYH)
[44]. MTH1 hydrolyses 8-oxo-dGTP, thus removing it from the
nucleotide pool so that it cannot be incorporated into DNA by DNA
pols. OGG1 targets the C:8-oxo-G mispair, removes the lesion and
in subsequent processing by other enzymes of the BER pathway the
C:G base pair is restored. However, when the replicative DNA pols
incoporate A opposite an 8-oxo-G, it is MUTYH that recognizes the
resultant A:8-oxo-G base pair and removes the misincorporated
A. The detailed mechanisms involving MTH1 have been reviewed
recently [45], thus we will focus here entirely on the roles of the
DNA glycosylases MUTYH and OGG1 in the repair of 8-oxo-G.
2.1. MUTYH initiated base excision repair
The Escherichia coli adenine DNA glycosylase, MutY is amember
of helix-hairpin-helix (HhH) glycosylase family.MutY is an enzyme
with mainly monofunctional DNA glycosylase and only weak and
fully uncoupled AP lyase activities [46]. This glycosylase mediates
removal of A paired with 8-oxo-G, G, faPyG, 5-hydroxyuracil or C.
Human MUTYH is encoded by the MUTYH gene, located on
the short arm of chromosome 1 (1p32.1-p34.3). MUTYH is signifi-
cantly larger than the bacterial protein and consists of catalytic core
domainwith an [4-Fe–4S] iron sulfur cluster in N-terminus [47,48],
followed by an additional C-terminal MutT-like domain [49]. The
extendedN-terminaldomain is involved inmitochondrial targeting
of MUTYH and interaction with replication protein A (RP-A) while
the C-terminal domain contains the nuclear localization sequence
and thePCNA interactingmotif [52–56]. There are at least two types
of MUTYH protein: a mitochondrial and a nuclear form [52].
The full-length structure of MutY cross-linked to DNA contain-
ing anA:8-oxo-Gmispair hashelped tounderstandhowtheprotein
recognizes both A and 8-oxo-G [50,51]. The catalytic core and the
MutT-like domains, both encircle the DNA, individually making
close contacts to the appropriate DNA strand. The A is than flipped
out into a deep active site pocket, which gets engaged in multiple
direct hydrogen bonding and hydrophobic interactions [51], while
8-oxo-G stays in the base stack. The MutT-like domain establishes
extensive contacts with 8-oxo-G, which in anti conformation gets
stabilized in the MutY complex structure. Further, through acid-
catalyzed protonation of the nucleobase, glycosidic bond cleavage
is promoted. Interestingly,whenmispaired oppositeA, the 8-oxo-G
in syn conformation is the energetically favored conformer.
The MUTYH activity can be modulated through interaction
with other proteins. APE1 physically interacts with MUTYH [55]
and enhances the MUTYH glycosylase activity [57]. Interestingly,
this effect is independent of the APE1 endonuclease activity [57].
MUTYH also directly associateswith both PCNA and RP-A [55]. This
is of great importance since, in order to prevent mutations during
DNA replication, theMUTYH activitymust be directed to the newly
synthesizedstrand. Indeed, itwas shownthatDNAreplicationstim-
ulates theMUTYH initiated repair of A:8-oxo-Gmispairs in vivo and
interaction between MUTYH and PCNA is critical for this repair to
occur [58]. In addition, MUTYH efficiently co-localizes with PCNA
at replication foci [59].
2.2. OGG1 initiated base excision repair
The human OGG1 DNA glycosylase shares a significant homol-
ogy with the Saccharomyces cerevisiae OGG1, but not with E. coli
Fpg enzyme. All three enzymes are bifunctional DNA glycosylases
with an associated AP lyase activity and ability to excise 8-oxo-G
and faPyGwhen present in the DNA [60–69]. Finally, OGG1 can also
remove 8-oxo-A [70,71].
Human OGG1 is present in at least four different splice forms
[72]. The two most abundant ones have distinct cellular localiza-
tions. The ! form of OGG1 is targeted in the nucleus and " form
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Fig. 3. Model of the different pathways to repair 8-oxo-guanine. Upon oxidation in the nucleus 8-oxo-G damage and 8-oxo-dGTP are produced among others (see Fig. 1).
If 8-oxo-dGTP becomes utilized during DNA replication, it could be misincorporated opposite an A in the template strand (upper right). The resulting A:8-oxo-G mispair
may further be processed and damage removed by MMR components, such as MutS and MulL. To repair this 8-oxo-G damage created in the DNA several pathways can
be activated. (1) The majority of 8-oxo-G damages is removed by OGG1 mediated SP-BER. Upon the removal of the damage, DNA pol ! is recruited and the final ligation
step is mediated by DNA ligase III/XRCC1. NEIL1 or 2 could also play a role in this process. (2) When the damage is not removed before the DNA replication takes place,
replicative DNA pols " and # with a high frequency inaccurately incorporate dAMP opposite 8-oxo-G. The resulting mispair in the next round of replication leads to C:G to
A:T transversion mutations (right). If during DNA replication a correct dCMP gets incorporated opposite 8-oxo-G (left), in the subsequent step the damage will be removed
by OGG1mediated SP-BER as shown in (1). (3) In order to prevent C:G to A:T transversion mutations, A:8-oxo-G mispair is recognized by MUTYH in post-replicative LP-BER.
Upon the removal of the inaccurate A by MUTYH and APE1, DNA pol $ in the presence of RP-A, PCNA and RF-C mediates accurate bypass by incorporating dCMP opposite
8-oxo-G and further elongating. The created flap is removed by FEN1 and DNA ligase I ligates a nick. In the subsequent OGG1 mediated SP-BER damage is removed. For
simplicity RP-A, PCNA and RF-C are not shownnext to DNApol$. (4) Upon the removal of A from the A:8-oxo-Gmispair byMUTYH andAPE1, repair synthesis can bemediated
by a rather inaccurate DNA pol, or in minority of cases by DNA pol $, resulting in formation of new A:8-oxo-G mispair. In subsequent SP-BER ligation of the nick is mediated
by DNA ligase III/XRCC1. If this newly formed mispair becomes a substrate for DNA replication, C:G to A:T transversion mutations will occur. (5) When the transcription
machinery encounters damaged DNA containing an A:8-oxo-G mispair TCR could possibly occur. CSA and CSB might play a role in this process. Note; XPC is not presented
in this model, as there are not many indications at which step of 8-oxo-G repair this protein would be involved. For further details, see text.
in the mitochondria [56]. OGG1 contains two DNA binding motifs,
a HhH and a Cys2-His2 zinc finger like motif. The general fea-
tures used by OGG1 to recognize the lesion are well illustrated
by the crystallographic X-ray analysis of the catalytically inac-
tive mutant of OGG1 [73]. Upon DNA binding, the C:8-oxo-G base
pair is disrupted and the 8-oxo-G flipped out of the double helix,
while the enzymeundergoes local conformational changes induced
by the preference for C in the opposite strand. Although OGG1
makes many specific connections with both nucleotides, only one
hydrogen-bonding contact would not be possible with undamaged
G. This is a bond between carbonyl oxygen of Gly42 of OGG1 and
the hydrogen at position N7 of the 8-oxo-G. However, it is unlikely
that the mechanism of the specificity for 8-oxo-G relays on a sin-
gle hydrogen bond, so the mechanism for the discrimination is
probably more complex. Upon excision of 8-oxo-G, OGG1 further
utilizes the damaged base as a cofactor in the subsequent !-lyase
cascade [74]. Several studies have indicated that OGG1 initiated
repair is following the SP-BER pathway [75,76] (Fig. 3). In this pro-
cess, DNA pol ! seems to be responsible for the re-synthesis step.
DNA pol !-deficient mouse cells exhibit a very low efficiency of
C:8-oxo-G base repair, thus suggesting a direct involvement of SP-
BER [75]. The in vitro reconstitution of BER of 8-oxo-G by using
humanenzymes, show that four proteins play a crucial role, namely
OGG1, APE1, DNA pol ! and DNA ligase I [77]. By addressing the
subnuclear redistribution of the proteins initiating the repair of 8-
oxo-G under oxidative stress conditions, recruitment of OGG1 to
the open euchromatic regions is reported [78]. At the same time
OGG1 is completely excluded from heterochromatin. This indi-
cates that upon induction of oxidative damage DNA glycosylases
are actively recruited to the regions of open chromatin.
Even though OGG1 initiated repair is the best characterized and
themost important for recognition of C:8-oxo-G base pairs, several
lines of the evidence indicate that this is not the only repair mech-
anism for the elimination of 8-oxo-G from genomic DNA [79,80].
Extracts from OGG1-deficient mouse embryonic fibroblast repair
8-oxo-G, although slowly and not very efficiently. Thus, beside the
GO system, cells likely possess alternative repair pathways that can
handle 8-oxo-G damage.
3. Additional DNA repair mechanisms involved in
8-oxo-guanine repair
Besides BER, other repair pathways are also important for the
repair of oxidative DNA lesions. The nucleotide excision repair
(NER) pathway recognizes helix-distorting base lesions, a broad
category of damage that affects one of the two DNA strands
[19,81,82]. A repair pathway closely linked toNER and possibly BER
is transcription-coupled repair (TCR). This pathway targets lesions
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Table 2
Proteins involved in the repair of 8-oxo-guanine.
Protein Function
OGG1 DNA glycosylase, AP lyase, removes 8-oxo-G
pared opposite C and formamidopyrimidines
MUTYH DNA glycosylase, removes A paired opposite
8-oxo-G
NEIL1 DNA glycosylase, AP lyase, removes 8-oxo-G
paired opposite C
NEIL2 DNA glycosylase, AP lyase, removes 8-oxo-G
when present in bubble structures
APE1 AP-endonuclease, 3′-phosphodiesterase
PNK 3′-phosphatase
DNA polymerase ! DNA polymerase, dRP lyase
DNA polymeras " DNA polymerase, dRP lyase
DNA polymerases # and $ DNA polymerase, 3′ →5′ exonuclease
PCNA Auxiliary protein of DNA polymerases
RF-C Loads PCNA AAA ATPase
RP-A Auxiliary protein of DNA polymerases
DNA ligase III/XRCC1 DNA ligase
FEN1 Flap endonuclease. 5′ →3′ exonuclease
DNA ligase I DNA ligase
hMTH1 8-oxo-dGTPase
hMSH2 Recognition of DNA mismatches
hMLH1 Repair of DNA mismatches
CSB Repair of 8-oxo-G from the overall genome
CSA Repair of 8-oxo-G from the overall genome
XPC Repair of 8-oxo-G from the overall genome
thatobstruct transcription [83,84]. Inmismatch repair (MMR) small
insertion/deletion loops and mismatched bases that result from
replication errors or polymerase slippage are removed [85,86].
Additionally, some other DNA lesions are not repaired, but stay
present in the genome and are bypassed during DNA replication by
DNA pols that tolerate less stringent base pairing than replicative
DNA pols [87].
BesidesMUTYH andOGG1, the twoDNA glycosylases NEIL1 and
NEIL2 (Table 2) couldpossibly be involved inBERof 8-oxo-G (Fig. 3).
Both NEIL1 and NEIL2 are bifunctional DNA glycosylases with a
broad substrate range. Preferred substrates of NEIL1 are faPy-A,
faPy-G, 5-hydroxyuracil or thymine glycol. NEIL1 can additionally
excise an 8-oxo-G from a duplex DNA containing C:8-oxo-G base
pair [88]. NEIL2 can also excise 8-oxo-G, but onlywhen it is present
inside of a bubble structure, while the ability of NEIL1 and OGG1 to
excise 8-oxo-G from a bubble is almost completely lacking [89].
Since the bubble structure mimics a transcription intermediate,
NEIL2 could be involved in the TCR. NEIL1 is specifically activated
in the S-phase, suggesting that it could play a role in the removal
of base lesions prior the replication [90]. NEIL1 can also stimulate
OGG1, but these two DNA glycosylases do not stably interact [91].
OGG1 alone has a low turnover, but in the presence of NEIL1, sim-
ilarly to APE1, its turnover is increased [91]. Both NEIL1 and NEIL2
interact with the BER proteins DNA pol! andDNA ligase III [43,92].
In addition NEIL2 is isolated from human cells in a complex with
the BER proteins DNA pol !, DNA ligase III/XRCC1 and PNK, but not
with APE1 [92].
The MMR system, coordinated by the hMutS and hMutL pro-
teins, is the best-studied pathway for the correction of replication
errors (Table 2). DNA glycosylases like MUTYH compete with the
MMR machinery for the binding and processing of mispairs, such
as A:8-oxo-G [57]. DNA glycosylases eliminate the DNA damage
irrespectively whether it is located in the template or the nascent
strand during DNA synthesis. Thus, if under these conditions a DNA
glycosylase gets access to amispair, the template strandwill be cor-
rected, thereby generating a mutation [93]. It has been suggested
that the interaction of MUTYH with PCNA is crucial for the ori-
entation of MUTYH to the newly synthesized DNA strand [55,59].
Discriminationbetween templateandnascent strandestablished in
this way would (i) allowMUTYH to excise A that gets incorporated
opposite a template 8-oxo-G (G or C) only, (ii) while preventing
MUTYH mutagenic processing of the parental A following misin-
corporation of 8-oxo-dGTP (Fig. 3). Furthermore it has been shown
that the humanMMR proteins hMSH2 and hMSH6, components of
MutS% complex, bind to the A:8-oxo-G mispair and that hMSH6
interacts with MUTYH [94]. Binding of hMutS% to a substrate con-
taining an A:8-oxo-G mismatch is not affected by MUTYH. On the
other hand, the specific binding affinity of MUTYH to an A:8-oxo-G
mismatch is enhanced by hMutS%. Inactivation of the Msh2 gene
leads to a mutator phenotype and increased cancer susceptibility
[95]. The 8-oxo-G levels in several organs of hMSH2/MUTYH-
deficient animals are significantly higher than in the organs of
single knock-out animals, suggesting that in vivoMSH2andMUTYH
provide separate repair functions and contribute independently to
the control of oxidativeDNAdamage.AnotherMMRproteinhMLH1
seems also to play a role in the 8-oxo-G repair, since cells defective
in MMR, due to silencing of the hMLH1 gene, have 4-fold higher
levels of 8-oxo-G than parental MMR-proficient cells [96].
Published data suggest a possible role of both the Cockayne
syndrome B (CSB) and A (CSA) proteins in the repair of 8-oxo-G
(Table 2). Both CSA and CSB are components of transcription-
coupled nucleotide excision repair (TC-NER) and assist RNApol II in
dealing with transcription blocking lesions [19]. Human cells lack-
ingCSBarehypersensitive to&-irradiation anddefective in repair of
8-oxo-G damage. Accordingly, 8-oxo-G accumulates more in CSB-
deficient cells than in wild type cells after exposure to &-radiation
[97]. In human CSB-deficient cells OGG1 protein and mRNA lev-
els are lower than in wild type cells [98]. In addition, CSB and
OGG1 co-localize upon &-irradiation, but do not physically inter-
act. Depletion of the CSB protein from human whole cell extracts
leads to a reduction in the incision rate of 8-oxo-G [98]. This directly
suggests the possible effect of CSB in the catalytic process of 8-oxo-
G removal. Furthermore, CSB interacts with other BER proteins,
such as APE1 [99]. Similarly to CSB, CSA is involved in the response
to oxidative stress. Human primary fibroblasts defective in CSA
show hypersensitivity to potassium bromate (KBrO3), a specific
inducer of oxidative damage [100]. Even though several studies
show that CS proteins are involved in the repair of 8-oxo-G, the
exact mechanism is still unknown. 8-oxo-G does not represent a
strong transcription block and is efficiently bypassed in inaccurate
fashion by RNA pol II [101–103]. Recent measurements of changes
in gene expression upon presence of oxidized guanine residues
bring some new insight in the possible interplay between CSB and
OGG1 [104]. The absence of OGG1 does not have a strong effect on
the gene expression. In contrary lack of CSB activity leads to the
inactivation of the genes containing oxidized bases. Interestingly
this effect was attenuated by an additional OGG1 deficiency. This
implicates that CSB could ensure the transcription functions in the
process of DNA repair (Fig. 3) and accelerate the completion of DNA
repair;whileOGG1wouldplayadual role in initiationofDNArepair
and gene inactivation [104].
Another member of the NER pathway, the Xeroderma Pigmen-
tosum complementation group C (XPC) protein, might also be
involved in 8-oxo-G repair. Human primary skin cells derived from
XPC patients are hypersensitive to oxidants and exhibit a slower
8-oxo-G repair rate [105]. Complementation of these cells with the
XPC wild-type gene product rescues the hypersensitivity as well
as the defective DNA repair phenotype. Similarly, mice deficient in
XPCdisplayanelevated sensitivity tooxidativedamage, resulting in
lung carcinogenesis [106]. In addition, lympohocytes of those mice
contain increased levels of hprt spontaneousmutations, in particu-
lar C:G to A:T transversionmutations [107]. XPC has been shown to
enhance the activity ofOGG1, possibly throughactivedisplacement
of DNA glycosylase from its product, the AP site [105]. This effect
is abrogated in cells from patient with neurological symptoms that
have a single mutation in XPC [108]. The P334H mutation thwarts
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the interaction between XPC and OGG1, thus preventing the OGG1
stimulation.
4. Cells require a repair DNA polymerase that can
accurately bypass 8-oxo-guanine
Asmentioned above, the 8-oxo-G is efficiently, but inaccurately
bypassed by the replicative DNA pols [109], resulting in the forma-
tionof a stableA(anti):8-oxo-G(syn)Hoogsteenmispair (Fig. 3). This
mispairmimics a normal base pair and is not detected by the 3′ →5′
exonuclease proofreading activity of the replicative DNApols ! and
". In order to reduce themutational burden of ROS, the repair is ini-
tiatedbyMUTHYglycosylase that recognizes theA:8-oxo-Gmispair
and removes the A. During subsequent BER, cells need a specialized
repair DNA pol that will catalyze with high preference the accurate
bypass of 8-oxo-G.
In vitro studies have indicated that several DNA pols may be
involved in BER [110–112]. DNA pol #, a member of DNA pol
family X, was shown to be the major enzyme involved in gap
filling [39,113,114], thus playing a central role in BER [115,116].
Another member of the DNA pol family X, DNA pol $ [117], has
been implicated in BER [110,118], non-homologues end joining
[119,120] and translesion synthesis [109,121,122]. In addition, ear-
lier investigations suggested that the LP-BER pathway, involving
aphidicolin-sensitiveDNApols, such asDNApols! and ", is respon-
sible for the repair of A:8-oxo-G mispairs [39,123]. However it is
not known whether the aphidicolin sensitive DNA pols catalyze
both insertion opposite 8-oxo-G and extension, or the extension
only, since both DNA pol ! and " are significantly inaccurate during
8-oxo-G bypass [109].
We have recently shown that DNA pol$ is very efficient in accu-
rate bypass of 8-oxo-G lesion both on primed and one nucleotide
gapped DNA templates [109,124,125]. On the other hand, human
DNA pols %, ! and & show a much lower fidelity than DNA pol
$ to incoporate the correct dCMP [109]. Moreover, the two aux-
iliary proteins PCNA and RP-A are able to additionally promote
accurate gap filling by DNA pol $. In the presence of RP-A and
PCNA, DNA pol $ incorporates dCMP opposite 8-oxo-G on a one
nucleotide gapped template 750-fold better than dAMP [124]. At
the same time, these two auxiliary proteins prevent binding of
DNA pol # to one nucleotide gapped 8-oxo-G template. Overall,
the presence of RP-A and PCNA results in a 145-fold more efficient
DNA pol $ than DNA pol # incorporation of dCMP opposite 8-oxo-
G on one nucleotide gaps [124]. Immunofluorescence experiments
in cells exposed to ROS suggest the involvement of MUTYH and
DNA pol $ in the 8-oxo-G repair [125]. Additionally, upon treat-
ment of the cells with H2O2, a dramatic increase in protein levels
of MUTYH and DNA pol $ is observed, directly indicating the acti-
vation of MUTYH/DNA pol $-dependent repair pathway [125]. A
cross-linking assay with human whole cell extracts provides evi-
dence that MUTYH, DNA pol $, PCNA, FEN1 and DNA ligases I and
III are the crucial components of A:8-oxo-G repair pathway [125].
In vitro reconstruction experiments further show that the accurate
repair of A:8-oxo-G mispairs involves MUTYH, DNA pol $, FEN1
and DNA ligase I [124] (Fig. 3). However, it is suggested that when
DNA pol $, or one of the other repair DNA pols, incorporates dAMP
opposite 8-oxo-G, an inaccurate loop is initiated. The ligation step
in this loop is mediated by DNA ligase III/XRCC1, resulting in the
formation of the product that contains an A:8-oxo-G mispair [125]
(Fig. 3). The product of this step could possibly be further recog-
nized by MUTYH and APE1, thereby creating another chance for
the accurate repair to occur.
The X-ray crystal structure of the catalytic domain of human
DNA pol $ helps in understanding why exactly DNA pol $, and not
anyotherof theDNApols fromXfamily, has sucha remarkablepref-
erence for accurate bypass of 8-oxo-G. A structure of human DNA
pol$ in complexwithprimer/template containing a twonucleotide
gap shows thatDNApol$has twoDNAbinding sites that bendDNA,
thereby exposing the 3′ primer terminus [126]. The polymerase
domain binds the primer terminal base pair and the upstream
duplex, while the 8kDa domain binds the DNA downstream of
the gap. The interactions between the polymerase domain and the
duplex DNA upstream of the primer 3′ terminus are not extensive
[126]. Furthermore, the template-binding groove in DNA pol $ is
not as positively charged as in DNA pol #, suggesting weaker inter-
actionswith the template strand [127]. This feature could be crucial
for the accurate bypass of 8-oxo-G damage. However, the binding
of the DNA downstream of the gap is predominantly mediated via
the interaction of 5′ terminus of the gapwith the positively charged
residues of the 8kDa domain. This binding is further enhanced by
thepresenceof 5′ terminal phosphate,whichat the same timestim-
ulates the DNA pol $ polymerase activity on a gapped substrate
[127]. A very recent crystal structure reveals that DNA pol $, upon
binding to 2nt gapped double-stranded DNA, “scrunches” the tem-
plate strand and binds the additional uncopied template base in
an extrahelical position within a highly conserved binding pocket
[128]. Mutation of the amino acids within this pocket into alanine
results in less processive gap filling and less efficient DNA repair
[128]. Thus, scrunching of the template strand by DNA pol $ likely
occurs during gap filling DNA synthesis and is of advantage to the
repair of 8-oxo-G.
Though the present data strongly suggests the role of DNA pol
$ in BER and the repair of 8-oxo-G, many questions still stay unan-
swered. Among all, it remains to be explored how the MUTYH and
DNA pol $ coordinated repair of A:8-oxo-Gmispairs is achieved on
the chromatin and how is it regulated.
5. Regulations of the key proteins involved in the repair of
8-oxo-guanine
The importance of the proper function of the BER pathway has
become evident from numerous clinical studies. Mutations in BER
proteins observed in various humanpathologies provide extremely
interesting and informative data and contribute to better under-
standing of the role of those proteins in vivo. The components of
DNA damage repair have to be tightly regulated in order to ensure
their proper and timely function. In addition to mutations that
directly affect the protein activity, mere dysregulation of some of
the components of theDNArepairmachinerymightwell contribute
to the development of human diseases [129]. Since the relevance
of mutations in components of BER pathway in human pathologies
has been reviewed recently [6,14],wewould like to focus in this last
chapter on what is known about the regulation of MUTYH, OGG1
and DNA pol $more in detail.
5.1. Regulation of MUTYH
Data alluding to how MUTYH is regulated in vivo exist, but
no detailed mechanism has been established yet. Findings from
Boldoghet al. [59] showthatnuclearMUTYHco-localizeswithBrdU
and PCNA at replication foci. Furthermore, nuclear levels ofMUTYH
increase 3- to 4-fold during progression through the cell cycle and
to reach a maximum in S phase compared to early G1 phase. These
data are in line with findings of Hayashi et al. [58] who, by inves-
tigating A:8-oxo-G repair in an in vivo repair system, observed a
14-fold higher repair efficiency when a replication-proficient sub-
strate was used compared to a not replicating one. In addition, the
replication-associated repair of A:8-oxo-G byMUTYH is dependent
on its interactionwith PCNA. These findings are in clear accordance
with a replication-associated activity of MUTYH.
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Table 3
Post-translational modifications of key proteins involved in BER of 8-oxo-guanine.
Protein Post-translational modification
OGG1 Phosphorylation [149,150], acetylation [152]
MUTYH Phosphorylation [131]
APE1 Phosphorylation [153–155], acetylation [156], ubiquitination [157]
DNA polymerase ! Phosphorylation [134,135], ubiquitination [135]
DNA polymerase " Phosphorylation [158,159], acetylation [160], methylation [161], ubiquitination [136,137]
DNA polymerase # Phosphorylation [162,163], SUMOylation [164], ubiquitination [164]
PCNA Phosphorylation [165], acetylation [166], SUMOylation [133,167], ubiquitination [133,167]
RF-C Phosphorylation [168,169], ubiquitination [170]
RP-A Phosphorylation [171–174]
XRCC1 Phosphorylation [175–177], SUMOylation [178], ubiquitination [179]
DNA ligase III Phosphorylation [180]
FEN1 Phosphorylation [181,182], acetylation [183–185]
DNA ligase I Phosphorylation [186–188]
Very little is known about post-translational modifications of
MUTYH. Parker et al. [130] investigated the role of MUTYH in a cell
line displaying a C:G to A:T transversionmutator phenotype. Inter-
estingly, the observed phenotype was not caused by a mutation in
the MUTYH gene, but rather by a decrease in MUTYH mRNA and
protein levels. Subsequent work by the same group showed that
MUTYHisphosphorylatedbyproteinkinaseC (PKC) in vitroand that
this phosphorylation enhancesMUTYHA:8-oxo-G repair activity in
vitro [131] (Table 3). Accordingly, treatment with the PKC activator
phorbol-12-myristate-13-acetate (PMA) leads to phosphorylation
of MUTYH and to an increase in A:8-oxo-G repair activity. This
increase is abolished upon immunodepletion of MUTYH from the
cell extracts and leads to a decrease in the elevated 8-oxo-G levels.
Even thoughphosphorylationofMUTYHbyotherkinases cannotbe
excluded, these findings implicate that phosphorylation of MUTYH
is a prerequisite for its stabilization and activity and it remains to be
investigated in further detail. In addition, the findings by Parker et
al. support the idea that dysregulation of components of BERmight
contribute to the generation of mutations in a similar extent as a
germline mutation in one of the genes encoding the BER proteins
does.
MUTYH and the Rad9-Rad1-Hus1 complex (9-1-1 complex)
interact in vitro and this interaction stimulates MUTYH activity in
vitro [132]. In addition Rad9 and MUTYH co-localize in HeLa cells
upon treatment with H2O2, suggesting that either MUTYH serves
as a sensor for DNA damage, subsequently recruiting the 9-1-1
complex to the damage, or that the 9-1-1 complex is loaded inde-
pendently of MUTYH onto damaged DNA, merely stimulating its
activity. Further studies are needed in order to shed more light
on the function, regulation and consequences of the interaction of
these two proteins.
Taken together, it would be extremely interesting to inves-
tigate the cell-cycle phase dependent association of PCNA with
MUTYH more closely, thus possibly gaining better insight into the
regulatorymechanisms of this interaction. Post-translationalmod-
ifications, such as ubiquitination or SUMOylation of PCNA at Lysine
164 (reviewed in [133]) or phosphorylation of MUTYH represent
an intriguing possibility for such a subtle regulation.
5.2. Regulation of DNA polymerase !
The first data about regulation of DNA pol ! in vivo came from
a study performed in our laboratory by Frouin et al. [134], show-
ing that the cyclin-dependent kinase 2 (Cdk2)-cyclin A complex
interacts with and phosphorylates DNA pol ! in vitro in the prolin-
serine rich domain (Table 3). This phosphorylation does not affect
DNA pol ! polymerization activity and is decreased when PCNA
interacts with DNA pol !. Finally, phosphorylation of DNA pol !
in vivo during the cell cycle mimics the phosphorylation pattern
of Cdk2-cyclin A. In a follow-up study, Wimmer et al. [135] could
demonstrate that DNA pol ! is phosphorylated at Threonine 553
and that this phosphorylation protects the enzyme from being
ubiquitinated (Table 3) and subsequently degraded via the protea-
somal pathway. This phosphorylation and subsequent stabilization
takes place in the late S and G2 phase, consistent with a possible
role of DNA pol ! in the post-replicative repair of A:8-oxo-G mis-
pairs. It remains to be investigated howand towhat extent DNApol
! is regulated in vivo. Post-translationalmodifications such as ubiq-
uitination, as has been shown for DNA pol " [136,137], represent
one possible means of regulation, and the role of phosphorylation
in the stability and subcellular localization of DNA pol ! remains to
be elucidated in more detail.
5.3. Regulation of OGG1
The regulation of OGG1 has been investigated by various
approaches, but the completemechanism is not completely under-
stood yet. When investigating the OGG1 promoter, Dhénaut et al.
[138] found a lack of TATA or CAAT boxes, suggesting that OGG1
is a housekeeping gene. In line with this finding is also the notion
that OGG1 expression does not vary during the cell cycle. Lee et al.
[139] show an up-regulation of OGG1 expression in HCT116 cells
treatedwithMMS through the induction of the transcription factor
nuclear factor YA (NF-YA). This increase further correlates with an
increase in enzyme activity, providing to the cell functional protec-
tion fromMMS. Interestingly, OGG1mRNA or protein levels do not
change upon the treatment of HCT116 cells by H2O2 [138]. Induc-
tion of OGG1 by oxidative stress seems to be tissue- and cell-type
dependent, as there are several reports showing an induction (e.g.
[140,141]), while others find no change in OGG1 levels upon treat-
mentwith oxidative agents (e.g. [138]). Habib [142] defined a novel
mechanism of regulation of OGG1 through Tuberin in HEK andMEF
cells. Knockdown of Tuberin in those cells leads to a downregula-
tion of OGG1 and accumulation of 8-oxo-G, with NF-YA acting as
important regulator of OGG1 transcription.
The activity of the repair enzyme OGG1 in the nucleus is upreg-
ulated significantly by regular exercise in rats [143] and activation
of OGG1 and other BER components by ischemia may contribute
to neuroprotection by enhancing the repair of endogenous oxida-
tive DNA damage after ischemic injury [144,145]. Observation of
age-dependent down-regulation of OGG1 in accelerated senes-
cence mice hints towards an involvement of OGG1 activity in
age-dependent diseases [146]. Mirbahai et al. showed that induc-
tion of OGG1 activity upon KBrO3 treatment is not a result of
induction of OGG1 gene expression, but rather protein stabilization
[147]. Taken together, there seem to be multiple layers and mech-
anisms of induction of OGG1 expression that are either cell-type or
damage specific.
Amouroux et al. [78] revealed that induction of 8-oxo-G leads
to recruitment of OGG1 to euchromatin regions rich in RNA and
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RNA pol II while being completely excluded fromheterochromatin.
This recruitment does not require direct interaction of the pro-
tein with the oxidized base. Results by de Souza-Pinto et al. [148]
indicate that RAD52 interacts with OGG1 in vitro and in vivo, coop-
erates with OGG1 to repair oxidative DNA damage and enhances
the cellular resistance to oxidative stress. OGG1 is shown to be
preferentially associated with chromatin and the nuclear matrix
during interphase and to becomeassociatedwith chromatin during
mitosis. Recently, OGG1 has been suggested to be a microtubule-
associated protein during interphase and mitosis. In this way, by
“riding” on microtubules, the redistribution of OGG1 within the
cell might be facilitated [149]. Finally, there is one report concern-
ing the degradation of OGG1, showing that upon oxidative stress
and cisplatin exposure, OGG1 is degraded in a Calpain-dependent
manner [150].
OGG1 was shown to be phosphorylated (Table 3) on a serine
residue in vivo possibly by PKC [149]. Additionally, the kinases
cyclin-dependent kinase 4 (Cdk4) and cellular Abelson murine
leukemia viral oncogene homolog 1 (c-Abl) phosphorylate and
interact with OGG1 in vivo. The phosphorylation of OGG1 by Cdk4
stimulates its 8-oxo-G incision activity in vitro [151]. OGG1 was
also shown to be acetylated by p300 (Table 3). This acetylation pre-
dominantly takes place at the residues K338 and K341 and results
in an enhancement of OGG1 activity in vitro and in vivo [152]. Thus,
there is extensive data underlining OGG1 role in 8-oxo-G repair in
vivo, but many questions remain to be elucidated. How, when and
where theexpressionofOGG1 is regulated, how it is recruited to the
chromatin parts that are in need of repair and what determines its
stability are just some of thematters that remain to be investigated
in the future.
6. Conclusions and perspectives
OxidationdamagebyROS is a frequent event in any livingorgan-
ism. High levels of ROS can lead to mutations, possibly result in
transformation and eventually give rise to cancer. We have sum-
marized the actors thatmight be important to keep the steady-state
level of oxidative damage low enough not to harm an organ-
ism. Basic ideas and mechanisms about the repair possibilities
are known, but we are still at an early stage of understanding
the complete pathways in detail. As can be seen from Table 3
and the references therein, most components of the BER pathway
are shown to be post-translationally modified by phopshorylation,
acetylation, methylation, ubiquitination and SUMOylation [153].
Upon genotoxic stress, these modifications give numerous possi-
bilities to regulate the repair actors in time and space. Studies of
recruitment ofmodified proteins to chromatin during the cell cycle
and under various stress conditions should further illuminate the
repair processes.
In conclusion, a more thorough understanding of the exact
mechanisms that help cells to cope with oxidative DNA damage,
in particular 8-oxo-G, is needed. This should lead to new insights
and understanding as to what is going wrong when malignancies
arise and, more important, how to combat them.
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FRPSOH[HV WKDWJXDUDQWHH WKHFRUUHFWVSDWLDODQGVWUXFWXUDODUUDQJHPHQWRI WKLVKXJHFRPSDFWPROHFXOH'XH WR WKH
FRPSOH[LW\RIWKLVVWUXFWXUHLWVHHPVORJLFDOWKDWWKHDFFHVVLELOLW\IRUUHSDLUFRPSOH[HVRIR[LGDWLYH'1$GDPDJHFDQ
EHUHVWULFWHGE\GLIIHUHQWFKURPDWLQFRQ¿JXUDWLRQVDVZDVGHPRQVWUDWHGLQDVWXG\E\.KRURQHQNRYDet  al7KH\
provide  evidence  that  chromatin  remodeling  mediated  by  the  deubiquitinating  enzyme  USP7  is  important  for  BER  of  
R[LGDWLYHOHVLRQVDVWUDQVLHQW863NQRFNGRZQGLGQRWFKDQJHWKHOHYHOVRUDFWLYLW\RI%(5HQ]\PHVEXWVLJQL¿FDQWO\
reduced  chromatin  DNA  accessibility  and  consequently  the  rate  of  repair  of  oxidative  lesions.  
Not  only  the  chromatin  status  but  also  the  differentiation  state  of  a  cell  seems  to  play  a  role  in  determining  its  capacity  
WRSHUIRUPR[LGDWLYH'1$GDPDJHUHSDLUDVVKRZQLQDVWXG\XVLQJXQGLIIHUHQWLDWHG(6FHOOVRU(6FHOOVGLIIHUHQWLDWHG
IRUDQGGD\V$PRXQWVRIR[R*DQGWKHH[SUHVVLRQOHYHOVRI2JJ0XW<+DQG07+LQWKHFHOOVZDV





DQGFHOOGLYLVLRQ+RZHYHULWZDVVKRZQLQSaccharomyces  cerevisiaeS.cerevisiae)  that  mutations  arising  during  times  
of  cell  cycle-­arrest  stemming  from  endogenous  oxidative  stress  might  considerably  contribute  to  aging  and  carcinogenesis  
$GLVWLQFWLQFUHDVHLQ526LQWKHFRXUVHRIVWDUYDWLRQLQGXFHGFHOOF\FOHDUUHVWDQGDQDFFXPXODWLRQRIDSXULQLF
DS\ULPLGLQLFVLWHV$3VLWHVDQG'6%VXQGHUWKHVHFRQGLWLRQVFRXOGEHREVHUYHGVXSSRUWLQJWKHK\SRWKHVLVWKDWWKH
LQFLGHQFHRI VSRQWDQHRXV IUDPHVKLIWPXWDWLRQV LQ D FHOO F\FOHDUUHVWHG VWDWH LV FRQVLGHUDEO\ LQÀXHQFHGE\R[LGDWLYH
stress.
5HFHQWO\ LQVWHDG RI RQO\ FRQFHQWUDWLQJ RQ WKH UHSDLU RI VLQJOH LVRODWHG OHVLRQV RFFXUULQJ LQ'1$ WKH DWWHQWLRQ RI
researchers  has  also  been  shifting  toward  investigation  of  the  repair  of  so-­called  ‘clustered  DNA  lesions’.  A  clustered  
'1$OHVLRQLVGH¿QHGDVWKHRFFXUUHQFHRIWZRRUPRUHGDPDJHVLQWKH'1$ZLWKLQRQHWRWZRKHOLFDOWXUQVXVXDOO\
only  induced  by  ionizing  radiation  and  certain  chemicals  in  this  non-­random  way.  Such  lesion  clusters  are  more  toxic  
WRFHOOVWKDQLVRODWHGOHVLRQVDQGDOVRDUHWKHUHDVRQZK\LRQL]LQJUDGLDWLRQDQGEOHRP\FLQVXOIDWHDUHPRUHHI¿FLHQWLQ
killing  cells  than  damage  produced  by  ROS  as  H2O2.  The  question  what  happens  if  instead  of  single  lesions  8-­oxo-­G  is  
present  in  a  whole  cluster  of  DNA  damage  was  addressed  in  an  interesting  paper  by  Eccles  et  al)RUWKLVVWXG\V\QWKHWLF
oligonucleotides  with   three-­lesion   clusters   containing  AP   sites   and   8-­oxo-­G   lesions  were   utilized.  They   found   that  
$3VLWHVFORVHWRDQR[R*OHDGWRWKHIRUPDWLRQRI'6%VSUREDEO\DULVLQJYLDOHVLRQSURFHVVLQJUDWKHUWKDQVWDOOHG
UHSOLFDWLRQLQF\FOLQJFHOOV7KLVVWXG\SURYLGHVHYLGHQFHWKDWLWLVQRWRQO\WKHGLUHFWIRUPDWLRQRI'6%VWKDWKDV
implications  for  cell  survival  but  that  non-­DSB  clusters  can  be  converted  into  DSBs  during  processing  and  attempted  
UHSDLU)RUPRUHGHWDLOVFRQFHUQLQJ WKH¿HOGRIFOXVWHUHG'1$OHVLRQV LQ\HDVWDQGPDPPDOLDQFHOOV VHH WKH UHFHQW
UHYLHZE\6DJHDQG+DUULVRQ
1HZLQVLJKWVUHJDUGLQJWKHRFFXUUHQFHDQGUHSDLURIR[LGDWLRQGDPDJHLQWHORPHULF'1$WKHH[WUHPLWLHVRIFKURPRVRPHV
have  been  gained  recently.  Lu  et  al  showed  that  Ogg1  also  repairs  8-­oxo-­G  lesions  occurring  in  the  G-­rich  telomeric  DNA  
E\%(5DQGDEODWLRQRI2JJLQS.cerevisiae  leads  to  an  increase  in  8-­oxo-­G  in  telomeric  DNA  and  induces  telomere  
OHQJWKHQLQJ E\ WHORPHUDVH5DGPHGLDWHG KRPRORJRXV UHFRPELQDWLRQ  7KHVH UHVXOWV VXJJHVWHG WKDW R[R*
may  perturb  telomere  length  equilibrium  by  disturbing  telomere  length  maintenance  and  propose  that  interfering  with  
telomere  length  homoeostasis  may  be  one  of  the  mechanisms  by  which  oxidative  stress  damages  the  genome.  Wang  




DEQRUPDOLWLHV WHORPHUH VLVWHU FKURPDWLG H[FKDQJHV LQFUHDVHG WHORPHUH 66%V DQG'6%V DQG SUHIHUHQWLDO WHORPHUH
ORVVHVRI WKH ODJJLQJRU*VWUDQGZHUHREVHUYHG LQGLFDWLQJ WKDW R[R*GDPDJHFDQ DULVH LQ WHORPHUHV DIIHFWLQJ
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OHQJWKKRPHRVWDVLVUHFRPELQDWLRQ'1$UHSOLFDWLRQDQG'1$EUHDNUHSDLU$ORQJWKHVDPHOLQHVDVWXG\H[DPLQLQJ
the   susceptibility   of   telomeric  DNA   to   oxidative   base   damage   demonstrated   that   telomeric  TTAGGG   repeats  were  
PRUHSURQHWRR[LGDWLYHEDVHGDPDJHDQGUHSDLUHGOHVVHI¿FLHQWO\WKDQQRQWHORPHULF7*UHSHDWV in  vivo7KH\





The  question  if  and  how  transcription  is  affected  by  the  presence  oxidative  DNA  damage  within  a  DNA  segment  that  
is  transcribed  was  addressed  by  Khobta  and  co-­workers.  They  described  that  8-­oxo-­G  does  not  constitute  a  barrier  to  
WUDQVFULSWLRQLWVHOIFRQFRPLWDQWZLWKWKHQRWLRQWKDWR[R*LVQRWUHJDUGHGDVDEORFNLQJOHVLRQper  se  (99)+RZHYHU
8-­oxo-­G  was  converted  into  a  transcription-­blocking  damage  by  the  presence  of  Ogg1  even  if  present  only  in  the  non-­
WUDQVFULEHGVWUDQGVXJJHVWLQJWKDWWKHLQWHUUXSWLRQRIWUDQVFULSWLRQZDVLQGXFHGE\WKHIRUPDWLRQRI%(5LQWHUPHGLDWHV
As  also   the  non-­blocking   lesion  uracil  was   found   to   induce  a  similar  blockage   independently  of  Ogg1  activity.  The  
EORFNDJHRIWUDQVFULSWLRQFRXOGWKHUHIRUHEHDFRPPRQFRQVHTXHQFHRIYDULRXV'1$EDVHPRGL¿FDWLRQV$V&RFND\QH

























probably  rather  rarely  occurs  in  a  cell.




those  enzymes  was  inducible  by  oxidative  stress  caused  by  H2O2  treatment  of  cells.
5HJDUGLQJWKHTXHVWLRQZKLFK3ROLVWKHPDLQUHVSRQVLEOHIRUGHDOLQJZLWKR[R*'1$GDPDJHDFU\VWDOORJUDSKLF
study  assessing  a  complex  of  Pol  f  with  8-­oxo-­G  was  performed.  The  results  showed  that  the  exceptionally  narrow  active  
site  of  Pol  f can  prevent  the  dual  coding  properties  of  8-­oxo-­G  by  inhibiting  the  syn/anti  conformational  equilibrium  
7KHDXWKRUVFODLPWKDW WKLVZRUNSURYLGHV WKHVWUXFWXUDOPHFKDQLVPRIKLJK¿GHOLW\R[R*UHSOLFDWLRQE\D
KXPDQ3RO+RZHYHUWKHDXWKRUVGRQ¶WFRPPHQWLQDQ\ZD\RQWKHGDWDVKRZLQJWKDW3ROhLVDWOHDVWIROGPRUH
faithful  in  bypassing  8-­oxo-­G  in  vitroDQGDFWVRQVLWHVRIR[LGDWLYH'1$GDPDJHin  vivo  (20)  or  on  all  the  other  
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experimental  data  indicating  Pol  dPLJKWDOVRSOD\DUROHLQR[R*UHSDLUHJ,WUHPDLQVWREHVHHQKRZ
much  of  8-­oxo-­G  repair  is  really  attributable  to  the  action  of  Pol  f.  
0RQRXELTXLWLQDWLRQRI3&1$DW.E\WKHFRRUGLQDWHGDFWLRQRI WKH(5DGDQGWKH(XELTXLWLQ OLJDVH5DG
WDNHVSODFHIROORZLQJWUHDWPHQWRIFHOOVZLWK'1$GDPDJLQJDJHQWVWKDWLQGXFHEXON\'1$UHSOLFDWLRQIRUNEORFNLQJ
OHVLRQV  ,Q D YHU\ UHFHQW VWXG\E\.DQQRXFKHet   al   LWZDV IRXQG WKDW3&1$EHFRPHV UDSLGO\ DQG WUDQVLHQWO\
PRQRXELTXLWLQDWHG LQ UHVSRQVH WR R[LGDWLYH VWUHVV DQG WKDW WKLV WDNHV SODFH LQGHSHQGHQWO\ RI WKH 6 SKDVH 
0RQRXELTXLWLQDWLRQRI3&1$LVIXUWKHUSURPRWHGE\WKHKHWHURGLPHU0VK0VKLQDSDWKZD\LQGHSHQGHQWIURPWKH
‘canonical’  MMR  -­  and  subsequently  recruits  Pol  d  to  the  chromatin.  This  suggests  the  existence  of  a  mechanism  in  
which  Pol  d  coordinates  with  Msh2/Msh6  to  remove  complex  oxidative  DNA  lesions  from  chromatin  in  human  cells.  
This  study  also  underlines  the  intricate  network  and  the  multiple  layers  of  redundancy  in  place  regarding  the  repair  of  
oxidative  DNA  damage  in  vivo  that  slowly  begin  to  emerge.  
DNA  Polymerase  h
Recent  data  from  the  Wilson  lab  using  Polh-­/-­  Pol`-­/-­  double  knockout  MEFs  suggested  that  both  of  these  Pols  mediate  
RYHUODSSLQJDVZHOODVLQGHSHQGHQWUROHVLQ%(5LQ0()V7KHGRXEOHNQRFNRXWFHOOVVKRZHGDK\SHUVHQVLWLYLW\WR
alkylating  and  oxidizing  agents.  The  contribution  of  Pol  hWRVLQJOHQXFOHRWLGH%(5ZDVRQO\PRGHVWEXWERWK3ROh  and  
Pol  `  were  shown  to  interact  with  the  upstream  DNA  glycosylases  involved  in  the  repair  of  alkylated  as  well  as  oxidized  
'1$EDVHVLQGLFDWLQJWKHVHLQWHUDFWLRQVWREHLPSRUWDQWLQFRRUGLQDWLQJWKH3ROFKRLFHGXULQJ%(53ROh  is  the  only  
PHPEHURIWKH;IDPLO\LQSODQWV$VWXG\E\$PRURVRHWDODGGUHVVHG3ROh’s  role  in  the  plant  Arabidopsis  thaliana  (A.  
thaliana)ZKHUHWKH\FRXOGVKRZWKDW3ROhLVDVHI¿FLHQWLQSHUIRUPLQJHUURUIUHH7/6SDVWR[R*DVLWVPDPPDOLDQ
KRPRORJ3ODQWVRYHUH[SUHVVLQJRUVLOHQFHGIRU3ROhVKRZHGDOWHUHGJURZWKSKHQRW\SHV)XUWKHUPRUHWKH\FRXOG
show  that  Pol  hLQWHUDFWVRQO\ZLWK3&1$RQHRIWKHWZR3&1$JHQHVSUHVHQWLQA.  thalianaDQGWKDWWKLVLQWHUDFWLRQ
HQKDQFHVWKH¿GHOLW\DQGHI¿FLHQF\RI3ROhLQ7/6,QWHUHVWLQJO\IXUWKHUXQGHUOLQLQJWKHLPSRUWDQFHRI3ROh  for  A.  
thaliana WKHSURPRWHURIWKH32//JHQHFRXOGEHDFWLYDWHGE\89$FROODERUDWLRQZLWKWKH9LOODQLJURXSVHHWKH
RULJLQDOPDQXVFULSWVDWWDFKHGEHORZSXWVIRUZDUGH[SHULPHQWDOHYLGHQFHIRUWKHLQYROYHPHQWRI3ROhWRJHWKHUZLWK
Pols  `  and  dLQWKHE\SDVVRI$3VLWHVLQYLWUR,QWHUHVWLQJO\WKHQDWXUHRIWKHWHPSODWHGRZQVWUHDPWRWKHOHVLRQ
seemed  to  dictate  the  choice  of  the  Pol  used  for  bypassing  an  AP  site.  Whereas  the  presence  of  a  downstream  primer  did  
QRWLQÀXHQFHWKHE\SDVVHI¿FLHQF\E\3ROdLWZDVUHTXLUHGIRUWKHE\SDVVRIWKH$3VLWHE\3ROVh  or  `0RUHRYHUWKH
1WHUPLQDO%5&7DQG36ULFKGRPDLQRI3ROh  seemed  to  be  prerequisite  for  the  ability  of  Pol  h  to  perform  TLS.  In  
FRQFOXVLRQWKLVVWXG\LQGLFDWHGWKHH[LVWHQFHRID3ROVZLWFKDWDQ$3VLWHIURPWKHUHSOLFDWLYH3RO¡  to  the  repair  Pols  
h  and  `.
MutYH  DNA  glycosylase
A  recent  study  by  Molatore  et  al  LQYHVWLJDWLQJVHYHUDOPXWDWLRQVRI0XW<+WKDWDUHIRXQGLQ0$3SDWLHQWVLQV,:
5:(GHO<&DQG*'E\XVLQJDQHZFHOOEDVHGDQDO\VLVZLWKmutyh-­/-­  MEFs  demonstrated  that  all  
RIWKHWHVWHG0XW<+YDULDQWVZHUHG\VIXQFWLRQDOLQ%(57KLVZDVFRUURERUDWHGE\in  vitroGDWDZLWKWKHRQO\
H[FHSWLRQRI WKH*'PXWDQWZKLFKVKRZHGDJO\FRV\ODVHDFWLYLW\YHU\VLPLODU WR WKHZLOGW\SHSURWHLQ6XUIDFH
plasmon  resonance  studies  by  D’Agostino  et  alWRDVVHVVWKHELQGLQJDI¿QLW\WRZDUGVDQ$R[R*VXEVWUDWHUHYHDOHG
D VHYHUH UHGXFWLRQ IRU0XW<+YDULDQWV5:(GHO DQG<&ZKLFKZDV DVVRFLDWHGZLWK DQ LPSDLUPHQWRI
WKHJO\FRV\ODVHDFWLYLW\EXWRQO\DVOLJKWGHFUHDVH LQELQGLQJE\ WKHLQV,:DQG*'PXWDQWV 6X]XNLet  
al  LQYHVWLJDWHGWKHUHSDLURIR[R*LQ'1$DQGR[RG*73LQ7FHOOVE\2**0XW<+17+DQG1(,/




VXSSUHVVHVPXWDWLRQV LQGXFHGE\&R[R* LQ'1$EXW HQKDQFHV WKRVHJHQHUDWHGE\R[RG*73$QRWKHU VWXG\
DGGUHVVLQJ6\QWKHWLFVLFNQHVVOHWKDOLW\66/E\WKHFRPELQHGGH¿FLHQF\RI0VKZLWK3RO`   or  MLH1  with  Pol  a  found  
WKDWWKH66/SKHQRW\SHFRXOGEHUHVFXHGE\WKHNQRFNGRZQRI0XW<+VXJJHVWLQJWKDWOHWKDOLW\FRXOGEHFDXVHGE\WKH
IRUPDWLRQRIOHWKDO'1$EUHDNVXSRQR[R*DFFXPXODWLRQ
7KH OLQN EHWZHHQ LQFUHDVHG FDQFHU ULVN DVVRFLDWHG ZLWK LQÀDPPDWRU\ ERZHO GLVHDVHV FRPSDUHG WKH LQÀDPPDWRU\





0DVV VSHFWURPHWULF GDWD DQDO\VLQJ SRVWWUDQVODWLRQDO PRGL¿FDWLRQV 370V RI 0XW<+ VKRZHG WKDW DQ in   vivo  
SKRVSKRU\ODWLRQVLWHLVSUHVHQWDW6ZKLFKLVORFDWHGLQWKH&WHUPLQDOR[R*UHFRJQLWLRQGRPDLQZLWKLQWKH3&1$
ELQGLQJUHJLRQ&KDUDFWHUL]DWLRQRIWKHSKRVSKRPLPHWLF6'DQGSKRVSKRGH¿FLHQW6$PXWDQWVVXJJHVWHG












Reversible  protein  phosphorylation  is  a  key  event  in  cellular  regulation  and  it  was  for  the  discovery  of  this  mechanism  
that  the  Nobel  Prize  in  physiology  or  Medicine  1992  was  awarded  jointly  to  Edmond  H.  Fischer  and  Edwin  G.  Krebs  
“for  their  discoveries  concerning  reversible  protein  phosphorylation  as  a  biological  regulatory  mechanism”.
Figure  2:  Scheme  of  the  protein  phosphorylation  and  -­dephosphorylation  reaction.
3KRVSKRU\ODWLRQLVEURXJKWDERXWE\WKHWUDQVIHURID3KRVSKDWHPRLHW\3IURP$73WRDWDUJHWSURWHLQE\SURWHLQ
NLQDVHVWKHUHE\FKDQJLQJWKHIXQFWLRQVRIWKHWDUHWSURWHLQ'HSKRVSKRU\ODWLRQLVWKHUHYHUVHPHFKDQLVPDQGLV





3KRVSKRU\ODWLRQ LV WKHDGGLWLRQRIDSKRVSKDWH 3243-­JURXS WRDSRO\SHSWLGHRUSURWHLQE\HQ]\PHVFDOOHGSURWHLQ
kinases.  Those  kinases  move  a  phosphate  group  from  ATP  to  the  target  protein  Figure  2  The  reverse  mechanism  –  the  
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removal  of  a  phosphate  group  from  a  target  protein  to  revert  it  back  to  its  original  state  –  is  termed  dephosphorylation  
and  is  catalysed  by  protein  phosphatases.  Regulation  of  proteins  by  phosphorylation  plays  an  important  role  in  both  
SURNDU\RWLFDQGHXNDU\RWLFRUJDQLVPV$QHQRUPRXVDUUD\RIFHOOXODUIXQFWLRQVDUHWLJKWO\UHJXODWHGE\DQG
heavily  rely  on  phosphorylation.  Many  enzymes  and  receptors  are  switched  forth  and  back  between  their  “on”  and  “off”  
VWDWHE\SKRVSKRU\ODWLRQDQGGHSKRVSKRU\ODWLRQEHFDXVHWKHDGGLWLRQDQGUHPRYDORIVXFKDPRLHW\IUHTXHQWO\UHVXOWV
LQDFRQIRUPDWLRQDOFKDQJHLQWKHVWUXFWXUHRIWKHPRGL¿HGWDUJHWSURWHLQ7KLVFKDQJHLVRIWHQEURXJKWDERXWE\WKH











cyclinB   during   the  G2/M   transition.  The   diversity   of   targets   that   those   complexes   phosphorylate   is   far   from  being  
FRPSOHWHO\LGHQWL¿HGDQGWKHHQWLUHIXQFWLRQDORXWFRPHRIWKHVHHYHQWVLVXQGHUVWRRGVRIDULQRQO\DPLQRULW\RIFDVHV
Future  phosphoproteome  analysis  will  give  further  insight  into  this  very  complex  regulatory  cellular  network.
Ubiquitination:  the  cell’s  way  to  dispose  of  waste  –  and  more
3RVWWUDQVODWLRQDOPRGL¿FDWLRQRISURWHLQVE\FRQMXJDWLRQRIXELTXLWLQXELTXLWLQDWLRQLVLPSRUWDQWIRUPDQ\DVSHFWVRI
HXNDU\RWLFOLIH$VIRUWKHDIRUHPHQWLRQHGSKRVSKRU\ODWLRQXELTXLWLQLVUHYHUVLEO\DWWDFKHGWRWKHWDUJHWSURWHLQPDNLQJ
it  ideal  for  regulatory  purposes.  Ubiquitin  is  a  76  amino  acid  polypeptide  that  can  be  attached  to  a  K  residue  in  the  target  
SURWHLQDQGFDQDOVRLQFRQWUDVWWRSKRVSKRU\ODWLRQEHDWWDFKHGWRDQRWKHUXELTXLWLQUHVLGXHWKXVJLYLQJULVHWRWKH
IRUPDWLRQRIPRQRGLDQGSRO\XELTXLWLQFKDLQVWKDWFDQHYHQUHVXOWLQEUDQFKHGWUHHOLNHVWUXFWXUHV
The   conjugation   of   ubiquitin   is   performed   in   an  ATP   dependent   mechanism   and   involves   the   concerted   action   of  
XELTXLWLQDFWLYDWLQJHQ]\PHV(XELTXLWLQFRQMXJDWLQJHQ]\PHV(DQGXELTXLWLQOLJDVHV(DOORIZKLFKKDYH
EHHQWKRURXJKO\UHYLHZHG7KRVHWKUHHFODVVHVRIHQ]\PHVKDYHWRZRUNWRJHWKHULQDYHU\RUJDQLVHGZD\WR
perform  their  task  of  attaching  ubiquitin  to  the  target.  Some  of  them  also  possess  elongating  activities  that  support  the  





a  combination  of  E3s  with  E2s.  The  only  two  E1  present  in  human  cells  are  standing  in  gross  contrast  to  the  abundance  
RIWKH(VDQG(VWRDFKLHYHDKLJKUHJXODWRU\SRWHQWLDODQGVSHFL¿FLW\RIWKHXELTXLWLQDWLRQUHDFWLRQPDPPDOLDQ
FHOOV H[SUHVV DPXOWLWXGH RI (V HVWLPDWLRQV DUH DURXQG  LQ KXPDQV DQG HYHQPRUH (V HVWLPDWHGPRUH WKDQ
LQKXPDQV6SHFLDOL]HGXELTXLWLQELQGLQJGRPDLQVLQLQWHUDFWLQJSURWHLQVUHFRJQLVHWKHXELTXLQDWHGSURWHLQVDQG
allow  non-­covalent  protein-­protein  interactions  with  the  ubiquitin  itself  or  the  region  around  the  ubiquitin  attachment  
to  take  place.  The  reverse  reaction  of  ubiquitination  is  termed  deubiquitination  and  is  accomplished  via  the  action  of  
GHXELTXLWLQDWLQJHQ]\PHVDIDPLO\RILVRSHSWLGDVHVWKDWUHPRYHVWKHXELTXLWLQPRLHWLHVIURPWKHWDUJHWSURWHLQV









and  cytosol  per  cell.  
Figure  3:  The  26S  proteasome.
7KHSURWHDVRPHLVEXLOWRIWZRVXEFRPSOH[HVWKHFRUH6FDWDO\WLFSDUWLFOHDQGWKH6UHJXODWRU\SDUWLFOHWKH
SURWHLQFRPSRQHQWVRIZKLFKDUHYDULDEOH$7KH6SDUWLFOHFRQVLVWVRIKHSWDPHULFULQJVWZR_-­rings  and  two  
`-­rings  that  form  a  channel.  The  central  two  rings  lining  this  channel  are  made  of  the  `-­subunits  `1  -­  `ZKLOH
the  two  rings  at  either  side  of  those  comprise  of  _1  -­  _VXEXQLWV7KLVFKDQQHOLVWRSSHGRQRQHHQGRIWHQDOVR
RQERWKHQGVE\WKHµOLG¶OLNHVWUXFWXUHRIWKH6UHJXODWRU\SDUWLFOH7KHVXEVWUDWHELQGLQJRFFXUVSUREDEO\YLD
the  polyubiquitin  chains  on  the  target  protein  to  the  19S  subunit.  The  19S  subunit  then  inserts  the  substrate  via  an  





three  pairs  of  proteolytically  active  `-­subunits  residing  in  the  two  `-­rings.  In  addition  to  mediating  the  substrate  
UHFRJQLWLRQWKH6SDUWLFOHDOVRFRQWDLQVGHXELTXLWLQDWLQJHQ]\PHVWKDWDOORZWKHUHF\FOLQJRIXELTXLWLQ$GDSWHG









assembly  and  disassembly  of  the  proteasome  itself  and  the  degradation  of  some  of  its  subunits  are  processes  that  are  also  
UHJXODWHG(YHQWKRXJKWKHSURWHDVRPHLVJHQHUDOO\UHJDUGHGDVDYHU\VWDEOHSURWHLQFRPSOH[WKHHQWLUHSURWHDVRPH
or  its  subcomplexes  are  probably  subject  for  degradation  by  the  lysosome  via  the  microautophagy  pathway.  Different  
IDFWRUV DV$73 SURWHDVRPH LQKLELWRUV DQG XELTXLWLQDWHG VXEVWUDWHV FRQWURO WKH DVVHPEO\ RI WKH SURWHDVRPH DQG WKH
disassembly  of  the  proteasome  to  its  regulatory  particle  and  core  particle  subunits  can  be  induced  by  different  stress  
VWLPXOL VXFKDVR[LGDWLYH VWUHVVDQGFHOOXODU VWDUYDWLRQ7KH UHJXODWRU\SDUWLFOHFDQEH IXUWKHUGLVDVVHPEOHG LQWR LWV
LQGLYLGXDOVXEXQLWVZKLFKDUHSUREDEO\DOVRGHJUDGHGE\XELTXLWLQGHSHQGHQWSURWHDVRPDOGHJUDGDWLRQ
Maintenance  of  balanced  levels  of  proteins  is  of  pivotal  importance  for  the  correct  functioning  and  survival  of  each  cell.  
It  is  clear  that  it  could  prove  detrimental  for  many  functions  if  either  too  much  or  too  little  of  certain  protein  components  
ZHUHSUHVHQW)RULQVWDQFHIDLOLQJWRGHJUDGH&GNVLQWLPHZRXOGOHDGWRDVWDOORUZRUVWFDVHHYHQEUHDNGRZQRIWKH
FHOOF\FOH$OVRRQHFDQLPDJLQHWKDWXQFRQWUROOHGOHYHOVRID'1$UHSDLUSURWHLQFRXOGOHDGWRWKHDFFXPXODWLRQRI
deleterious  mistakes  in  the  genomic  DNA.  It  is  this  regulation  that  is  mediated  by  the  ubiquitin-­dependent  proteasomal  
GHJUDGDWLRQ,PSRUWDQWO\WKHGHJUDGDWLRQRIDWDUJHWSURWHLQFDQEHUHJXODWHGDQGLQÀXHQFHGLQWXUQE\RWKHU370V
such  as  phosphorylation.  This  crosstalk  of  different  PTMs  adds  a  whole  different  layer  of  complexity  to  the  question  
KRZZKHQDQGWRZKDWHQGSURWHLQVDUHUHJXODWHG LQ WKHFHOO ,QFRQFOXVLRQUHJXODWLRQRIFHOOXODUSURWHLQ OHYHOVE\
the  ubiquitin-­proteasome  system  is  an  important  feature  of  healthy  cells  and  that  the  interplay  between  ubiquitination  
RIDSURWHLQDQGRWKHU370VFRQVWLWXWHVDFRPSOH[¿HOGRILQYHVWLJDWLRQWKDWVWLOOKDVDORWOHIWWRH[SORUHLQRUGHUWR
understand  its  full  implications.  












UHVXPH WKHSRO\PHUL]DWLRQRI ORQJVWUHWFKHVRI'1$ ,QDGGLWLRQ WREHLQJPRQRXELTXLWLQDWHG3&1$KDVDOVREHHQ
shown   to  undergo  polyubiquitination  by   the  E2  Ubc13-­Mms2  and   the  E3  Rad5  on   the  same   residue   in  yeast.  Most  
SUREDEO\WKLVSRO\XELTXLWLQDWLRQOHDGVWRWKHDFWLYDWLRQRIDQHUURUIUHHUHSDLUSDWKZD\UHO\LQJRQWHPSODWHVZLWFKLQJ
the  exact  mechanisms  of  which  remain  unclear.  
5HJDUGLQJWKHUHJXODWLRQRIFRPSRQHQWVRIWKH%(5PDFKLQHU\E\XELTXLWLQDWLRQRQO\OLWWOHLVNQRZQVRIDU'LDQRY









targeted  enzyme’s  function  positively  or  negatively  and  also  constitute  a  signal  for  further  PTM’s.









cross-­talk  of  different  PTMs  will  be  of  high  interest  in  the  near  future  in  order  to  unveil  the  mechanisms  by  which  they  
FRRUGLQDWHWKHDEXQGDQFHWKHDFWLYLW\DQGWKHORFDOL]DWLRQRIWKHGLIIHUHQWUHSDLUFRPSOH[HVZLWKLQWKHFHOO
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AIM  OF  THE  THESIS:
UNDERSTANDING  THE  REGULATION  OF  CELLULAR  DNA  POLYMERASE  h  LEVELS    
BY  PHOSPHORYLATION  AND  UBIQUITINATION
The  main  focus  of  the  work  presented  in  this  thesis  was  to  elucidate  the  mechanisms  that  regulate  the  protein  levels  and  activity  of  Pol  hLQWKHFHOO&OLQLFDOHYLGHQFHWKDWWKHUHJXODWLRQRI3ROh  as  a  rather  promiscuous  DNA  repair  enzyme  is  important  comes  from  a  study  performed  by  Ohba  et  al.  They  showed  that  the  expression  of  Pol  h  in  
KXPDQEURQFKLRODUHSLWKHOLDFRUUHODWHVZLWKWKHDPRXQWRIKDELWXDOVPRNLQJ7KLVLVLQOLQHZLWKWKH¿QGLQJVE\
Albertella  et  al  who  found  Pol  hDPRQJRWKHU3ROVWREHPRUHWKDQWZRIROGRYHUH[SUHVVHGLQRIFDQFHUVDPSOHV
FRPSDUHGWRWKHLUQRUPDOWLVVXHFRXQWHUSDUWV
Background
7KH¿UVWGDWDUHJDUGLQJWKHUHJXODWLRQRI3ROh  in  vivo  came  from  a  study  by  Frouin  et  al  showing  that  Pol  h  interacts  
ZLWKDQGLVSKRVSKRU\ODWHGE\&GNin  vitroLQWKH36ULFKGRPDLQ:KLOHWKLVSKRVSKRU\ODWLRQGLGQRWDIIHFW3RO
h¶VSRO\PHUDVHDFWLYLW\WKHSKRVSKRU\ODWLRQZDVGHFUHDVHGE\DQLQWHUDFWLRQRI3ROhZLWK3&1$)LQDOO\LWZDVVKRZQ
that  Pol  h   is  phosphorylated   in  vivo  during  the  cell  cycle  and  that   the  phosphorylation  pattern  mimicked  the  pattern  
RI&GN&\FOLQ$¶VÀXFWXDWLRQGXULQJ WKHFHOOF\FOH)ROORZXSZRUNE\:LPPHUet  al   WKHQ OHG WR WKH LGHQWL¿FDWLRQ
of   several   phosphorylation   sites   of   Pol  h.   Experiments  with   phosphorylation-­defective  mutants   suggested   a   critical  
function  for  the  residue  T553  in  the  maintenance  of  Pol  h¶VVWDELOLW\WKURXJKRXWWKHFHOOF\FOHDQGVSHFL¿FDOO\GXULQJODWH
6DQG*SKDVH$ORVVRISKRVSKRU\ODWLRQRIWKH7UHVLGXHOHDGWRLQFUHDVHGXELTXLWLQDWLRQDQGSURWHDVRPDO
degradation  of  Pol  h7KXVWKHVWDELOL]DWLRQRI3ROh  during  the  S  and  G2  phases  is  likely  to  enable  it  to  conduct  DNA  
damage  repair  at  this  stage  of  the  cell  cycle.  Since  it  is  known  that  all  the  replicative  Pols  preferentially  incorporate  an  
$RSSRVLWHR[R*LQVWHDGRIWKHFRUUHFW&WKHVH¿QGLQJVDUHLQOLQHZLWKDSXWDWLYHUROHRI3ROh  in  post-­replicative  
repair  of  8-­oxo-­G.
6R IDU RQO\ OLWWOH LV NQRZQ KRZ WKH %(5 FRPSRQHQWV DQG WKHLU DFWLYLW\ DUH UHJXODWHG LQ WKH FHOO 370V VXFK DV
SKRVSKRU\ODWLRQDFHW\ODWLRQVXPR\ODWLRQPHWK\ODWLRQDQGXELTXLWLQDWLRQSURYLGHDQLQWULJXLQJSRVVLELOLW\RIUHJXODWLRQ







ZKHWKHU WKH SURWHLQ LV WDUJHWHG IRU SURWHDVRPDO GHJUDGDWLRQ RU UHFUXLWHG WR FKURPDWLQ WR IXO¿O LWV IXQFWLRQ LQ'1$
UHSDLUZDVYHU\LQWULJXLQJ7KHDLPRIWKLVWKHVLVZDVWKHUHIRUHWRWDNHDFORVHUORRNDWWKHUHJXODWLRQRI3ROh  in  vivo  
by  ubiquitination  and  phosphorylation.  It  led  to  the  formulation  of  two  core  questions  that  constitute  the  basis  of  the  
SUHVHQWHGWKHVLV¿UVWO\ZHZDQWHGWRLGHQWLI\WKH(UHVSRQVLEOHIRUWKHGHJUDGDWLRQRI3ROh  in  vivoDQGVHFRQGO\WR
see  if  and  how  this  degradation  could  be  regulated  by  phosphorylation  of  Pol  hE\&GN&\FOLQ$7KHUHVXOWVRIWKLV









of  Pol  h  levels  and  the  E3  Mule  upon  treatment  of  cells  with  H2O2  as  agent  that  causes  oxidative  stress  was  shown.  
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a b s t r a c t
DNA polymerase (pol) k, one of the 15 cellular pols, belongs to the X family. It is a small 575 amino-
acid protein containing a polymerase, a dRP-lyase, a proline/serine rich and a BRCT domain. Pol k
shows various enzymatic activities including DNA polymerization, terminal transferase and dRP-
lyase. It has been implicated to play a role in several DNA repair pathways, particularly base excision
repair (BER), non-homologous end-joining (NHEJ) and translesion DNA synthesis (TLS). Similarly to
other DNA repair enzymes, pol k undergoes posttranslational modifications during the cell cycle that
regulate its stability and possibly its subcellular localization. Here we describe our knowledge about
ubiquitylation of pol k and the impact of this modification on its regulation.
! 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
1. DNA polymerase k, a multitask repair enzyme
Seven DNA polymerase (pol) families have been defined based
on sequence homologies. They are called family A, B, C, D, X, Y
and reverse transcriptase (RT) [1,2]. The eukaryotic pols can be di-
vided into the five families A, B, X, Y and RT. Pol k belongs to the X
family of DNA pols, which comprises pol b, pol l and terminal
deoxyribonucleotidyl transferase in addition to pol k [1].
Pol k is the product of the POLL gene, localized on chromo-
some 10 in humans and chromosome 19 in mice and is com-
posed of 575 amino acid residues (the murine form having
573 residues) [3]. The C-terminal part of pol k shows the typical
‘right-hand’ folding with a palm, finger, thumb and an additional
8 kDa dRP-lyase containing subdomain. The first 230 N-terminal
amino acids compose the BRCT and the proline/serine rich do-
main [4,5] (Fig. 1A). The BRCT domain is believed to be impor-
tant for protein/protein interactions with components of non-
homologous end-joining (NHEJ) such as XRCC4/DNA ligase IV
[6]. A possible role of the non-enzymatic proline/serine-rich do-
main might be modulation of pol k fidelity, since pre-steady
state kinetic studies suggested that this domain contributes to
its accuracy [7]. Pol k possesses multiple activities (reviewed in
[2]): in addition to template dependent DNA polymerization it
displays dRP-lyase, as well as template-independent terminal
deoxynucleotidyl transferase and polynucleotide synthetase
activities (Fig. 1B). Also, it efficiently adds DNA bases to a RNA
primer [8]. The dRP-lyase activity of pol k hints towards an
involvement in base excision repair (BER) [9] and in vitro experi-
ments suggest that pol k participates in double strand break
DNA repair (DSBR) via NHEJ [10]. In addition, biochemical evi-
dence supports a prominent role of pol k in the correct repair
of oxidative DNA lesions such as 8-oxo-guanine [11–13] and 2-
hydroxy-adenine [14], and it seems to perform those functions
in cooperation with the auxiliary proteins replication protein A
(RP-A) and proliferating cell nuclear antigen (PCNA) (see below).
Only in the presence of these two auxiliary proteins the remark-
ably accurate incorporation opposite 8-oxo-G can be achieved,
since the bias of C versus A incorporation increases over 1200
(see Ref. [12] and Table 1 therein). Moreover, pol k isolated from
calf thymus tissue was shown to efficiently bypass apurinic/apy-
rimidinic (AP) sites [15]. A polymorphic variant of pol k (R438W)
was found to affect the homologous recombination (HR) path-
way and sister chromatin exchanges, suggesting that pol k also
has a function in HR [16].
Biochemical studies in Suo’s laboratory suggested that an in-
crease in gap size results in lower accuracy for pol k [17]. The
observed decrease in the fidelity appears to be regulated by non-
enzymatic N-terminal domains (also see above). Moreover, dCTP
was the preferred misincorporated base for full-length pol k and
its N-terminal domain truncation mutants. Their results also
indicated that pol k catalyzes nucleotide incorporation with the
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highest combination of efficiency and accuracy when the DNA sub-
strate contains a single-nucleotide gap.
Non-overlapping functions of pols l, k, and terminal deoxyribo-
nucleotidyl transferase have been described during immunoglobu-
lin V(D)J recombination in vivo [18]. Pol k knockout mice are viable
and fertile and display a normal hypermutation pattern [19]. Pol
k!/!mouse embryonic fibroblasts were shown to be more sensitive
to oxidative DNA damage and this phenotype was further en-
hanced when combined with inactivation of the closely related en-
zyme pol b, suggesting backup functions these two proteins in the
repair of DNA oxidative lesions [20,21]. Furthermore, ionizing radi-
ation sensitivity has been seen in pol k knockout cells [22].
The pol X family is well characterized on the structural level (re-
viewed in [23]). Figuratively speaking a pol resembles a human
right hand consisting of a palm fingers and a thumb (reviewed in
[24]). In general, structural motions of the whole enzyme are ob-
served upon binding of the dNTP’s into the active site located in
the palm domain. In contrast to this general feature of pols, pol k
was found not to require that subdomain motion (e.g. in fingers
and thumb) for catalysis [25], thus making this enzyme particular
within all the pol families. When the binary (pol k/template/pri-
mer) and the ternary (pol k/template/primer/dNTP) complexes
were compared, it was found that the essential Asp427, Asp429
and Asp490 possess the same positions whether or not an incom-
ing dNTP was present. Key amino-acids are the Tyr505 and the
Phe506 [26] that form the contact with the minor groove of the
correctly positioned DNA [25]. Further, it was shown that pol k
can generate single-base deletions during DNA synthesis [27]. This
feature was explained on the structural level to be due to DNA
strand repositioning induced by the dNTP catalysis, thus control-
ling the strand slippage [28]. Finally, when the catalytically active
form of pol k was bound to the template/primer with an extrahe-
lical template nucleotide upstream of the active site, pol k gener-
ated strand slippage mutations [29]. In other studies using a
mass spectrometry-based protein footprinting approach a solu-
tion-phase protein conformational change in pol k was found
[30]. The discrepancy between this observation and the previous
structural studies might be due to the fact that the crystallographic
structural studies were performed with the catalytic domain only,
while the solution studies were carried out with full-length pol k
also containing the BRCT and the proline/serine-rich domains.
In summary, pol k is a multifunctional enzyme with important
functions in BER, NHEJ and translesion DNA synthsis (TLS), the
pathways that evolved to reduce the mutational burden in a cell.
Unique structural features of pol k reflected in its enzymatic activ-
ity, might be essential for its role as a multifunctional DNA repair
pol.
2. Regulation by posttranslational modifications of BER
proteins in general and DNA polymerase k in particular
At present little is known about regulation of BER and its com-
ponents in the cell. Post-translational modifications (PTM) of BER
proteins offer an intriguing possibility to ensure that the compo-
nents involved act at the right time at the chromatin in the nucleus
(reviewed in Refs. [31,32]). PTM’s likely involved in this regulation
are phosphorylation, acetylation, sumoylation, mono- and polyub-
iquitylation as well as methylation (Table 1). Dianov and his group
showed that BER components are targeted for destruction by the
E3 ubiquitin ligase CHIP under normal conditions. However, when
DNA damage occurs, those components undergo stabilization to in-
crease the cellular capacity to perform BER [33]. In their work, Dia-
nov and his group found that proteins such as pol b, XRCC1 and
DNA ligase III are stabilized when they are bound to chromatin,
forming an active repair complex. But when they are not attached
to chromatin, meaning that they are not engaged in DNA repair,
those components are polyubiquitinated by the concerted action
of the E3 ubiquitin ligases CHIP and Mule, and consequently de-
graded. In a ‘‘preview’’ in the same issue of Mol. Cell Sobol con-
cluded, that ‘‘the next goal is now to assess the crosstalk
between PTM’s, the ability to form productive repair complexes
and the stability of these complexes’’ [34]. Here the concept was
put forward that a single PTM, such as phosphorylation, might pos-
itively or negatively influence the enzyme’s function and consti-
tute a signal for further PTM’s.
Initial data concerning the regulation of pol k in vivo came from
a study performed in our laboratory in 2005 when, in a proteomic
search for novel interaction partners of pol k by affinity chroma-
tography, we found cyclin dependent kinase 2 (Cdk2) to interact
with pol k [35]. We showed that pol k can be phosphorylated
in vitro by several Cdk/cyclin complexes, including Cdk2/cyclin A,
in its proline-serine rich domain (Fig. 1). Phosphorylation by
Cdk2/cyclin A did not affect any biochemical properties of pol k
but the level of this PTM was decreased when pol k interacted with
PCNA, the ring-like moving platform that can interact with 10 dif-
ferent pols (reviewed in [2]). Finally, the phosphorylation-pattern
of pol k in vivo reflected the presence of Cdk2-cyclin A during
the cell cycle. In a follow-up work, we could further demonstrate
that pol k was phosphorylated at four distinct sites, among which
phosphorylation at Thr553 had a strongest impact on its stability
[36].
3. Ubiquitylation of DNA polymerase k and its implications in
repair of 8-oxo-G
When we further investigated the impact of the Thr553 phos-
phorylation on the stability of pol k, we found that an increase
in the phosphorylation positively correlates with the levels of
Table 1




APE1 Phosphorylation, acetylation, ubiquitylation
MUTYH Phosphorylation
Pol b Phosphorylation, acetylation, methylation, ubiquitylation
Pol k Phosphorylation, ubiquitylation
Pol d Phosphorylation, sumoylation, ubiquitylation
Pol e Phosphorylation
PCNA Phosphorylation, acetylation, sumoylation, ubiquitylation
Fenl Phosphorylation, acetylation
DNA lig I Phosphorylation
DNA lig III Phosphorylation
XRCC1 Phosphorylation, sumoylation, ubiquitylation




DNA polymerase DNA synthesis (TLS, BER, NHEJ, HR) 
Terminal transferase V(D)J recombination, NHEJ 
dRP lyase Short-patch BER  
Fig. 1. Structure and functions of DNA polymerase k. For details see text and
references therein.
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pol k in the cell. This increase was found to be due to the fact
that the phosphorylation of Thr553 protected pol k from being
ubiquitinated and subsequently degraded via the proteasomal
pathway [36]. The phosphorylation-dependent stabilization was
shown to take place in the late S and G2 phase, consistent with
a possible role of pol k in the post-replicative repair of A:8-oxo-
G mispairs, likely enabling pol k to properly conduct repair of
damaged DNA during and after S phase [13]. It remains to be
Fig. 2. Regulation of DNA polymerase k by ubiquitination in response to oxidative DNA damage. (A) The CHIP E3 ligase ubiquitinates pol k in vitro. The amounts of CHIP E3-
ligase, titrated in the presence of E1 activating enzyme and the 10 E2 conjugating enzymes, were 25, 50, 100, 200, 500 and 1000 ng, with 200 ng of pol k, respectively. (B) HeLa
cells were treated for 1 h with H2O2 (1 mM) and the cells were subsequently released for the indicated time points. It can be seen that pol k protein levels (white bars) in
whole HeLa cell extracts increase, while the levels of the Mule E3 ligase (dark bars) decrease, with the effect being most prominent 1 h upon the release. Values presented on
the right are mean of three independent experiments. Error bars are ±SD values. For description of the experiment see text. (C) When an analogous experiment in HeLa cells
was performed upon treatment with MMS (500 lM) for 1 h, no changes in pol k levels could be observed. The experiment was carried out as described in B. (D) Pol k levels
upon 1 h H2O2 (1 mM) treatment and 2 h release in HeLa cell nuclear and chromatin fractions, suggesting an increase in both of the fractions. (E) Functional consequences of
ubiquitination on pol k activity. The single nucleotide incorporation over an 8-oxo-G immediately following the primer terminus (so-called standing start conditions) were
performed as outlined in Ref. [12]. Note that the in vitro monubiquitinated pol k is less active in correct TLS over 8-oxo-G.
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investigated in more detail by what other means pol k is regu-
lated in vivo and how this regulation influences its activity.
To pursue our interest in the issue of shedding more light on the
regulation of pol k in the cell, we set out to determine which of the
many cellular E3 ubiquitin ligases might be responsible for pol k
ubiquitination. Due to the fact that pol k is closely related with
pol b, we hypothesized that the ubiquitin E3 ligases that are in-
volved in the ubiquitination of pol b might perform the task in
the case of pol k as well. For this end, we performed an in vitro
ubiquitination assay, as originally developed by the Dianov’s group
[33].
In this assay, as for pol b [33], we found that pol k can be ubiq-
uitinated in vitro by the E3 ligase CHIP in dependence of the E1
activating enzyme and the 10 E2 conjugating enzymes (H2, H3,
H5a, H5b, H5c, H6, H7, H8, H10 and H13) (Fig. 2A). Additionally,
we found that pol k can also be ubiquitinated by Mule in a similar
in vitro reaction and that the extent of this reaction is concentra-
tion-dependent as well (data not shown).
8-oxo-G is a common lesion that arises from insults to DNA
caused by reactive oxygen species (ROS) which in turn stem
from various different endogenous and exogenous sources [37–
40]. The steady-state levels of 8-oxo-G have been estimated to
be around 1000-2000 lesions per cell per day in normal tissues
and up to 100,000 per cell per day in the case of cancer [41,42].
8-oxo-G is considered a mutagenic lesion as it readily pairs with
an incorrect A instead of the correct C when present in syn con-
formation. This is due to the fact that an 8-oxo-G base pairing
with its correct counterpart C induces template and polymerase
distortions as they are seen when a pol encounters a mismatch
[43]. Data obtained in our laboratory implicate pol k to play a
pivotal role in the post-replicative repair pathway of 8-oxo-G
lesions by incorporating the correct nucleotide C opposite an
8-oxo-G lesion up to 1200 times more faithfully than any other
pol tested [11–13].
In light of this situation, we expect the presence of pol k to
be particularly important during the late S and G2 phase of
the cell cycle, where such a post-replicative repair step is
needed. This is supported by the fact that pol k is stabilised ex-
actly during these cell cycle phases [36]. Additionally, the model
would predict pol k to be needed whenever there is oxidative
DNA damage present that can give rise to 8-oxo-G lesions. A rise
in the supply of pol k could be achieved by either an increased
production of the protein (by means of increased transcription
and/or translation), or by a decrease in its turnover due to lower
degradation via the ubiquitin-proteasome-system (UPS). Keeping
the amount of pol k constant, but stimulating its enzymatic
activity would be an additional mean of coping with more 8-
oxo-G damage under conditions of oxidative stress. To test
whether an increase in oxidative DNA damage leads to a change
in pol k protein levels, we treated HeLa cells with hydrogen per-
oxide (H2O2) for the duration of 1 h, after which the cells were
washed and released into normal medium again. A time-course
analysis of whole cell extracts for pol k protein levels revealed
that pol k levels increase up to 1 h after the treatment, followed
by a phase in which the protein amount slowly decrease again
to reach initial levels 4 h after the treatment (Fig. 2B). This find-
ing demonstrates that cellular levels of pol k seem to be respon-
sive to the levels of oxidative DNA damage, in this case inflicted
by the use of H2O2. As we had established that pol k can be
ubiquitinated in vitro by Mule, we were interested in monitoring
whether this increase in pol k could be due to a change in levels
of Mule upon treatment. Indeed, when protein levels of Mule
were analysed in the same experiment, it became clear that they
responded reciprocally to the levels of pol k, reaching the lowest
levels 1 h after treatment (Fig. 2B). These data are in line with
Mule regulating levels of pol k in response to oxidative DNA
damage. The next question that arose was whether pol k levels
respond similarly to any other kind of genotoxic insult or if
the observed increase was a specific response to oxidative stress.
Thus, we tested how the levels of pol k respond to methyl meth-
ane sulfonate (MMS), an alkylating DNA damaging agent not
known to induce 8-oxo-G in particular. In contrast to the treat-
ment with H2O2, we could not observe any effect on the pol k
protein levels by MMS (Fig. 2C). This result indicated that an in-
crease in pol k levels is only induced when 8-oxo-G is produced
by the presence of oxidative stress. When a cell fractionation
experiment of HeLa cells was performed after 1 h of H2O2 treat-
ment and subsequent release into normal medium for 2 h, we
found an accumulation of pol k protein in both the nuclear
and chromatin-bound fractions (Fig. 2D). Thus, it seems that,
after oxidative stress, also the fraction of the pol that is actively
working on the DNA is increased and not only the ‘backup-pool’
present in the nucleus. This result is directly in line with the
hypothesis that pol k is up-regulated upon oxidative DNA dam-
age to more efficiently perform its repair functions.
Finally, we were interested in looking at the functional conse-
quences of ubiquitination on the enzymatic activity of pol k. To test
this, we used a single-nucleotide incorporation assay as originally
published in [12]. This assay uses a standing start primer/template
combination that allows the quantitative and qualitative monitor-
ing of the incorporation step of either incorrect A or correct C oppo-
site 8-oxo-G. The first incorporation step in this set-up is taking
place opposite 8-oxo-G, while the second templating base is a nor-
mal G. Thus, when C is used in the reaction, two products can be
observed: the first one representing the correct incorporation
opposite 8-oxo-G and the second one an elongation step of one
nucleotide. On the contrary, when A is used, only one incorporation
event will take place which represents the erroneous incorporation
of A opposite 8-oxo-G. Using this assay with 1 lM of the respective
nucleotides, we found that in vitro ubiquitylation of pol k strongly
decreased the correct 8-oxo-G TLS activity of pol k (Fig. 2E), hinting
at the possibility that ubiquitination decreases the enzymatic
activity of pol k, additionally to targeting it for proteasomal
degradation.
4. Summary and perspectives
Taken together, this assembly of very preliminary data suggests
the existence of an inducible repair mechanism for correct incorpo-
ration of C opposite 8-oxo-G in mammalian cells upon induction of
oxidative DNA damage. This induction might be controlled by the
ubiquitin E3 ligases CHIP and/or Mule. It will be appealing to elab-
orate the possible role of ubiquitination in the regulation of pol k.
This is of particularly high interest as there is increasing evidence
hinting towards the fact that misregulation of pol k and also other
TLS pols including pol b can lead to diseases in general [44] and to
cancer in particular [45].
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It is of pivotal importance for genome stability that repair DNA
polymerases (Pols), such as Pols λ and β, which all exhibit consider-
ably reduced fidelity when replicating undamaged DNA, are tightly
regulated, because their misregulation could lead to mutagenesis.
Recently, we found that the correct repair of the abundant and
highly miscoding oxidative DNA lesion 7,8-dihydro-8-oxo-2′-de-
oxyguanine (8-oxo-G) is performed by an accurate repair pathway
that is coordinated by the MutY glycosylase homologue (MutYH)
and Pol λ in vitro and in vivo. Pol λ is phosphorylated by Cdk2/
cyclinA in late S and G2 phases of the cell cycle, promoting Pol λ
stability by preventing it from being targeted for proteasomal
degradation by ubiquitination. However, it has remained amystery
how the levels of Pol λ are controlled, how phosphorylation
promotes its stability, and how the engagement of Pol λ in active
repair complexes is coordinated. Here, we show that the E3 ligase
Mule mediates the degradation of Pol λ and that the control of Pol
λ levels by Mule has functional consequences for the ability of
mammalian cells to deal with 8-oxo-G lesions. Furthermore, we de-
monstrate that phosphorylation of Pol λ by Cdk2/cyclinA counter-
acts its Mule-mediated degradation by promoting recruitment of
Pol λ to chromatin into active 8-oxo-G repair complexes through
an increase in Pol λ’s affinity to chromatin-bound MutYH. Finally,
MutYH appears to promote the stability of Pol λ by binding it to
chromatin. In contrast, Pol λ not engaged in active repair on chro-
matin is subject for proteasomal degradation.
base excision repair ∣ Mule E3 ubiquitin ligase
Genetic stability is of crucial importance for any form of lifeand if not properly maintained can result in many human
diseases (1). Reactive oxygen species (ROS) are among the many
insults that can affect the stability of DNA by causing damage to
the highly reactive DNA bases, such as guanine. Because of its
prevalence and high mutagenic potential, 8-oxo-2′-deoxyguanine
(8-oxo-G) is recognized as one of the most abundant mutagenic
oxidative DNA lesions arising from such insults (reviewed in
ref. 2). The cardinal problem with 8-oxo-G is that the majority
of polymerases (Pols), including the three replicative Pols α, δ,
and ϵ, bypass 8-oxo-G in an inaccurate manner by frequently
incorporating the “wrong” adenine (A) opposite 8-oxo-G. This
error can lead to the formation of GC → TA transversion muta-
tions, which in turn can give rise to diseases such as cancer (3). In
sharp contrast to the other Pols, mammalian Pol λ, a member of
the X family Pols (4), is the main Pol capable of correctly handling
an oxidatively damaged DNA strand with very high fidelity in col-
laboration with the auxiliary factors proliferating cell nuclear anti-
gen (PCNA) and replication protein A (RP-A), and incorporates
over 1000-fold more efficiently the correct cytosine (C) opposite
8-oxo-G than the incorrect A (5, 6) in vitro. Furthermore, we have
shown the existence of an accurate repair pathway for 8-oxo-G that
is coordinated by the MutY glycosylase homologue (MutYH) and
Pol λ in vitro and in vivo (7). These findings suggest that Pol λ is the
most likely candidate among the fifteenmammalian Pols to play an
important role in the accurate repair of oxidative DNA lesions and
that this task is achieved by correctly using the damaged (oxidized)
DNA strand as a template (7, 8).
Components of DNA repair complexes and especially of base
excision repair (BER) need to be tightly regulated in order to
guarantee that they are active only when needed [(9) and as dis-
cussed in ref. 10]. This regulation is of special importance for the
DNA repair Pols, which show a much lower fidelity in polymer-
ization of long stretches of DNA than the replicative Pols, and
therefore could introduce many point mutations when replicating
undamaged DNA. This hypothesis is supported by increasing evi-
dence that deregulation of Pol λ and also other translesion synth-
esis Pols including Pol β can lead to diseases in general (11) and
cancer in particular (12). Also, it has been shown that repair Pols
are overexpressed in many tumors, a feature that may contribute
to disease manifestation (13) further strengthening the idea that a
tight control of repair Pols is pivotal. Nevertheless, the regulation
of DNA repair enzymes, and Pols in particular, is so far poorly
understood. Posttranslational modifications (PTMs) constitute a
fascinating means of regulation to ensure proper temporal and
spatial organization of repair components in the cell. Data from
the Dianov lab have shown that BER components, such as Pol β, a
close relative to Pol λ, undergo ubiquitination by the ubiquitin E3
ligase carboxy terminus of Hsc70 interacting protein (CHIP),
which is an E3 ubiquitin ligase containing a C-terminal U box
domain providing interaction with an E2 enzyme and an N-term-
inal tetratricopeptide mediating its interaction with heat shock
proteins (14). CHIP plays an important role in the heat shock
response (15, 16) and has been shown to be involved in regulating
cellular levels of proteins like p53 (17). CHIP-mediated ubiqui-
tination of Pol β leads to its degradation by the proteasome under
normal circumstances (9, 18). However, upon DNA damage,
those BER proteins are stabilized and recruited to chromatin
to fulfill their roles in the maintenance of genomic integrity
in vivo.
To date, very little is known about the regulation of Pol λ
during the cell cycle. In previous work, we have shown that Pol λ
interacts with cyclin-dependent kinase 2 (Cdk2) and is phosphory-
lated in vitro by the Cdk2/cyclinA complex (19). Phosphorylation
per se does not affect the polymerization activity of Pol λ, but
phosphorylation is decreased when Pol λ interacts with PCNA.
Furthermore, the phosphorylation pattern of Pol λ coincides with
the presence of Cdk2/cyclinA during the cell cycle. In follow-up
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work we demonstrated that phosphorylation prevents Pol λ from
being degraded by the ubiquitin-proteasome pathway in vivo (20).
In the present study, we were interested in elucidating how the
levels of Pol λ are controlled, how phosphorylation promotes its
stability, and how the engagement of Pol λ in active repair com-
plexes is coordinated. We found that Pol λ can be ubiquitinated
by the E3 ligase Mule in vitro and in vivo and that this interaction
is functionally connected to the phosphorylation-dependent sta-
bilization of Pol λ by Cdk2/cyclinA. Importantly, the control of
Pol λ levels by Mule has functional consequences for the ability
of mammalian cells to deal with 8-oxo-G lesions in vitro. Further-
more, we demonstrate that phosphorylation of Pol λ by Cdk2/
cyclinA counteracts its Mule-mediated degradation by promoting
recruitment of Pol λ to chromatin into active 8-oxo-G repair com-
plexes through an increase in Pol λ’s affinity to chromatin-bound
MutYH in vitro and in vivo. Finally, MutYH appears to promote
the stability of Pol λ by binding it to chromatin. In contrast, Pol λ
not engaged in active repair on chromatin is subject for protea-
somal degradation. Our data elucidate how precisely and tightly
PTMs can control Pol λ’s activity status along with its overall
cellular levels by orchestrating its subcellular localization and
stability.
Results
Identification of Mule as E3 Ligase for DNA Polymerase λ. In order to
shed more light on the regulation of Pol λ in vivo, we set out to
identify the E3 ubiquitin ligase responsible for the ubiquitination
of Pol λ. To this end, we tested fractions originating from an assay
established by the Dianov lab (9), where Pol λ ubiquitination
activity was purified from HeLa whole cell extracts in a series
of biochemical fractionations via chromatographic columns com-
bined with an in vitro ubiquitination assay (Fig. S1A). The final
Mono Q fractions D14–D10 clearly displayed Pol λ mono- and
polyubiquitination activity of Pol λ (Fig. 1A), and they were sent
for mass spectrometric analysis to identify the E3 ligase present
in the fractions. The MS/MS data clearly identified Mule to be
the major ubiquitin E3 ligase present in these fractions (18). In
the same fractions, the E3 ligase CHIP was also identified and has
been shown to ubiquitinate Pol λ in vitro (21). Mule is a 482 kDa
protein in which the catalytically active homologous to the E6-AP
carboxyl terminus (HECT) domain has been mapped to the C-
terminal 370 amino acids (22) and has previously been shown
to play a role in the regulation of another member of the Pol
X family, Pol β (18). We thus used the recombinant truncated
catalytically active HECT domain of Mule and confirmed that
this protein mono- and polyubiquitinates Pol λ in a concentra-
tion-dependent manner in vitro (Fig. 1B). The ubiquitination re-
action could be efficiently supported by any of the three E2
conjugating enzymes H5b, H5c, or H7 (Fig. S1B). When the
band of in vitro ubiquitinated Pol λ was excised from a Coomassie
stained SDS-PAGE gel (Fig. S1C) and subjected to MS/MS ana-
lysis, two lysines (K27 and K273) were identified to be ubiquiti-
nated (Fig. S1D). In vitro ubiquitination assays were performed
by using Pol λ with mutated K27, K273, or both residues using a
mutant ubiquitin, not capable of forming polyubiquitin chains, in
order to better quantitatively visualize the total ubiquitination.
Although the single K273R mutant did not display any signifi-
cantly reduced in vitro ubiquitination by Mule, both the single
K27R and the double (K27R/K273R; named K2R) ubiquitina-
tion-deficient mutants of Pol λ showed 10 and 5 times reduced
in vitro ubiquitination by Mule, respectively (Fig. S1E), suggest-
ing that K27 is the major site of ubiquitination. The residual ubi-
quitination of the 2KR mutant Pol λ that was observed most
probably stems from other K residues in the vicinity of K27
and K273 that are minor ubiquitination sites and can be ubiqui-
tinated more strongly after the loss of the two main ubiquitination
sites identified in the MS/MS approach.
Next, we addressed the question of whether Mule also regu-
lates the protein levels of Pol λ in vivo. To test this, we knocked
down Mule in HEK 293T cells by siRNA and found that this
knockdown resulted in a significant increase in Pol λ protein le-
vels (p ¼ 0.006) (Fig. 1 C and D). The increase in Pol λ levels
upon knockdown of Mule was less pronounced, but still signifi-
cant (p ¼ 0.006), in HeLa cells (Fig. S2 A and B), which are
known to overexpress Mule protein (23). At the same time, the
mRNA level of Pol λ remained constant (Fig. S2E), which sug-
gests that transcription of the POLL gene was not affected by
the knockdown of Mule. The effect of the Lipofectamine control
was similar to controls using either nonspecific siRNA or siRNA
against luciferase (Fig. S3 A and B).
Mule directly binds and ubiquitinates targets like p53 (22) and,
thus, represses p53-mediated tumor suppressor functions leading
to cell cycle arrest or aging (24). In response to DNA damage,
the alternative reading frame of the INK4a/ARF locus (ARF)
protein is induced, inhibits the activity of Mule, and thus leads
to a stabilization of Mule targets as p53 (22) and Pol β (18). Im-
portantly, ARF has not been shown to influence the levels of
Mule but merely to inhibit its ubiquitin ligase activity (18, 22).
To test whether this inhibitory effect of ARF on Mule affects
Pol λ levels as well, we next knocked down ARF by siRNA. As
expected, protein levels of Pol λ decreased upon knockdown of
ARF in either HEK 293T (Fig. 1E and F) in HeLa cells (Fig. S2 C
Fig. 1. Identification of Mule as an E3 ubiquitin ligase regulating cellular protein levels of DNA polymerase λ. (A) E3 ubiquitin ligase activity of the final Mono
Q fractions from HeLa cell extracts (D14–D10) against Pol λ protein. (B) Ubiquitination of Pol λ by the purified recombinant HECT domain of Mule. (C) Effect of
siRNA-mediated Mule knockdown on Pol λ levels in HEK 293T cells, analyzed by Western blotting. (D and F) Quantification of protein levels shown in C and E
(three independent experiments each) showing meanþ SD and p values obtained from one-sample t tests performed on the data. The Pol λ signal was normal-
ized to tubulin. (E) Effect of siRNA-mediated ARF knockdown on Pol λ levels in HEK 293T cells, analyzed by Western blotting.
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and D) and reflected the effect of increased Mule activity, even
though the decrease was too small to prove significant (p ¼ 0.204
for HEK and p ¼ 0.166 for HeLa, respectively). At the same
time, the mRNA level of Pol λ remained constant (Fig. S2E),
which further supports the evidence that Mule regulates Pol λ
protein levels by ubiquitination-dependent proteasomal degra-
dation.
The Correct 8-oxo-G Bypass by DNA Polymerase λ Is Regulated
Through Mule.We have previously shown that Pol λ is the Pol that
bypasses 8-oxo-G containing DNA most accurately and incorpo-
rates the correct C opposite the lesion in vitro and that the
specificity of correct nucleotide incorporation is provided by
RP-A, PCNA, and MutYH in vitro (5–7). Therefore, we set out
to determine whether modulation of Pol λ levels by Mule affects
the amount of bypass of 8-oxo-G lesions. To assess this question,
single-nucleotide incorporation assays using crude cell extracts
with a primer-template combination that allows the quantitative
monitoring of the incorporation of incorrect dATP or correct
dCTP opposite a template containing 8-oxo-G (Fig. 2A) were per-
formed as previously described (5). Crude cell extracts fromHEK
293T cells treated with either siRNA against Mule [showing ele-
vated levels of Pol λ (Fig. 1 C and D)] or Lipofectamine as a con-
trol were prepared, and their single-nucleotide incorporation
activity opposite 8-oxo-G was analyzed. The extracts from cells
with a Mule knockdown showed higher levels of correct C incor-
poration opposite 8-oxo-G than the control extracts, consistent
with a role for Pol λ, or another Pol that is regulated by Mule,
in the bypass of 8-oxo-G in vivo (Fig. 2 B and C and Fig. S4).
When the relative differences of dCTP to dATP incorporation
were analyzed, the extracts treated with siRNA against Mule
showed a higher relative difference of dCTP to dATP incorpora-
tion (Fig. 2C) compared to the control-treated extracts. This dif-
ference could be further stimulated by the addition of PCNA and
RP-A to the reaction, which is in line with our previous findings
that PCNA and RP-A stimulate the correct bypass of 8-oxo-G by
Pol λ (5).
To show that the amount of error-free bypass of 8-oxo-G le-
sions specifically depends on Pol λ and not on another Pol, and
to confirm the functional effect of modulation of Pol λ levels by
Mule in another cell line, we knocked down Mule by siRNA in
Pol λþ ∕þ and Pol λ − ∕− mouse embryonic fibroblasts (MEFs)
(Fig. 2D). We found that in Pol λþ ∕þMEFs the cellular protein
levels of Pol λ were increased upon Mule knockdown (Fig. 2D).
Importantly, only in cell extracts generated from MEFs contain-
ing Pol λ (Pol λþ ∕þMEFs) was the incorporation of dCTP high-
er in extracts when Mule was knocked down in comparison to the
Lipofectamine-only–treated cells (Fig. 2 E and F). This result
corroborated the fact that the increase in 8-oxo-G lesion bypass
observed after Mule knockdown specifically depends on Pol λ.
The Phosphorylation Status of DNA Polymerase λ Regulates Its Sub-
cellular Localization and thus Orchestrates Its Degradation Mediated
by Mule. In order to investigate the functional link between the
stabilizing phosphorylation of Pol λ and its degradation by Mule,
we analyzed HEK 293T cells stably transfected with either myc-
Pol λWTor myc-Pol λ 4A (a phosphorylation-deficient mutant of
Pol λ lacking all four phosphorylation sites S167A, S177A,
S230A, and T553A), because we previously observed that the lack
of phosphorylation in this mutant increases its ubiquitination and
thus leads to decreased cellular protein levels (20). As expected,
examination of total cellular protein levels confirmed a reduction
of 75% of the levels of Pol λ 4A compared to the WT protein
(Fig. 3A). Furthermore, the majority of the Pol λWT protein was
present in a phosphorylated form (P-Pol λ), whereas the 4A
mutant clearly showed a faster mobility following SDS-PAGE
analysis. Treatment of these cells with siRNA against Mule dra-
matically increased the levels of Pol λ 4A by 3.9-fold compared to
Fig. 2. The extent of error-free bypass of 8-oxo-G by DNA polymerase λ in human and mouse cell extracts is dependent on Mule. (A) 5′ labeled DNA primer/
template pair used for the single-nucleotide incorporation assays. The first incorporation event is opposite 8-oxo-G. The incorporation of dATP yields a 40-mer
product, whereas incorporation of dCTP gives rise to a 40-mer and a 41-mer. (B) Single-nucleotide incorporation by crude extracts from HEK 293T cells treated
with siRNA against Mule. Experiments were performed with 10 μg of extracts, 10 μM dATP or dCTP, and þ∕− RP-A (40 nM) and PCNA (100 nM), respectively. (C)
Quantification for B, mean of three independent experiments #SD. (D) siRNA-mediated knockdown of Mule in Pol λ þ∕þ or −∕− MEFs. (E) Single-nucleotide
incorporation by extracts shown in D, performed with 10 μg of crude extracts and 0.5 μM dATP or dCTP, respectively. (F) Quantification for B, mean of four
independent experiments #SD.









an increase of 1.4-fold in the WT protein (Fig. 3 B and C), which
hints toward an inhibitory effect of phosphorylation of Pol λ on
its degradation by Mule. In order to examine the mechanism of
this cross-talk between phosphorylation and ubiquitination more
closely, we next fractionated the stable HEK 293T Pol λ WTand
4A cells into cytoplasmic, nuclear, and chromatin-bound protein
fractions. Analysis of these extracts revealed a substantial de-
crease in chromatin-bound Pol λ 4A mutant compared to the
WT protein (Fig. 3 D and E). A different fractionation protocol
of these cells into soluble and chromatin fractions under harsher
conditions further corroborated the difference in chromatin as-
sociation between the WT Pol λ protein and its 4A mutant
(Fig. S5). Taken together, these findings indicated that phosphor-
ylation of Pol λ establishes or enhances its interaction either
directly with chromatin or with a protein tightly bound to chro-
matin and that this binding to chromatin prevents Pol λ from
being degraded by Mule-mediated ubiquitination.
Phosphorylation of DNA Polymerase λ Enhances Its Interaction with
MutYH on Chromatin and thus Regulates Its Activity State in the Cell.
The next question to be addressed was how and why phosphor-
ylation orchestrates the subcellular localization of Pol λ and,
more precisely, its binding to chromatin. We hypothesized that
phosphorylation might enable and/or strengthen the interaction
of Pol λ with a binding partner on chromatin. MutYH, a known
interactor of Pol λ (7), recognizes 8-oxo-G:A mismatches and cat-
alyzes the excision of the wrong A (reviewed in ref. 2). This step is
followed by incision of the apurinic/apyrimidinic (AP) site by the
action of apurinic/apyrimidinic endonuclease 1 (Ape1) to gener-
ate the substrate for Pol that performs the subsequent gap filling
reaction (25). Thus MutYH is a protein that, according to our
model of Pol λ’s involvement in correct incorporation of
C opposite 8-oxo-G (7), precedes the action of Pol λ in repair
of 8-oxo-G lesions. To test whether MutYH influences the
subcellular localization of Pol λ, we treated HEK 293Tcells with
siRNA against MutYH. Fractionation of siRNA- and Lipofecta-
mine-only–treated cells revealed that both the total cellular levels
as well as the chromatin-bound fraction of Pol λ were markedly
reduced upon treatment with siRNA against MutYH (Fig. 4 A
and B). This finding suggested that the interaction of Pol λ with
MutYH stabilizes, and possibly also recruits, Pol λ to chromatin
into active repair complexes and that this interaction is depen-
dent on, or can be enhanced by, phosphorylation of Pol λ. Thus,
we next asked whether the phosphorylation status of Pol λ has any
effect on its binding to MutYH. To investigate this question, re-
combinant purified His-tagged Pol λ was phosphorylated by
Cdk2/cyclinA in an in vitro phosphorylation assay and GST-
pull-down experiments were carried out by using recombinant
GST-MutYH and different amounts of His-Pol λ (Fig. 4C).
The results of this interaction study clearly show that phosphor-
ylation of Pol λ strongly enhances its interaction with MutYH.
Chromatin-association of DNA Polymerase λ Is Inducible by Oxidative
Stress. The ultimate question to be answered was whether this
fine-tuning of Pol λ levels had a physiological relevance under
conditions of increased cellular stress due to oxidative DNA
damage. To address this, cell fractionation experiments were per-
formed by using T24 cells. T24 cells are human bladder carcino-
ma cells with the particular property that they are arrested in the
G0 phase of the cell cycle by contact inhibition upon reaching
100% confluency. Importantly, these cells synchronously reenter
the cycling phase upon seeding and, thus, enable analysis of
synchronized cells without the need to use DNA damaging and
cellular stress-inducing synchronization regimes, which could inter-
fere with cell-cycle-dependent analysis of DNA repair pathways.
G0-arrested T24 cells were seeded, either treated with 500 μM
H2O2 for 45 min or mock-treated in the early S phase and frac-
tionated at 2-h intervals upon release into normal medium. Ana-
lysis of chromatin fractions of H2O2-treated cells revealed an
increase in chromatin-bound Pol λ levels that peaked to 1.7-fold
4 h after release compared to the control fractions, which did not
show alterations in Pol λ levels (Fig. 4D and E). Although the con-
trol cells clearly progressed through S to the G2/M phase, the
H2O2-treated cells arrested in the S phase and failed to enter
G2/M for the duration of the experiment (Fig. 4D). These results
are consistent with an inducible chromatin recruitment of Pol λ
dependent on oxidative DNA damage during the S phase.
Discussion
The data presented in this paper shed more light on the intricate
control mechanisms that are in place to regulate protein levels
of Pol λ, its subcellular localization, and its engagement into ac-
tive repair complexes on chromatin upon induction of oxidative
DNA damage. We now identify Mule as an E3 ligase responsible
for ubiquitination of Pol λ, leading to degradation of Pol λ via the
Fig. 3. Phosphorylation of DNA polymerase λ inhibits its ubiquitination byMule and promotes its binding to chromatin. (A) Total cellular Pol λ protein levels in
HEK cells stably transfected with myc-Pol λ WT or myc-Pol λ 4A constructs. Relative Pol λ levels were normalized to tubulin and are indicated below the
respective column. P-Pol λ, phosphorylated form of Pol λ. (B) siRNA mediated knockdown of Mule or Lipofectamine control treatment in HEK cells stably
transfected with myc-Pol λWTor myc-Pol λ 4A constructs.(C) Quantification for B, mean of three independent experiments þSD. The Pol λ signal was normal-
ized to tubulin. The relative Pol λ levels of siMule treated fractions to the respective Lipofectamine-treated controls are indicated. (D) Cell fractionation of HEK
cells stably transfected with myc-Pol λWTor myc-Pol λ 4A constructs. Cyto ¼ cytoplasmic, Nuc ¼ nuclear, and CHR ¼ chromatin-bound fraction. (E) Quantifica-
tion for D, mean of two independent experiments#SD. The Pol λ signal was normalized to tubulin (for the cytoplasmatic fraction), to fibrillarin (for the nuclear
fraction), or to histone H1 (for the chromatin-bound fraction). H1 ¼ Histone 1.
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ubiquitin-proteasome pathway. Although we found that Mule
mainly monoubiquitinates Pol λ, the formation of di- or polyubi-
quitin chains can also be observed. It is still unclear whether it is
Mule alone that is responsible for the degradation of Pol λ or if,
like in the case of Pol β (18), monoubiquitination by Mule stimu-
lates polyubiquitination by another E3 ligase. The possible role of
the E3 ligase CHIP, also found to ubiquitinate Pol λ in vitro (21),
in the regulation of Pol λ levels in vivo still remains to be assessed.
In line with our findings concerning the regulation of Pol λ levels
by Mule, we demonstrate that this regulation influences the ca-
pacity of HEK 293T cells to perform correct 8-oxo-G repair.
Furthermore, we show that this repair is mainly carried out by
Pol λ, as shown with single-nucleotide incorporation experiments
using Pol λþ ∕þ or Pol λ − ∕− MEF cell extracts depleted of
Mule. Experiments assessing the phosphorylation of Pol λ, which
has previously been found to stabilize Pol λ by decreasing its ubi-
quitination (20), reveal an decrease in chromatin association of
nonphosphorylated Pol λ, as determined by fractionation experi-
ments comparing HEK 293T cells stably transfected with Pol λ
WTor Pol λ 4A phosphomutant. The phosphorylation-dependent
chromatin binding protects and stabilizes Pol λ levels, as it pre-
vents Pol λ from being shuttled to the cytoplasm, where it is sub-
sequently ubiquitinated by Mule (a cytoplasmic protein) and
degraded by the proteasome. Therefore, levels of Pol λ are con-
trolled by means of changes in subcellular localization, which is
dependent on the protein’s phosphorylation status. MutYH is the
DNA glycosylase that catalyzes the excision of an incorrect A op-
posite 8-oxo-G, followed by the action of Ape1, and thus precedes
the role of Pol λ in incorporating a correct C opposite 8-oxo-G.
We show that phosphorylation of Pol λ enhances its binding to
MutYH and that depletion of MutYH in HEK 293T cells leads
to a decrease in total cellular levels of Pol λ, as well as a decrease
in the chromatin-associated Pol λ fraction. Phosphorylation of
Pol λ by Cdk2/cyclinA has been shown to take place in the late
S and G2 phases of the cell cycle. Considering that frequent mis-
incorporation of A opposite 8-oxo-G is performed by the repli-
cative Pols δ and ϵ, high levels of A:8-oxo-Gmispairs are expected
to be present immediately after DNA synthesis in the S phase. It
is pivotal that those mispairs are corrected before mitosis pro-
ceeds, because otherwise GC to TA transversion mutations can
manifest themselves. Under these circumstances, the Cdk2/
cyclinA phosphorylation-dependent recruitment of Pol λ to
chromatin makes a lot of sense, because Pol λ is so far the most
likely candidate to work together with MutYH to achieve a cor-
rect repair of A:8-oxo-G lesions. This model is further substan-
tiated by the finding that the chromatin-bound fraction of Pol λ
can be increased 1.7-fold upon induction of oxidative stress
(Fig. 4 D and E) in the early S phase and is in line with previous
findings implicating the involvement of Pol λ in repair of oxida-
tive DNA damage in vivo (7).
Studies assessing the regulation of Pol β protein levels have
recently shown that the levels of Pol β are regulated by Mule
and CHIP in vivo (9, 18). Importantly, these studies showed that
ubiquitin-mediated proteasomal degradation mainly regulates
the protein levels of Pol β and not its activity. So far, we do not
have any evidence indicating that ubiquitination of either Pol λ or
β influences the choice of a specific Pol in the BER pathway
directly. Rather, the results from this study point to the possibility
that this Pol choice is brought about by other PTMs, as phosphor-
ylation, enabling a subtle regulation of Pol’s subcellular localiza-
tion, and thus contributes to the regulation of its degradation. It
remains to be seen whether the polymerase activity of any of the
repair Pols can be stimulated directly by means of PTMs, if PTMs
control their association with other proteins to form entire repair
complexes, or if their repair activity can be enhanced simply by
changes in subcellular localization.
In the early Lindahl paper, a steady state of 100–500 8-oxo-G
per cell was suggested (26). Subsequent work warned about arti-
factual DNA oxidation during isolation and suggested an amount
of approximately 1,500 8-oxo-G per genome measured (see, e.g.,
ref. 27). Friedberg et al. indicated that around 1,000–2,000 8-oxo-
G can be repaired per cell per day (28). Such a high steady-state
level of DNA oxidation asks for a robust and tightly controlled
repair system. With the data presented here, not only do we ad-
dress the fine-tuning of Pol λ levels during physiological cellular
conditions, we also provide evidence for what occurs upon induc-
tion of oxidative stress. ROS encountering a C:G base pair during
any cell cycle phase devoid of DNA synthesis will lead to the
formation of a C:8-oxo-G base pair, which is a substrate for Ogg1
(reviewed in ref. 2). Ogg1 will remove the damaged base 8-oxo-G,
Fig. 4. Chromatin-binding of DNA polymerase λ is mediated by MutYH, enhanced by phosphorylation of DNA polymerase λ by Cdk2/cyclinA, and inducible by
oxidative DNA damage. (A) Cell fractionation of HEK 293T cells treated with siRNA against MutYH. Cyto ¼ cytoplasmic, Nuc ¼ nuclear, and
CHR ¼ chromatin-bound fraction. (B) Quantification for A, mean of two independent experiments #SD. The Pol λ signal was normalized to tubulin (for
the cytoplasmic fraction), to fibrillarin (for the nuclear fraction), or to histone H1 (for the chromatin-bound fraction). H1 ¼ Histone 1. (C) GST-pull-down
of different amounts of recombinant purified His-Pol λ by recombinant purified GST-MutYH after in vitro phosphorylation of Pol λ WT by Cdk2/cyclinA.
Non-P-Pol, λ ¼ non-phosphorylated control reactions for Pol λ, were carried out as the phosphorylation reaction but without the addition of Cdk2/cyclinA.
Negative control for unspecific binding was carried out by adding GST instead of GST-MutYH to the reactions. Immunoblot: GST ¼ GST-MutYH. (D) Analysis of
chromatin-bound Pol λ levels in T24 cells upon induction of oxidative DNA damage in the early S phase by H2O2 treatment. The Pol λ signal was normalized to
Histone H3 and the 0h control cell time point. The cell cycle progression was monitored by analysis of cyclin E and cyclin B. (E) Quantification of D, mean of two
independent experiments #SD.









and subsequent BER will take care of the resulting AP site. Con-
sequently, 8-oxo-G lesions caused by ROS inflicted on the cell in
any of these nonreplicative phases will mainly necessitate the
action of Ogg1. On the other hand, A:8-oxo-G mispairs are
thought to mainly arise from inaccurate bypass of an 8-oxo-G
lesion by replicative Pols during the S phase. For this reason, late
S and G2 are the phases during which the removal of A opposite
8-oxo-G is needed. This notion is supported by the fact that
MutYH levels reach their maximum during the S phase (29)
and that the repair of A:8-oxo-G mismatches in vivo by MutYH
is fourteenfold more efficient when the substrate is replication-
proficient compared to a nonreplicating one (30). Those results
are in accordance with a replication-associated activity of
MutYH. Hence, because Pol λ is stabilized by phosphorylation
by Cdk2/cyclinA in late S and G2 as well (20), we believe that
the stabilization of an interaction between MutYH and Pol λ
during exactly these phases of the cell cycle can promote repair
of A:8-oxo-G mismatches.
Taken together, we have unveiled an important feature in the
dynamics and control of Pol λ, a repair Pol pivotal for correct
repair of oxidative DNA damage, which is crucial for the main-
tenance of genetic stability. Our results are consistent with a
model in which Pol λ is recruited to and/or retained on chromatin
in a phosphorylation-dependent manner into active repair com-
plexes by MutYH in the late S and G2 phases of the cell cycle.
Importantly, this recruitment is increased upon exposure of
S-phase cells to oxidative DNA damaging agents. This phosphor-
ylation-dependent chromatin recruitment further protects Pol λ
from being sent to the cytoplasm, where it undergoes ubiquitina-
tion by Mule and is then sent for proteasomal degradation.
Materials and Methods
In Vitro Ubiquitination of Pol λ. Purification of the ubiquitination activity for
Pol λ from HeLa whole cell extracts and the in vitro ubiquitination assays
were performed as described in ref. 18.
In Vitro Phosphorylation of Pol λ. This experiment was performed as outlined
in ref. 20.
GST Pull-down Assay of Pol λwith MutYH. This interaction was done as recently
described in ref. 7. Single-nucleotide incorporation assays were performed as
described in ref. 5 with modifications as indicated in the figure legends.
RNAi Interference. Cells were transfected by using the Lipofectamine RNAi
max (Invitrogen) according to the manufacturer’s protocol and analyzed
72 h after transfection.
Statistical Analysis. For all the statistical analysis, the program GraphPad
Prism (www.graphpad.com) was used.
Full Materials and Methods can be found in SI Materials and Methods.
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DNA polymerase (pol) ! is thought to be the leading strand
replicase in eukaryotes, whereas pols " and # are believed to be
mainly involved in re-synthesis steps of DNA repair. DNA elon-
gation by the human pol ! is halted by an abasic site (apurinic/
apyrimidinic (AP) site). In this study, we present in vitro evi-
dence that human pols ", #, and $ can perform translesion
synthesis (TLS) of an AP site in the presence of pol !, likely by
initiating the 3"OHs created at the lesion by the arrested pol !.
However, in the case of pols " and#, this TLS requires the pres-
ence of aDNAgapdownstream from the product synthesized by
the pol !, and the optimal gap for efficient TLS is different for
the twopolymerases. Thepresence of gaps didnot affect theTLS
capacity of human pol $. Characterization of the reaction prod-
ucts showed that pol # inserted dAMP opposite the AP site,
whereas gap filling synthesis by pol" resulted in single or double
deletions opposite the lesion. The synthesis up to the AP site by
pol ! and the subsequent TLS by pols " and# are not influenced
by human processivity factor proliferating cell nuclear antigen
and human single-stranded DNA-binding protein replication
protein A. The bypass capacity of pol " at the AP site is greatly
reduced when a truncated form of the enzyme, which has lost
the BRCA1 C-terminal and proline-rich domains, is used. Col-
lectively, our in vitro results support the existence of a mecha-
nism of gap-directed TLS at an AP site involving a switch
between the replicative pol ! and the repair pols " and #.
Chromosomal DNA replication in eukaryotic cells requires
three DNA polymerases (pols)3: pol !, pol ", and pol #. pol ! is
the only polymerase that has an associated activity for synthesis
of RNA primers and is able to extend from such primers by
synthesizing short stretches of DNA (1, 2). Subsequently, pro-
cessive DNA synthesis is resumed by pol " and/or pol #. Recent
work in yeast supports a model wherein, during normal DNA
replication, pol # is primarily responsible for copying the lead-
ing strand, and pol " is primarily responsible for copying the
lagging strand (3).
Abasic sites (AP sites) arise frequently by spontaneous
hydrolysis of purines in DNA, represent a common intermedi-
ate of numerous DNA repair systems, and are among the most
common endogenous DNA lesions generated during normal
cell growth (4, 5).
An AP site poses a serious problem to the advancement of a
pol because the modified base has lost its coding capacity.
Accordingly, its replication requires the intervention of one or
more Y family polymerases in a process called translesion syn-
thesis or TLS (for reviews see Refs. 6, 7). Recent publications
have shown that among these polymerases human pol $ was
able to insert nucleotides opposite theAP site and extend prim-
ers further past the lesion in vitro (8). Moreover, pol $ showed
higher abasic lesion bypass capacity in vivo than pols %, &, and
Rev1 (9). Furthermore, it has also been reported that an AP site
could be bypassed in vitro by polymerases of other families such
as pol ! (10), pol " in the presence of the processivity factor
PCNA (11), and pols ' and ( (12). Concerning pol #, a limited
capacity of TLS of an AP site has been reported for the yeast
enzyme (13) but not for its human counterpart, which appeared
to be blocked mainly at the base preceding the lesion with
minor incorporation opposite to it (14).
A widely accepted model of DNA lesion bypass is the poly-
merase-switchingmodel that is believed to act at the replication
fork to enable replication to continue by bypassingDNA lesions
that halt the progression of the replicative polymerases. In this
model, protein-protein interactions mediate a pol handoff at
the template-primer terminus from the replicative pol to one or
more specialized polymerases. In eukaryotes, this switching
appears to be mediated by a monoubiquitinated form of the
processivity clamp factor PCNA. A further switch restores the
replicative pol to the primer terminus, and accurate synthesis
resumes (reviewed in Ref. 7).
Conversely, a secondmodel, named gap-fillingmodel, can be
envisaged to account for TLS-assisted bypass of DNA lesions
outside the context of the replication fork, and its purpose
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would be to seal gaps containing lesions resulting from re-prim-
ing events or processing of closely spaced lesions on opposite
DNA strands (7). In contrast to the polymerase-switching
model, the molecular mechanism(s) underlying the gap-filling
model are still largely unknown.
In this work, we report in vitro DNA gap-dependent TLS at
an AP site by human DNA repair polymerases, pol ! and pol ",
in the presence of the replicative human pol #. Human pol$ can
also performTLS that does not appear to depend onDNAgaps.
We also present evidence that TLS by pols ! and " is not influ-
enced by the human processivity factor PCNA and the human
single-stranded DNA-binding protein RPA. We also show that
the capacity of pol ! to bypass an AP site is greatly reduced
when a truncated form of the enzyme, which has lost the BRCT
and proline-rich domains, is used. Taken together, our in vitro
results may suggest the existence of a novel pathway of DNA
repair, gap-directed TLS involving human pols #, !, and ".
EXPERIMENTAL PROCEDURES
Proteins—Recombinant human pol !, RPA, and PCNA were
expressed and purified as described previously (15–17).
Recombinant pol !(244–575) mutant was expressed as
described previously (18) and purified as described previously
(19). Recombinant human pol"was fromTrevigen Inc. (Gaith-
ersburg, MD). Recombinant human pol $ was from Enzymax
(Lexington, KY). Human pol # was purified from HeLa cells
through six purification steps as described previously (14, 20).
The glycerol gradient fraction used in this study had a specific
activity of 24,000 units/mg. Its purity was estimated to be
!50%, and the fraction was devoid of other replicative poly-
merases (14).
DNA Substrates and Chemicals—The 100-mer oligonucleo-
tide templates, either undamaged or containing a synthetic AP
site (tetradroxyfuran moiety), and the oligonucleotide primers
were from Eurogentec. The oligonucleotides complementary
to the 5" end of the templates were from Sigma, and all mole-
cules carried a 5"-phosphate. All oligonucleotides were purified
by PAGE. The DNA substrates used in this study are indicated
in Table 1. Primers were 5"-labeled with T4 polynucleotide
kinase (New England Biolabs) in the presence of [%-32P]ATP
according to the manufacturer’s protocol. Each primer was
mixed with the templates at an equimolar ratio. When neces-
sary, the oligonucleotides complementary to the 5" end of tem-
plates were added to the reaction at an oligonucleotide/tem-
plate ratio of 2:1 to ensure complete hybridization to all
templates. [%-32P]ATP was from PerkinElmer Life Sciences;
dNTPs were from Fermentas Life Science, and ddGTP was
from GE Healthcare. 20# glycerol tolerant gel (GTG) buffer
was from United States Biochemical Corp.
Primer Extension Assays—Reaction solutions of 10 &l were
incubated at 37 °C and contained 0.15 pmol of DNA templates,
50mMHepes, pH 7.5, 5mMMgCl2, 1mMDTT, 200&g/ml BSA,
and 100 &M each of dATP, dCTP, dGTP, and dTTP. The incu-
bation times and the amount of proteins used are indicated in
the legends of the figures. The reactionswere stoppedby adding
5 &l of stop solution containing 0.1% xylene cyanol and 0.1%
bromphenol blue in 90% formamide. Before loading onto the
gel, samples were denatured by heating at 100 °C for 3min. The
reaction productswere resolved on denaturing PAGE (7Murea,
10% acrylamide) run in GTG buffer (90 mM Tris, pH 9, 30 mM
taurine, and 5 mM EDTA) and visualized and quantified using
phosphorimager (GE Healthcare) and ImageQuant software.
The percentage of TLS was calculated as the ratio of the inten-
sity of bands present at the position opposite the lesion or
beyond to the intensity of these bands plus the intensity of the
band present one nucleotide before the lesion.
DNASequencing of Reaction Products—Reaction solutions of
10 &l were incubated at 37 °C and contained 50 mM Hepes, pH
7.5, 5 mM MgCl2, 1 mM DTT, 200 &g/ml BSA; 100 &M each of
dATP, dCTP, dGTP, and dTTP; and 0.15 pmol of DNA tem-
plates containing a single AP site within either a 2- or a 4-nu-
cleotide gap. The 2- and 4-nucleotide gap templates were rep-
licated by pol # for 15min followed by addition of pol " or pol !
for 5 min, respectively. Gap-filled products were converted to
100-mer by addition of 10 units of T4 DNA ligase and incuba-
tion at 37 °C for 10 min. Ligated products were amplified by 30
cycles of PCR in the presence of 1.25 units of Pfu DNA poly-
merase (Fermentas) and 25 pmol of both 5"-ACTACATTTAC-
TTTCAATTACATAATTTCAAATCCTAATAATCT-3" and
5"-TAAGGTAGTAGTATTATAAATTATG-3" primers. PCR-
amplified products from three independent reactions were
pooled and purified. 29 and 28 individual clones were
sequenced after TOPO cloning of the purified products for pols
" and !, respectively (Millegen, Toulouse, France).
Gel Mobility Shift Assay—Reaction of 10 &l contained 0.3
pmol of DNA substrates and 1.5 pmol of pol " in 50 mMHepes,
pH 7.5, 5 mMMgCl2, 1 mM DTT, and 200 &g/ml BSA. After an
incubation time of 15 min at 37 °C, 1 &l of loading buffer (50%
glycerol, 0.20% bromphenol blue, 0.20% xylene cyanol, and
0.2 M EDTA) was added, and the mixture was loaded on an 8%
native gel in 0.5# TBE running buffer (89 mM Tris borate, pH
8.3, and 2 mM EDTA) and electrophoresed at 4 °C at 10 V/cm
for 3 h.
RESULTS
DNA Polymerase ! Requires a DNA Gap with a Specific
Length to Perform Translesion Synthesis in the Presence of DNA
Polymerase #—DNA elongation by human pol # is severely
blocked by an abasic site (14), although human pol ! can bypass
such a DNA lesion (12). We therefore investigated whether pol
! could resume DNA synthesis when pol # was stalled at an AP
site. For initial experiments, the 100-mer template shown in
Table 1a was used. The template contains a unique synthetic
AP site at a defined position, and it was annealed to a primer of
44-mer, because aminimal primer length of$40 bp is required
to maximize the binding and processivity of pol # (21). As
reported previously (14), when incubated with the 100- to
44-mer template-primer (which is defined in this work as sin-
gle-stranded template-primer), pol # was unable to replicate
past the abasic site and stopped primarily at the base preceding
the lesion, with some incorporation opposite the lesion (lane 2
of Fig. 1A and quantified in Fig. 1B). Addition of pol ! (0.25
pmol) at this stage and further incubation for 5 min did not
resume DNA synthesis (Fig. 1A, lane 4).
pol ! is a family X pol that is involved in DNA repair and has
higher incorporation efficiency on gapped than single-stranded
Gap-directed Translesion DNA Synthesis
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DNA (see Ref. 22 and references therein). We therefore con-
structed template-primers containing gaps of different lengths
around the abasic site and tested the capacity of pol ! to per-
form TLS in presence of pol ". To this purpose, we hybridized
the 100:44-mer single-stranded template-primer with oligonu-
cleotides of different lengths placed downstream from the aba-
sic site. With these template-primers, arrest of the elongation
catalyzed by pol " at theAP site results in gaps of a size from1 to
13 nucleotides starting from the base that follow the abasic site
(Fig. 1A). Because pol ! possesses a 5!-deoxyribose-phosphate
lyase activity and it has been shown that a 5!-phosphate present
in a gap strengthens the binding of the enzyme (23), all oligo-
nucleotides placed downstream from the AP site were synthe-
sized with a 5!-phosphate.
As can be seen in Fig. 1A, DNA gaps of 2, 4, and 6 nucleotides
starting from the lesion radically changed the behavior of pol !
that now acquired the capacity to performTLS of the AP site in
the presence of pol " (see lanes 7, 10, and 13). The gaps enabled
pol ! to catalyze both incorporation opposite the lesion and
beyond and to fill the gaps with no or little strand displacement
synthesis consistent with the known limited strand displace-
ment capacity of the enzyme (Fig. 2) (19). The TLS capacity of
pol ! appears to increase from gaps of 2 nucleotides to gaps of
4–6, but it is dramatically reduced with a gap of 13 nucleotides
(see quantifications in Fig. 1B), where the enzyme almost
behaved as with the single-stranded template-primer in lane 4.
Thus it appears that the TLS capacity of pol ! is strongly mod-
ulated by the size of the DNA gap.
As seen in Fig. 1, when 0.25 pmol of pol !were incubated for
5 min with the substrates in the absence of pol ", the products
synthesized were all too short to reach the lesion (lanes 3, 6, 9,
12, and 15). This finding suggested that pol ! catalyzed TLS by
using the 3!OHs created by pol ", arrested either at the base
preceding the lesion or opposite it, rather than using shorter
primers generated during its own synthesis.
To further clarify this point, an experiment was devised in
which the template-primers shown in Table 1b were used. If
one compares template 1a to 1b in Table 1, it can be seen that in
the latter the sequence between the 3!OHof the primer and the
AP site has been changed, so that the only cytosines present in
the template are now within this sequence. This allows specific
inhibition of any elongation from3!OHs in this regionwhen the
chain elongation inhibitor ddGTP is used. Oligonucleotides
were hybridized to this template-primer to create gaps of 4 and
13 nucleotides. The rationale of this approach is that simulta-
neous addition of both pol ! and ddGTP in the presence of the
stalled pol " will abolish any priming contribution not starting
from a pre-existing 3!OH. The result of this experiment is
shown in supplemental Fig. 1. Note that tomaximize the inhib-
itory effect of ddGTP, a concentration of 1 pmol of pol ! instead
of the usual 0.25 pmol was used. As expected, incubation of 1
pmol of pol ! for 5 and 10min in the absence of pol " resulted in
increased synthesis compared with that seen previously with
0.25 pmol (compare lanes 3 and 4 of supplemental Fig. 1 with
lane 3 of Fig. 1). Samples were incubated for 5 and 10 min, and
at 10 min one can see some TLS because of the intrinsic AP
bypass activity of pol !. Addition of ddGTP restrained incorpo-
ration to the first G following the 3!OH of the primer (supple-
mental Fig. 1, lanes 5 and 6). On single-stranded template-
primer, addition of 1 pmol of pol ! in the presence of pol "
induced some TLS, particularly at 10 min, and this is seen also
for the template-primer containing the 13-nucleotide gap (sup-
plemental Fig. 1, lanes 7 and 8 and 15 and 16). However, addi-
tion of ddGTP before addition of pol ! completely abolished
this TLS, indicating that it was due to elongation by pol ! of
pre-existing primers and not of those created by pol " (supple-
mental Fig. 1, lanes 9, 10 and 17, 18). Interestingly, the situation
appeared different with the template-primer containing the
4-nucleotide gap, where a substantial part of the TLS by a high
FIGURE 1. Ability of DNA pol ! to perform translesion synthesis of an AP
site in the presence of DNA pol " depends on the gap size. Experiments
were performed with templates shown in Table 1, part a. The enzymes and
the DNA substrates used are indicated at the top. ss (single-stranded) stands
for template-primer with no oligonucleotides hybridized downstream from
the AP site; 2, 4, 6, and 13 indicate the length of gap regions between the AP
site and the oligonucleotide hybridizeddownstream. Assayswere carried out
as described under “Experimental Procedures.”A, lane 1,nopolymerase pres-
ent. Lanes 2, 5, 8, 11, and 14, reactions incubated for 35minwith 0.025pmol of
pol ". Lanes 3, 6, 9, 12, and 15, reactions incubated for 5 min with 0.25 pmol
of pol!. Lanes 4, 7, 10, 13, and 16, reactionswere incubatedwith 0.025pmol of
pol " for 30 min; then 0.25 pmol of pol ! were added, and incubation was
continued for 5 min. The positions of the primer and of the AP site are indi-
cated. B, quantification of the percentage of TLS calculated as described
under “Experimental Procedures.” Mean" S.D. values for three independent
experiments are indicated. Light gray bars, pol " alone. Dark gray bars, pols "
and ! together.
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amount of pol ! took place also in the presence of ddGTP (sup-
plemental Fig. 1, compare lanes 11 and 12 with 13 and 14),
indicating that in this case pol ! could effectively use 3!OHs
created at the lesion by pol ".
To directly confirm that pol ! could extend past the lesion in
presence of a gap starting from 3!OH generated by pol ", as
suggested by the experiments shown in Fig. 1 and supplemental
Fig. 1, we created two template-primers in which the primer is
either a 45-mer bearing a 3!OH at the base preceding the AP
site or a 45-mer bearing the 3!OH at an A placed opposite the
lesion (Table 1, template-primers 1c). The choice of the latter
template-primer was motivated by our previous results that
showed that either A or C is incorporated by pol " opposite the
AP site (14). To these template-primers, appropriate oligonu-
cleotides were hybridized to generate gaps of 2, 4, 6, and 13
nucleotides, and they were used in reactions with 0.025 pmol of
pol " and 0.25 pmol of pol !.
Fig. 2A shows the results of reactions using the primer ending
at the nucleotide preceding the AP site. As expected, pol " can
incorporate in front of the lesion but is unable to elongate past
it with all the substrates tested (lanes 2–6). On the contrary, pol
! alone can replicate past theAP sitewhen gaps are present and,
importantly, with a gap preference similar to that observed
when the 3!OHs were generated by the arrest of pol " at the
lesion (compare lanes 9–12 of Fig. 2A with lanes, 7, 10, 13, and
16 of Fig. 1A).
Fig. 2B shows the results of reactions with the primer bearing
an A opposite the AP site. As can be seen, pol " is unable to
elongate from this nucleotide, likely because its 3!-5-!-exonu-
clease continuously excised the A, as indicated by the increased
intensity of the band preceding the lesion (compare lanes 2–6
of Fig. 2A with lanes 2–6 of B). Unlike pol ", pol ! can also
replicate from the A opposite the AP site, again with a gap
preference similar to the one observed in Fig. 1. It should be
noted that, as shown in Fig. 1, the amount of ! used in our study
essentially fills the gaps during TLS with no significant strand
displacement synthesis.
Taken together these data strongly suggest that the presence
of gaps of defined size is a major determinant allowing pol ! to
substitute for pol " to bypass the AP site (see also under “Dis-
cussion”). Related to our finding, it is interesting to note that a
recent work has shown that the polymerization activity of
human pol ! increases with DNA gaps from 1 to 4, remains
constant for gaps from 4 to 7, and then drops for gaps from 7 to
10 nucleotides (22).
Full-length DNA Polymerase ! Is Required for the AP Site
Translesion Synthesis in the Presence of DNAPolymerase "—pol
! has two nonenzymatic domains at its N terminus, a BRCA1
C-terminal (BRCT) domain and a proline-rich domain (for
review see Ref. 23). Little is known about the functions of these
domains, but BRCT domains are known to mediate protein-
protein and protein-DNA interactions (24), and both domains
have been suggested to up-regulate or down-regulate fidelity of
pol ! during gap filling activity, depending on the length of the
gaps (22, 25). We therefore compared the AP site TLS capaci-
ties of pol !WTand of the mutant formmissing the BRCT and
proline-rich domains (pol !(244–575)) in the presence or
absence of pol ". The results of this comparison are shown in
Figs. 3 and 4. Fig. 3A, quantified in B, shows that the !(244–
575), with both the 4- and 6-nucleotide gaps depicted in Table
1, had a severely reduced capacity to perform AP site transle-
sion synthesis in the presence of pol " compared with the WT
(compare lanes 5 with 6 and lanes 7 with 8). Note that the two
enzymes displayed the same activity on single-stranded tem-
plate-primer (lanes 3 and 4 of Fig. 3A). Next, we examined the
capacity of the two forms of pol ! to replicate past the AP site
when initiating elongation from a 3!OH preceding the lesion,
using the 100/45 template-primer shown in Table 1c. As can be
FIGURE 2.DNApol! can extendboth fromanucleotide preceding theAP
site and fromanA incorporatedopposite to itwhenplacedwithin aDNA
gap, although DNA pol " cannot. Experiments were performed with the
templates shown in Table 1c. The enzymes and the DNA substrates used are
indicated at the top. ss stands for a template-primerwith no oligonucleotides
hybridized downstream from the AP site, and 2, 4, 6, and 13 indicate the
length of gap regions between the AP site and the oligonucleotide hybrid-
ized downstream. Assays were carried out as described under “Experimental
Procedures.” A, experiments conducted with the template primed with the
45-mer terminating one nucleotide before the AP site. Lane 1, no polymerase
present. Lanes 2–6, reactions incubated for 35 min with 0.025 pmol of pol ".
Lane7,nopolymerasepresent. Lanes 8–12, reactions incubated for 5minwith
0.25pmol of pol!. Thepositions of theprimer andof theAP site are indicated.
B, experiments conducted with the template primed with the 45-mer termi-
natingwith anAopposite to theAP site. Lane 1,nopolymerase present. Lanes
2–6, reactions incubated for 35 min with 0.025 pmol of pol ". Lane 7, no
polymerase present. Lanes 8–12, reactions incubated for 5 min with 0.25
pmol of pol !. The positions of the primer and of the AP site are indicated.
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seen in Fig. 4,A and B, pol !(244–575) had also a clearly dimin-
ished intrinsic capacity to bypass the AP lesion compared with
the WT (compare lanes 4 with 5 and lanes 6 with 7). Note that
neitherWTnormutant pol ! could replicate past theAP site on
single-stranded template-primer or on a template bearing a gap
as long as 13 nucleotides (see lanes 2, 3, 8, and 9 of Fig. 4A and
quantified in B), in agreement with the results previously
shown.
These experiments show the following: 1) a pol ! mutant
lacking its BRCT and proline-rich domains has an impaired
capacity to perform TLS of an AP site in the presence of pol ",
and 2) this defect can be attributed to an intrinsic diminished
capacity to bypass the lesion, therefore suggesting a role of
these domains in facilitating TLS of an AP site by pol !.
DNA Polymerase # and DNA Polymerase ! Show Different
DNA Gap Size Preference for Translesion Synthesis Past an AP
Site in the Presence of DNA Polymerase "—Next we tested
whetherDNAgap sizes could influence, in the presence of pol ",
TLS of an AP site by pol #, another X family repair polymerase
that displays high affinity for very short DNA gaps. A direct
comparison between the TLS capacity of # and ! as a function
of DNA gap size is presented in Fig. 5.
First, it should be noted that on a single-stranded template-
primer and at the same protein concentration (0.25 pmol) pol#
could synthesize up to the AP site but pol ! could not (compare
lanes 5 and 6 with lanes 3 and 4 of Fig. 5A). However, the elon-
gation was blocked at the base preceding the lesion. Therefore,
it appears that pol # cannot bypass the AP site when acting
alone on a single-stranded template-primer. Furthermore, Fig.
5A also shows that neither pol ! nor # can perform TLS by
utilizing primers created by pol " in a single-stranded context
(lanes 7, 8, 13, and 14 and quantified in Fig. 5B). In the presence
of pol " and in agreement with the data shown in Fig. 1, pol !
could easily replicate past the AP site when the gaps were 2 or 4
nucleotides long (lanes 9–12).
Interestingly, pol # also showed the capacity to bypass an AP
site in the presence of pol ", but only when the gap was 2 nucle-
otides long; enlarging the gap to 4 nucleotides abolished the
TLS capacity of pol # (Fig. 5A, lanes 15–18). pol # appeared to
be less efficient than pol ! in TLS of a 2-nucleotides gap (see
quantifications in Fig. 5, B and C), which could be due to the
superior intrinsic capacity of pol ! to replicate an AP site (12).
The different gap size dependence of TLS between pols ! and
# (see also Figs. 7 and 8) corresponds to the preferences of the
respective polymerases for undamaged substrates. pol # fills
preferentially the gaps of one nucleotide, and its incorporation
efficiency decreases with the increase in gap size from 1 to 4
nucleotides (22). To directly investigate the affinity of pol # to
TABLE 1
DNA templates
X indicates the synthetic abasic site on the damaged template or a guanine on the undamaged template. All the oligonucleotides complementary to the 5! end of the 100-mer
templates bear a 5-phosphate.
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the templates-primers used, we measured its binding capacity
to substrates containing AP sites in gaps of 1–4, 6, and 8 nucle-
otides. These substrates were created by first annealing a
66-mer to the 100-mer primer containing the AP site, so that
the primer ended at the base preceding the AP site, as depicted
in Table 1d. Then the appropriate oligonucleotides were
annealed downstream from the lesion to create the substrates
mentioned above. The experiment in supplemental Fig. 2
FIGURE 3. Full-length DNA pol ! is required for the AP site translesion
synthesis in the presence of DNA pol ". Experiments were performed with
templates shown in Table 1a. The enzymes and the DNA substrates used are
indicated at the top. ss stands for template-primer with no oligonucleotides
hybridized downstream from the AP site, whereas 4 and 6 indicate the length
ofgap regionsbetween theAPsite and theoligonucleotidehybridizeddown-
stream. Assays were carried out as described under “Experimental Proce-
dures.”A, lane 1,nopolymerasepresent. Lane 2, reaction incubated for 35min
with 0.025pmol of pol !. Lane 3, reaction incubatedwith 0.25pmol of pol" for
5min. Lane 4, reaction incubatedwith 0.25 pmol of pol "(244–575) for 5min.
Lane 5, reaction incubated with 0.025 pmol of pol ! for 30 min and then 0.25
pmol of pol "was added and incubation continued for 5min. Lane 6, reaction
incubated with 0.025 pmol of pol ! for 30 min, and 0.25 pmol of pol "(244–
575) was then added and incubation continued for 5min. Lanes 7 and 8,were
as for lanes 5 and 6, respectively. The positions of the primer andof theAP site
are indicated. B,quantification of the data fromA, expressed as percentage of
TLS calculatedasdescribedunder “Experimental Procedures.”White bar,pol !
alone.Dark gray bar,pol !plus pol ". Light gray bar,pol !plus pol "(244–575).
FIGURE 4. Capacity of the !(244–575)-truncated form of DNA pol ! to
extend from the nucleotide preceding the AP site is impaired. Experi-
ments were performed with templates shown in Table 1c. The enzymes and
the DNA substrates used are indicated at the top. ss stands for template-
primer with no oligonucleotides hybridized downstream from the AP site,
whereas 4, 6, and 13 indicate the length of gap regions between the AP site
and the oligonucleotide hybridized downstream. Assays were carried out as
described under “Experimental Procedures.” A, lane 1, no polymerase pres-
ent. Lane 2, reaction incubated for 5 min with 0.25 pmol of pol ". Lane 3,
reaction incubated for 5 min with 0.25 pmol of pol "(244–575). Lane 4, reac-
tion incubated for 5minwith0.25pmolofpol". Lane5, reaction incubated for
5 min with 0.25 pmol of pol "(244–575). Lane 6, reaction incubated for 5 min
with 0.25 pmol of pol". Lane 7, reaction incubated for 5minwith 0.25 pmol of
pol "(244–575). Lane 8, reaction incubated for 5 min with 0.25 pmol of pol ".
Lane 9, reaction incubated for 5 min with 0.25 pmol of pol "(244–575). The
positionsof theprimer andof theAP site are indicated.B,quantificationof the
data from A, expressed as percentage of TLS calculated as described under
“Experimental Procedures.” Dark gray bar, pol ". Light gray bar, pol "(244–
575).
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shows that the amount of pol ! bound to the substrate was
highest with a 1-nucleotide gap and diminishedwith increasing
gap size. The reduction in binding efficiency parallels the
decrease of TLS by pol! in the presence of pol ", indicating that
the TLS capacity of the enzyme is directly correlated with its
binding capacity at gaps.
Nucleotide Insertion Opposite the AP Site by Polymerases !
and # during Gap-directed Translesion Synthesis—To deter-
mine the identity of the nucleotide inserted opposite the syn-
thetic abasic site by pol ! and #, we have ligated the elongated
primers to the downstream oligonucleotide and amplified the
full-length products by PCR (see “Experimental Procedures”).
Because Pfu DNA polymerase is blocked by the synthetic AP
site (data not shown), only the newly synthesizedDNA strand is
amplified during the PCR. As shown in supplemental Table 1,
sequencing of individual clones revealed that pol ! TLS of the
AP site in a 2-nucleotide DNA gap context resulted in incorpo-
ration of dAMP opposite the AP site in all the products
sequenced, according to the proposed model of bypass of an
abasic lesion by pol ! (26). However, a 4-nucleotide DNA gap
filling reactions by pol # resulted in single or double dele-
tions opposite the lesion, according to the known misalign-
ment capacity of the enzyme (27). It should be noted that, in
our template sequence, the AP site is followed by a run of 4
thymine residues; therefore, incorporation of dAMP by pol #
opposite the lesion followed by template-primer slippage
and annealing to a downstream thymine can lead to the
observed pattern.
Translesion Synthesis of an AP Site by DNA Polymerase $,
Acting Alone or in the Presence of DNA Polymerase ", Is Not
Influenced by the Presence of DNAGaps—Next, we investigated
the capacity of the human pol $ to perform TLS of an AP site
either in the presence of pol " or when acting alone (Fig. 6). 0.25
pmol of pol $, incubated with single-stranded template-primer
in a running start reaction, synthesized up to the AP site and,
differently from pol ", efficiently incorporated opposite the
lesion (compare lane 4 with lane 2 of Fig. 6A and data not
shown). When the reaction was performed in the presence of
pol ", pol $ performed TLS with the single-stranded template
primer, as indicated by the increase in incorporation in front of
the lesion and the appearance of some full-length products (see
lane 9 of Fig. 6A). However, this TLS was diminished in the
presence of gaps of 2, 4, and 6 nucleotides, and extension
past the lesion was not affected by the increase in their size
(see lanes 10 to 12 of Fig. 6A). This result was different from
what was observed with pol #, where no TLS was observed in
the presence of pol " with a single-stranded template-primer
(see lane 5 of Fig. 6A) whereas efficient gap filling was per-
formed with DNA gap sizes of 2, 4, and 6 nucleotides (see
lanes 6 to 8 of Fig. 6A).
We have also studied the TLS capacity of pol $ when acting
alone on gaps created in a template-primer where the primer is
a 45-mer with a 3!OH at the base preceding the lesion. As
shown in Fig. 6B, pol $ can performTLS on the single-stranded
template (lane 7) but to a lesser extent with gaps of 1, 2, 4, and 6
nucleotides and with no increase in efficiency with the increas-
ing gap size (see lanes 8–11). Conversely, TLS by pol # was
stimulatedwith gap size increasing from 2 to 6 nucleotides (Fig.
6B, lanes 4–6). Note that pol $ showed little TLS also with gap
size of 1 and 2 nucleotides that are optimal for TLS by pol! (see
Fig. 8). Taken together, these results show that, differently from
pol #, TLS of an AP site by pol $ is not stimulated by the pres-
ence of DNA gaps.
FIGURE 5. DNA pol ! favors smaller gap size than DNA pol " in TLS of an
AP site in the presence of DNA pol #. Experiments were performed with
templates shown in Table 1a. The polymerases and the DNA substrates used
are indicated at the top. ss stands for template-primer with no oligonucleo-
tides hybridized downstream from the AP site, whereas 2 and 4 indicate the
length of gap regions between the AP site and the oligonucleotide hybrid-
ized downstream. Assays were carried out as described under “Experimental
Procedures.” A, lane 1, no polymerase present. Lane 2, reaction incubated for
35min with 0.025 pmol of pol ". Lanes 3 and 4, reactions incubated with 0.25
pmolofpol# for 5 and10min, respectively. Lanes 5and6, reactions incubated
with 0.25 pmol of pol! for 5 and 10min, respectively. Lanes 7 and 8, reactions
were incubated with 0.025 pmol of pol " for 30 min, then 0.25 pmol of pol #
were added and the incubation continued for 5 and 10 min, respectively.
Lanes 9–12: as for lanes 7 and 8. Lanes 13 and 14, reactions were incubated
with 0.025 pmol of pol " for 30 min, then 0.25 pmol of pol !were added and
the incubation continued for 5 and 10 min, respectively. Lanes 15–18: as for
lanes 13 and 14. The positions of the primer and of the AP site are indicated.
B,quantificationof thedata fromAwithpol#, expressed as percentageof TLS
calculated as described under “Experimental Procedures.” White bar, pol "
alone. Light gray bars, incubation with pol " and then pol # added for 5 min.
Darkgraybars, incubationwithpol "and thenpol#added for 10min.C,quan-
tification of the data from A with pol !, expressed as percentage of TLS and
calculated as described under “Experimental Procedures.” Light gray bars,
incubation with pol " and pol ! added for 5 min. Dark gray bars, incubation
with pol " and pol ! added for 10 min.
Gap-directed Translesion DNA Synthesis
32100 JOURNAL OF BIOLOGICAL CHEMISTRY !  
<  <SEPTEMBER 16, 2011
 at SM
AC Consortium






PCNA and RPA Do Not Influence the Gap Size Preference of
DNA Polymerases ! and " to Perform Translesion Synthesis of an
AP Site in the Presence of DNA Polymerase #—The processivity
factor PCNA and the single-stranded DNA-binding protein RPA
play a fundamental role in DNA replication, repair, and recombi-
nation (2, 5). Therefore, we studied whether the TLS catalyzed by
pols ! and " at DNA gaps in the presence of pol # could be influ-
enced by human PCNA and RPA. To this aim we performed
experiments by adding 1.2 pmol of PCNA and 0.25 pmol of RPA.
With respect to the 0.15 pmol of template-primer used in the
study, the RPA concentration corresponds to roughly one mole-
cule of RPA for 30 nucleotides of single-stranded DNA.
Fig. 7 shows the results with pol !. As can be seen with a wide
range of DNA gaps (Fig. 7A), pol ! performed TLS with an effi-
ciency dictated by the size of the DNA gaps. This efficiency
increased with gaps from 1 to 4 nucleotides, remained constant
with 6 and8nucleotides, and thendeclined to an almost undetect-
able levelwith thegapof13nucleotides, asquantified inFig. 7B.As
shownpreviously, also in this reaction containing bothPCNAand
RPA, the TLS products length essentially matched the size of the
gaps, although low levels of strand displacement could also be
detected.
Fig. 8 shows the results with pol ". Ast can be seen, the TLS
by pol " is restricted to gaps of 1 and 2 nucleotides, becoming
almost undetectable with a gap of 4 nucleotides or longer (Fig.
FIGURE 6. Influence of DNA gap sizes on translesion synthesis of an AP
site by DNA pol ! and ". Experiments were performed with templates
shown in Table 1. The enzymes and the DNA substrates used are indicated at
the top. ss (single-stranded) stands for template-primer with no oligonucleo-
tides hybridized downstream from the AP site, whereas 1, 2, 4, and 6 indicate
the length of gap regions between the AP site and the oligonucleotide
hybridized downstream. Assays were carried out as described under “Exper-
imental Procedures.” A, experiments with templates in Table 1a. Lane 1, no
polymerase present. Lane 2, reaction incubated for 35minwith 0.025 pmol of
pol #. Lane 3, reaction incubated for 5 min with 0.25 pmol of pol !. Lane 4,
reaction incubated for 5minwith 0.25 pmol of pol $. Lanes 5–8, reaction was
incubated with 0.025 pmol of pol #, and then 0.25 pmol of pol ! were
added, and the reactionwas continued for 5min. Lanes 9–12, reactionwas
incubated with 0.025 pmol of pol #, and 0.25 pmol of pol $ were then
added, and the reaction was continued for 5 min. B, experiments with
templates in Table 1c primed with the 45-mer terminating one nucleotide
before the Ap site. Lanes 1 and 12, no polymerase present. Lanes 2–6,
reactions incubated 5 min with pol !. Lanes 7–11, reactions incubated 5
min with pol $. The positions of the primers, of the AP site, and of the
100-mer full-length product are indicated.
FIGURE7.PCNAandRPAhavenoeffectongapsize specificityofTLSofan
AP site by DNA pol ! in presence of DNA pol #. Experiments were per-
formed with templates shown in Table 1a. The proteins and the DNA sub-
strates used are indicated at the top. ss stands for template-primer with no
oligonucleotides hybridized downstream from the AP site, whereas 1, 2, and
4, 6, 8, 10, and 13 indicate the length of gap regions between the AP site and
the oligonucleotide hybridized downstream. Assays were carried out as
described under “Experimental Procedures.” A, lane 1, no polymerase pres-
ent. Lane 2, reaction incubated for 35minwith 0.025pmol of pol #, 1.2 pmol of
PCNA, and 0.25 pmol of RPA. Lanes 3–10, the reactions were incubated for 30
min with 0.025 pmol of pol #, 1.2 pmol of PCNA, and 0.25 pmol of RPA, and
then 0.25 pmol of pol !were added, and the incubation was continued for 5
min. The positions of the primer and of the AP site are indicated. B, quantifi-
cation of data from Fig. 6A, expressed as percentage of TLS calculated as
described under “Experimental Procedures.”White bar, reaction without pol
!. Gray bar, complete reaction.
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8A). In agreement with the experiments described previously,
the efficiency of TLS by pol ! was lower when compared with
that observed with pol " (quantified in Fig. 8B), and no strand
displacement was observed.
DISCUSSION
pols # and $ are the two eukaryotic polymerases that replicate
DNA. Evidence in yeast supports the conclusion that pol # is
primarily responsible for copying the lagging strand, whereas
pol $ primarily copies the leading strand (3). In addition, these
polymerases also participate in DNA repair processes such as
nucleotide excision repair (NER), long patch base excision
repair (LP-BER), and mismatch repair (2).
Apurinic or apyrimidinic sites are the most frequent sponta-
neous lesions in DNA. A number of polymerases, belonging
mainly but not exclusively to the Y family polymerases, can
perform in vitro TLS of an AP site (9, 28). pols " and !, two
polymerase of the X family believed to be implicated in re-syn-
thesis steps of DNA repair, can also bypass an abasic site (12).
Althoughmuch information is available in the literature con-
cerning the capacity of pol # to deal with an AP site (11, 29),
such information is scarce for pol $, particularly for the human
enzyme. In a recent publication, we have shown that in vitro
elongation by human pol $ stopped predominantly at the base
preceding the lesionwith roughly 10%of residual incorporation
opposite to it (14).
As indicated in the Introduction, it is generally accepted that
duringTLS specialized polymerases replace arrested replicative
polymerases at lesions to allow bypass. We have investigated
the ability of human pols ", !, and % to perform TLS of an AP
site in the presence of short DNA gaps created by the arrest of
human pol $ at the lesion. To this aimwe have set up a system in
which pol $ synthesizes on a DNA oligonucleotide template-
primer leaving gaps with lengths spanning from 1 to 13 nucle-
otides because of stalling at the AP site (Table 1).
pol " cannot bypass an AP site in the presence of pol $ if a
single-stranded stretch of 35 nucleotides is present down-
stream from the lesion, but it can do it with gaps from 1 to 10
nucleotides, with a maximum efficiency around 4 to 6 and with
almost no TLS with a gap of 13 nucleotides (Figs. 1, 3, 5, and 7).
Furthermore, our data indicate the following: (a) pol " can
bypass an AP site by using the 3!OHs generated by the arrest of
pol $ at the lesion (supplemental Fig. 1); (b) it can act alone to
bypass the AP site only when the lesion is present in a gap
context and, importantly, with a gap preference similar to the
one observed in the presence of pol $ (Fig. 2); (c) the BRCT and
proline-rich domains of the pol " are required for efficient TLS
of the lesion (Figs. 3 and 4). These results show that pol " can
replace pol $ and bypass an AP site utilizing 3!OHs created by
the arrest of pol $ at the base preceding the lesion or opposite to
it. Most interestingly, this switch can take place only on short
DNA gaps, whose size strongly influences the efficacy of the
process, and bypass of an AP site requires the presence of the
BRCT and proline-rich domain of the pol ". We attempted to
further characterize this scenario by investigating directly the
binding capacity of pol "with the gapped DNA substrates used
in this study. In contrast to experiments with pol ! (see below),
we were unable to detect stable interaction between pol " and
FIGURE8.PCNAandRPAhavenoeffectongapsize specificityofTLSofan
AP site by DNA pol ! in the presence of DNA pol ". Experiments were
performedwith templates shown in Table 1a. The proteins and the DNA sub-
strates used are indicated at the top: ss stands for template-primer with no
oligonucleotides hybridized downstream from the AP site, whereas 1, 2, and
4, 6, 8, 10, and 13 indicate the length of gap regions between the AP site and
the oligonucleotide hybridized downstream. Assays were carried out as
described under “Experimental Procedures.” A, lane 1, reaction incubated for
35 min with 0.025 pmol of pol $, 1.2 pmol of PCNA, and 0.25 pmol of RPA.
Lanes 2–9: the reactions were incubated for 30 min with 0.025 pmol of pol $,
1.2 pmol of PCNA, and 0.25 pmol of RPA, and then 0.25 pmol of pol ! were
added, and the incubation was continued for 5 min. The positions of the
primer and of the AP site are indicated. B, quantification of data from Fig. 7A,
expressed as percentage of TLS calculated as described under “Experimental
Procedures.”White bar, reaction without pol !. Gray bar, complete reaction.
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DNA substrates under a variety of conditions. However, our
results are in full agreement with the gap size preference of pol
! on undamaged DNA recently published (22).
pol" can also catalyzeTLSof anAP site in the presence of pol
#, but only if the gaps have a size of 1–3 nucleotides, with an
efficacy of 1 ! 2 ! 3 nucleotides and with no bypass of an AP
site at gaps longer than 3 nucleotides (Figs. 5 and 8 and data not
shown). This preference parallels the binding affinity of pol "
for the DNA substrates, as can be seen in supplemental Fig. 2,
and it is in agreement with the fact that its incorporation effi-
ciency for undamaged substrates is the highest with 1 nucleo-
tide gap and then decreases with the increase of gap size (22).
The efficiency of TLS by pol " appears to be reduced compared
with the one displayed by pol !, likely because of the superior
intrinsic capacity of pol ! to replicate an abasic site (12).
Sequencing of the replication products revealed that pol "
exclusively inserts dAMP in front of the abasic site in the con-
text of a 2-gap substrate, whereas pol ! bypass of an AP site in a
4-gap substrate induces single or double deletions (supplemen-
tal Table 1). Insertion of dAMP by pol " is in accordance with a
previous model of pol " translesion synthesis of an abasic site
that revealed its predisposition to inserting a nucleotide com-
plementary to the first downstream templating base, which is a
thymine in our template sequence (26). The observed behavior
of pol ! fits with the scrunching gap-filling model derived from
crystal structures of the ternary DNA-pol !-dNTP complex
(30).
pol $ was also proficient in TLS of an AP site when acting
alone or in the presence of pol #. However its TLS capacity was
not stimulated by the presence of DNA gaps (Fig. 6).
PCNA increases the processivity of the replicative pol % (2),
but its capacity to stimulate or not the processivity of pol #
remains controversial, possibly depending on the type of DNA
substrates and experimental conditions used (31–34). Further-
more, PCNA has been shown to stimulate TLS of an AP site by
pol ! when placed on a 73-mer template, 31 nucleotides away
from the 17-mer primer (35).
Because PCNA and RPA play a fundamental role in DNA
transactions such as DNA replication, repair, and recombina-
tion, we set up to studywhether the TLS catalyzed by pols ! and
" at DNA gaps in the presence of pol # would be influenced by
these proteins. When compared with previous figures, Figs. 7
and 8 show that PCNA and RPAhad no effect. In addition, Figs.
7 and 8 summarize the major findings of this work by showing
that human pols ! and " can perform TLS of an AP site in the
presence of human pol #, PCNA, and RPA only in DNA gaps no
longer than 10 nucleotides. However, the two polymerases
show distinctly different DNA gap size preference and effi-
ciency in performing such TLS.
Accordingly, our results suggest the simple model shown in
Fig. 9, in which the different role of pol " and ! in extending
primers generated by pol # arrested at an AP site can be visual-
ized.When long single-stranded DNA stretch is present down-
stream from the lesion, neither pol has sufficient affinity for the
DNA substrate to displace pol # and continue DNA synthesis
past the AP site (Fig. 9a). When the gap downstream from the
lesion is only 1 or 2 nucleotides long, both pols " and ! could
use their affinity for such gaps to bind and perform TLS (Fig.
9b). If the gap size is between 4 and 10 nucleotides, only pol !
would have the capacity to bind and extend past the lesion (Fig.
9c). If the gap size is larger than 13 nucleotides, neither ! nor "
could bind productively, and we are back to the initial situation
with single-stranded DNA downstream from the AP site (Fig.
9d).
What might be the physiological significance of our in vitro
observations? At least two possibilities exist. The first concerns
DNA repair, namely NER and LP-BER pathways. In mamma-
lian cells, it has been shown that pol # can fill the gap of about 27
nucleotides that is produced during NER in a reaction that
includes PCNA and RPA (36). The redundant roles of pols %
and # have been confirmed during NER of a defined lesion
reconstituted with recombinant or highly purified factors in
vitro (37). The requirement of pol # and RPA in the re-synthesis
step of NER in human cells has been further demonstrated
recently, together with another pathway involving pols % and &
(38). Because AP sites are among the most frequent endoge-
nous lesions, it is possible that the removal of the damaged
27-mer during NER uncovers an AP site in the DNA template
sequence of the gap to be filled. This gap filling will be per-
FIGURE 9. Tentative model of TLS over an AP site by DNA pol ! and " in
the presence of DNA pol #. For details see text.
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formed first by pol ! up to the lesion and subsequently by pol "
or # depending on the distance of the AP site from the 5! end of
the gap.
A similar situation can arise during the long patch BER path-
way. It has been suggested that either pol ! or pol $ catalyzed
elongation during long patch BER synthesis (39), and it has
been shown that both polymerases can participate in the re-
synthesis step of long patch BER (40). Furthermore, it is now
known that two clustered DNA lesions enhance the mutagen-
icity of individual lesions (for review see Ref. 41). This observa-
tion suggests that the delayed repair at one lesion because of the
initiation of repair on the opposite strand can lead tomutagenic
TLS of the unrepaired damage. Inmammalian cells, pols !,#, or
" could sequentially perform the replication of an AP site dur-
ing LP-BER of clustered DNA lesions in the way suggested by
our model.
The second possibility concerns gap-directed TLS in con-
nection with DNA replication where small single-stranded
DNA gaps accumulate along replicated duplexes. Such gaps
may arise either by re-priming of the leading strand (42) or the
initiation of a new Okazaki fragment (42, 43). Gap-directed
lesion bypass has the advantage that the TLS may be separated
from the fork progression, and in fact, recent results suggest
that a considerable fraction of TLS occurs in the G2/M phase of
the cell cycle, when DNA replication has essentially completed
(44). As in repair-dependent, gap-directed TLS, the nature of
the lesion and the size of the gap may determine which poly-
merase could be best suited for the bypass.
In summary, although based on in vitro experiments, our
study suggests the existence of DNA gap-directed TLS of an
abasic site involving human pols !, ", and #, and it might serve
as a working model for further investigations.
Acknowledgment—We thank Dr. Neil Johnson for critical reading of
the manuscript.
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IQWKHIROORZLQJWKHXQSXEOLVKHGSURFHGXUHVDQGUHVXOWVRIDVLGHSURMHFWLQLWLDWHGLQDQDWWHPSWWRFODULI\WKHWUXHrelevance  of  Pol  h  in  repair  of  8-­oxo-­G  damage  in  vivo  are  presented.
Introduction  and  background  of  the  approach
To  approach  the  question  whether  Pol  h  is  truly  relevant  in  repair  of  8-­oxo-­G  in  vivoDSURFHGXUHWKDWKDVEHHQHVWDEOLVKHG
E\=YL/LYQHK¶VODELQ,VUDHOZDVXVHGDVRXWOLQHGLQWKHIROORZLQJ,QVKRUWDJDSSHGSODVPLGZLWKDVLQJOH
stranded  region  containing  an  8-­oxo-­G  lesion  was  constructed.  This  gapped  plasmid  was  transfected  into  mammalian  
cells  that  were  harvested  after  an  appropriate  incubation  time.  The  single-­strand  gap  opposite  the  lesion  was  closed  by  
the  cellular  TLS  and  repair  machinery  of  the  cells.  After  an  alkaline  lysis  step  to  eliminate  any  not  fully  double-­strand  
SODVPLG LH DOO JDSSHGSODVPLGV LQZKLFK WKH JDSKDV QRW EHHQ FRPSOHWHO\ FORVHGE\ WKH FHOOXODUPDFKLQHU\ WKH
SODVPLGZDVH[WUDFWHGDQGSXUL¿HG7RGHWHUPLQHKRZDFFXUDWHO\WKHJDSRSSRVLWHWKHOHVLRQKDGEHHQFORVHGGLIIHUHQW
DSSURDFKHVZHUHSXUVXHGIURPWKLVSRLQWIRUZDUG,QSRVVLELOLW\QXPEHURQHWKHRULJLQDODVVD\GHYLVHGE\=YL/LYQHK
the  extracted  plasmid  mix  was  transformed  into  E.coli  mutY-­/-­  and  the  plasmids  in  the  resulting  colonies  were  subject  
WRVHTXHQFLQJDQDO\VLVUHYHDOLQJZKDWQXFOHRWLGHZDVLQVHUWHGRSSRVLWHWKHOHVLRQLQWKHPDPPDOLDQFHOOVLQWKH¿UVW
SODFH)RUWKLVLWLVLPSRUWDQWWRNHHSLQPLQGWKDWWKHE.coli  strain  used  for  the  transformation  is  mutY-­/-­  as  the  bacterial  
MutY  would  otherwise  have  removed  any  A  incorporated  opposite  8-­oxo-­G  and  thus  have  led  to  an  incorrectly  low  rate  
RIWUDQVYHUVLRQPXWDWLRQV$VDVHFRQGSRVVLELOLW\WRGHWHUPLQHWKHUDWHRIFRUUHFWR[R*E\SDVVWKHR[R*OHVLRQ
was  introduced  into  a  sequence  context  that  allowed  cleavage  by  a  restriction  enzyme  in  the  case  of  reconstitution  of  the  
FRUUHFW&*EDVHSDLULQJZKHUHDVWKLVUHVWULFWLRQVLWHZDVORVWXSRQWKHRFFXUUHQFHRID&*J  AT  transversion  mutation.  







in  a  real-­time  cycler.  
,QRUGHUWRDGGUHVVWKHQDWXUHRIWKH3ROLPSRUWDQWIRUWKHQRQPXWDJHQLFR[R*WUDQVOHVLRQV\QWKHVLVDNQRFNGRZQ
RIGLIIHUHQW3ROVE\VL51$ZDVSHUIRUPHG7KH\LQFOXGHG3ROVIURPIRXUPDPPDOLDQ3ROIDPLOLHV3ROVae  and  n  
RIWKHIDPLO\$WKH3ROV_b¡  and  cIURPWKHIDPLO\%WKH3ROV`h  and  +IURPWKHIDPLO\;DQGWKH3ROVgdf  and  
5HYIURPWKH<IDPLO\RI7/63ROVVHHDOVRTable  1IRUGHWDLOVRIWKH3ROV
Materials  and  methods
Production  of  the  substrates  for  the  assay  
,QRUGHUWRHVWDEOLVKWKHWUDQVOHVLRQV\QWKHVLV¿GHOLW\DVVD\GHYHORSHGE\=YL/LYQHK¶VODERUDWRU\WKHSODVPLGS6.6/
and  the  E.coli  muty-­/-­  strain  were  received  from  the  Livneh  lab.  Next  chemically  very  competent  E.coli  muty-­/-­  were  













site  of  the  8-­oxo-­G  in  the  damage-­carrying  oligonucleotide.  The  FauI  restriction  site  is  only  present  when  a  correct  
&*EDVHSDLULQJLVSUHVHQW
,QWRWDOWKHIROORZLQJFRQVWUXFWVZHUHSURGXFHG
   -­  Gapped  plasmid  with  normal  G  in  the  single-­strand  region








,Q RUGHU WR GHWHUPLQH ZKHWKHU WKH DOOHOHVSHFL¿F 3&5 $63&5ZDV D IHDVLEOH RSWLRQ WR DGGUHVV WKH LGHQWLW\ RI




FDUU\LQJDQR[R*&IURPDQR[R*$EDVHSDLULQJZKLFKUHSUHVHQW WKH UHDFWLRQ LQWHUPHGLDWHVDIWHUJDS¿OOLQJ
EXWVWLOOEHIRUHWKHR[R*EDVHKDVEHHQH[FLVHG)XUWKHUPRUHWKHDVVD\DOVRZRUNHGLQWKHH[WUDFWVIURP+H/DFHOOV
WUDQVIHFWHGZLWKWKHJDSSHGSODVPLGV7KXVWKHSURRIRISULQFLSOHIRUXVLQJWKH$63&5IRUWKHGHWHUPLQDWLRQRIWKH
nucleotide  inserted  opposite  the  8-­oxo-­G  could  be  given.  
Assessment  of  the  FauI  restriction  approach  
The   original   assay   by   Livneh   uses   transformation   of   the   plasmid   extracts   from   mammalian   cells   into  
muty-­/-­EDFWHULDPLQLSUHSSLQJRIWKHJURZLQJFRORQLHVDQGVXEVHTXHQWVHTXHQFLQJWRGHWHUPLQHWKHQXFOHRWLGHLQVHUWHG




Transformation  of  gapped  plasmids  into  mammalian  cells
)RUPDPPDOLDQFHOOWUDQVIHFWLRQZLWKWKHJDSSHGSODVPLGVLQLWLDOO\WZRGLIIHUHQWLQFXEDWLRQWLPHVDQGKRXUVZHUH
FKRVHQ7KLVZDVGXHWRIROORZLQJUHDVRQLQJ¿UVWO\$YNLQet  al.  used  the  7h  time-­point  in  their  publication  because  
MutYH  is  not  supposed  to  excise  wrongly  incorporated  A  opposite  8-­oxo-­G  at  this  early  time  point.  This  was  important  
IRUWKHDSSURDFKDVWKHDLPZDVWRGHWHUPLQHWKHprimaryWUDQVOHVLRQV\QWKHVLV¿GHOLW\VRLWZDVDSUHUHTXLVLWHIRUWKH




yield  completely  repaired  plasmids  that  do  not  carry  any  lesion  anymore.  Restriction  digestion  of  plasmids  from  muty-­
/-­  colonies  obtained  from  incubations  of  the  gapped  plasmids  in  HeLa  cells  for  7  or  24  hours  revealed  the  presence  of  a  
PXWDWLRQLQDQGRIDQGSUHSVDQDO\]HGTable  26HTXHQFLQJRIWKHPXWDWHGSUHSVUHYHDOHG&*J  AT  
WUDQVYHUVLRQVEHLQJSUHVHQWLQDQGRXWRIDOOWKHSUHSVUHVSHFWLYHO\7KHPXWDWHGSODVPLGVQRWVKRZLQJD
&*J  AT  transversion  displayed  mostly  small  deletions.  These  data  are  slightly  lower  but  still  in  line  with  the  mutation  
rate   established   by  Avkin  et   al.ZKR VDZRIZURQJ$ LQFRUSRUDWLRQ DIWHU K LQFXEDWLRQ LQ+ FHOOVZKHQ
DQDO\]LQJDWRWDORISUHSVE\VHTXHQFLQJ7KHVHUHVXOWVGHPRQVWUDWHGWKHUHSURGXFLELOLW\RIWKHDVVD\LQRXUKDQGV
Furthermore  it  can  be  said  that  the  restriction  analysis  for  the  screening  of  preps  to  be  sequenced  was  clearly  proven  to  
EHKHOSIXOIRUWKLVDSSURDFKDVWKH\VLJQL¿FDQWO\ORZHUHGWKHQXPEHURISODVPLGVLQQHHGIRUVHTXHQFLQJ







Table  2:  Mutational  analysis  by  restriction  digestion  versus  sequencing*














1        
2        
3        
4     -­ -­
Mean  7$  
([WUDFWVIURPPDPPDOLDQFHOOVWUDQVIHFWHGZLWKWKHR[R*EHDULQJJDSSHGSODVPLGIRUKDQGKUHVSHFWLYHO\
were  transformed  into  E.coli  myh-­/-­.  Single  colonies  were  picked  and  plasmid  isolation  was  performed.  The  plasmid  
SUHSDUDWLRQVZHUHVXEMHFWWRUHVWULFWLRQGLJHVWLRQZLWK)DX,DQGDQDO\VHGRQDQDJDURVHJHO7KHSHUFHQWDJH
RISUHSDUDWLRQV\LHOGLQJRQO\OLQHDU'1$LVVKRZQLQFROXPQVDQGIRUWKHKDQGKLQFXEDWLRQVUHVSHFWLYHO\
Subsequently   the   region  of   the   lesion-­bearing   insert  of  plasmids  yielding  only   linear  DNA  after  digestion  was  
VHTXHQFHG7KH&*ĺ$7WUDQVYHUVLRQVLQUHODWLRQWRWRWDODPRXQWRISUHSDUDWLRQVDQDO\VHGDUHVKRZQLQFROXPQV
DQGUHVSHFWLYHO\
Table  3:  Comparison  of  the  AS-­PCR  to  restriction  analysis  and  sequencing*







HeLa 8-­oxo-­G   7$






RI WKH LQLWLDO VLQJOHH[SHULPHQWV LQ+H/DZLWKNQRFNGRZQRI3ROV`e  and  dDVGHWHFWHGE\$63&5 UHVWULFWLRQ
analysis  and  sequencing  are  summarised  in  Table  4$JHQHUDOWHQGHQF\VHHPVWREHWKDWWKH$63&5\LHOGVFRQVLVWHQWO\
ORZHU QXPEHUV RI$7 WUDQVYHUVLRQV DV WKH VHTXHQFLQJ UHVXOWV ,W UHPDLQV WR EH GLVFXVVHG IXUWKHUZKLFK RI WKH WZR
DSSURDFKHVFDQEHWUXVWHGPRUHDQGLIWKRVHUHVXOWVVKRZDQ\VLJQL¿FDQWGLIIHUHQFHVZKDWVRHYHU
As  the  knockdown  of  Pol  hZDVVWLOOFDXVLQJSUREOHPVDWWKDWWLPHZHGHFLGHGWRFKHFNWKHWUDQVOHVLRQV\QWKHVLV¿GHOLW\
in  h-­/-­   and  b/h-­/-­0()V$GGLWLRQDOO\0()VVWDEO\ WUDQVIHFWHGZLWK3ROh  wt  and  Pol  h7$DSKRVSKRGHIHFWLYH
PXWDQWZHUH HYDOXDWHG LQ WKH VDPH VHWXS5HVXOWV IURP WKH LQLWLDO VLQJOH H[SHULPHQWV HYDOXDWHGE\$63&5DUH
summarised  in  Table  5.  Those  results  do  not  show  any  striking  differences  between  the  cell  lines  either.  In  conclusion  it  
VHHPVWKDWWKHUHDUHQRELJGLIIHUHQFHVLQWKHLQLWLDOWUDQVOHVLRQV\QWKHVLVVWHSLQWKHGLIIHUHQW3ROEDFNJURXQGV
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HeLa 1RQVSHFL¿F 8-­oxo-­G 7.8    
1RQVSHFL¿F Normal  G  -­ -­
HeLa 3ROȕ 8-­oxo-­G 9.1    
3ROȕ Normal  G  -­ -­
HeLa 3ROș 8-­oxo-­G 7.9    
3ROș Normal  G  -­ -­
HeLa 3ROȘ 8-­oxo-­G 8.6    
3ROȘ Normal  G  -­ -­
Table  5:  Results  from  transfection  of  gapped  plasmids  into  different  MEF  cell  lines  for  7h,  analysed  by  AS-­PCR.
&HOOV Genotype Plasmid 7$QRUPDOL]HG
MEF +/+ 8-­oxo-­G 
+/+ Normal  G 
MEF h<< 8-­oxo-­G 8.9
h<< Normal  G 
MEF `h<< 8-­oxo-­G 8.2
`h<< Normal  G 
MEF +  wt    h 8-­oxo-­G 9.2
+  wt    h Normal  G 
MEF +  h    T553A 8-­oxo-­G 9.4
+  h    T553A Normal  G 
Repair  of  8-­oxo-­G:A  mismatch  in  vivo  by  MutYH




to  be  initiated  by  the  action  of  MutYH.  It  might  thus  be  of  importance  that  MutYH  acts  on  the  8-­oxo-­G:A  mismatch  to  
UHFUXLWZKDWHYHUUHSDLU3ROPLJKWEHLQYROYHGLQWRWKHIROORZLQJR[R*E\SDVVVWHS7RDGGUHVVWKLVTXHVWLRQSODVPLGV
containing  a  fully  double-­stranded  insert  with  an  8-­oxo-­G:A  mismatched  base  pair  were  transfected  into  mammalian  
FHOOVDQGKDUYHVWHGDWGLIIHUHQWWLPHSRLQWV7KH¿UVWJRDOZDVWRGHWHUPLQHWKHNLQHWLFVRIWKHJO\FRV\ODVHDFWLYLW\RI
MutYH  in  such  an  experimental  set-­up  in  vivoDVKDGEHHQVKRZQDOUHDG\E\/H3DJHet  al.,QWKDWSDSHUWKH
NLQHWLFVRI0XW<+DFWLYLW\ZDVVKRZQWREHUDWKHUVORZ\LHOGLQJLQ&RVDQG05&9FHOOVRQO\RIUHSDLUK
after  transfection  and  taking  as  long  as  72h  to  observe  complete  repair  of  the  8-­oxo-­G:A  mismatch.  










somehow  failed  to  detect  this  repair.  Whether  one  of  those  two  observations  really  holds  true  remains  to  be  determined  
in  future  experiments.
Another  issue  that  arose  was  the  purity  of  the  8-­oxo-­G:A  fully  double-­stranded  plasmid.  Analysis  of  preparations  of  these  
SODVPLGVUHYHDOVDFRQWDPLQDWLRQRIOLQHDUDQGRUQLFNHGIRUPVRIWKHSODVPLGEHLQJSUHVHQW7KHVHSODVPLGV\LHOGDIWHU






Final  remarks  for  alternative  approaches
AV¿QDOUHPDUNWKHUHDUHVHYHUDOOLQHVRIDFWLRQWKDWFRXOGEHSXUVXHGLQRUGHUWRE\SDVVWKHGLI¿FXOWLHVUHJDUGLQJthe  MutYH-­related  glycosylase  activity.  
One   possibility   is   to   try   and   use   the   8-­oxo-­G:A  plasmid   in   an   in   vitro   system  with  mammalian  whole   cell  
extracts.  This  might  enable  the  in  vitroUHODWHGGLI¿FXOWLHVWREHRYHUFRPHDQGFRXOG\LHOGLQWHUHVWLQJGDWD+RZHYHUWKH
main  focus  –  to  demonstrate  what  is  happening  in  vivo  with  8-­oxo-­G  bypass  –  would  then  be  lost.  





YLUDO RULJLQV WKDW ¿UH FRQVWDQWO\ DQG WKXV DOORZ WKH OHVLRQEHDULQJ SODVPLG WR µHVFDSH¶ IURPGHWHFWLRQ E\ H[WHQVLYH
replication.  
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SUMMARY  OF  THE  MAJOR  FINDINGS
,QRUGHUWRJLYHDFOHDURYHUYLHZRIWKHGLIIHUHQWLPSRUWDQWUHVXOWVREWDLQHGLQWKHFRXUVHRIZRUNRQWKLVWKHVLVDOLVWRI
WKHPDMRU¿QGLQJVLVJLYHQEHORZ
 Pol  hLVXELTXLWLQDWHGE\WKH(OLJDVH&+,3in  vitro.
 Pol  h  is  ubiquitinated  by  the  E3  ligase  Mule  in  vitro  and  in  vivo.
 Ubiqutination  of  Pol  hE\0XOHLQÀXHQFHVFHOOXODUSURWHLQOHYHOVRI3ROhby  targeting  it  for  proteasomal  degradation.
 Regulation  of  cellular  levels  of  of  Pol  hE\0XOHLQÀXHQFHVWKHFDSDFLW\RIPDPPDOLDQFHOOVWRFRSHZLWKR[R*
lesions.
 Phosphorylation  of  Pol  hE\&GN&\FOLQ$VWDELOL]HVSURWHLQOHYHOVRI3ROh  by  increasing  its  chromatin-­association  
 Increased  chromatin-­association  of  phosphorylated  Pol  h LVEURXJKWDERXWE\HQKDQFLQJ WKHDI¿QLW\RI3ROh   to  
chromatin-­bound  MutYH.
 Increased  chromatin-­binding  of  phosphorylated  Pol  h  counteracts  the  degradation  of  Pol  h  by  Mule.




RLJKWDIWHUK\GURJHQDQGKHOLXPR[\JHQ2LVE\PDVVWKHWKLUGPRVWDEXQGDQWHOHPHQWRFFXUULQJLQWKHXQLYHUVHDQGWKHPRVWDEXQGDQWLQRXUELRVSKHUHDLUVHDDQGODQG2LVHVVHQWLDOIRUWKHFHOOXODUUHVSLUDWRU\FKDLQLQ DOO DHURELF RUJDQLVPV DQG LV XVHG LQPLWRFKRQGULD WKH FHOOXODU SRZHU SODQWV WR KHOS JHQHUDWH DGHQRVLQH
WULSKRVSKDWH$73LQDSURFHVVFDOOHGR[LGDWLYHSKRVSKRU\ODWLRQ$73±VRPHWLPHVUHIHUUHGWRDVµPROHFXODUFXUUHQF\¶
of  intracellular  energy  transfer  -­  is  the  universal  form  of  energy  transport  that  is  used  by  the  cellular  metabolism.  The  
JHQHUDWLRQRI$73E\WKHXVHRI2LVDQH[WUHPHO\HI¿FLHQWDQGSUR¿WDEOHSURFHVVWKDWLVWKHEDVLVRIDOOYHUWHEUDWHOLIH
RQHDUWK+RZHYHUDVWRHYHU\WKLQJHOVHLQOLIHEHVLGHVWKHSRVLWLYHDVSHFWVWKHUHDUHDOVRQHJDWLYHIDFHWVWKDWRULJLQDWH
from  the  use  of  O2  as  a  main  source  of  energy.  A  main  problem  of  O2  is  its  high  reactivity  that  results  in  the  formation  
RIDQLPPHQVHDUUD\RIR[LGDWLRQSURGXFWV$PRQJWKRVHR[LGDWLYH'1$GDPDJHEURXJKWDERXWE\526LVDGDQJHURXV
HYHQWIUHTXHQWO\RFFXUULQJLQDQ\OLYLQJRUJDQLVP'1$GDPDJHFDXVHGE\526FDQJLYHULVHWRPXWDWLRQVSRVVLEO\
result  in  cellular  transformation  and  eventually  give  rise  to  cancer.  In  an  attempt  to  combat  the  deleterious  effects  of  
R[LGDWLRQGDPDJHLQDFHOOQDWXUHKDVGHYLVHGDYDVWDUUD\RIGLIIHUHQWUHSDLUPHFKDQLVPV,QWKHUHYLHZµR[\JHQDVD
IULHQGDQGHQHP\±KRZWRFRPEDWWKHPXWDWLRQDOSRWHQWLDORIR[RJXDQLQH¶VHHLQWURGXFWLRQWKHDFWRUVLQYROYHG
in  BER  of  8-­oxo-­G  DNA  damage  were  summarized.  The  mechanisms  described  outline  the  key  proteins  that  might  be  
important  to  make  sure  that  the  steady  state  level  of  oxidative  damage  remains  low  enough  not  to  cause  harm  to  the  
RUJDQLVP)XUWKHUPRUHLQRUGHUWRSURYLGHDQXSGDWHRQWKHVXEMHFWWKHODWHVWGHYHORSPHQWVLQWKLV¿HOGDUHGLVFXVVHG
following  the  manuscript.


























RXW E\3RO Ȝ DVZDV VKRZQZLWK VLQJOHQXFOHRWLGH LQFRUSRUDWLRQ H[SHULPHQWV XVLQJ3RO ȜRU3RO Ȝ0()FHOO
H[WUDFWV GHSOHWHGRI0XOH3KRVSKRU\ODWLRQRI3RO Ȝ KDV SUHYLRXVO\EHHQ IRXQG WR VWDELOL]H3RO Ȝ E\GHFUHDVLQJ LWV
XELTXLWLQDWLRQ )UDFWLRQDWLRQ H[SHULPHQWV FRPSDULQJ+(.7FHOOV VWDEO\ WUDQVIHFWHGZLWK3RO ȜZW RU WKH
SKRVSKRU\ODWLRQGHIHFWLYH 3RO Ȝ $ PXWDQW UHYHDOHG D GHFUHDVH LQ FKURPDWLQDVVRFLDWLRQ RI 3RO Ȝ $ 7KXV WKH







MutYH  is  the  DNA  glycosylase  that  catalyzes  the  excision  of  an  incorrect  A  opposite  8-­oxo-­G.  Its  activity  is  followed  






to  be  present   immediately   after  DNA  synthesis   in   the  S  phase.  Those  mispairs  have   to  be   corrected  before  mitosis  
SURFHHGVDVRWKHUZLVH*&WR7$WUDQVYHUVLRQPXWDWLRQVFDQPDQLIHVWWKHPVHOYHV,QVXFKDVFHQDULRWKH&GN&\FOLQ$
SKRVSKRU\ODWLRQGHSHQGHQWUHFUXLWPHQWRI3ROȜWRFKURPDWLQPDNHVDORWRIVHQVHVLQFH3ROȜLVVRIDUWKHPRVWOLNHO\
candidate  to  work  together  with  MutYH  to  achieve  a  correct  repair  of  A:8-­oxo-­G  lesions.
8QIRUWXQDWHO\WKHSKRVSKRU\ODWLRQVWDWXVRI3ROȜLQYLYRFRXOGQRWEHDVVHVVHGGXHWRWKHODFNRIVXLWDEOHGHWHFWLRQ















during  physiological  cellular  conditions.  The  question  regarding  what  happens  upon  induction  of  oxidative  stress  with  
3ROȜDQGLWV370VLVVWLOOXQVROYHGDQGHODERUDWLQJIXUWKHURQWKLVZRXOGEHSXUHVSHFXODWLRQ+RZHYHUWKHUHJXODWRU\















































































 *DUFLD'LD]0 HW DO  6WUXFWXUHIXQFWLRQ VWXGLHV RI '1$ SRO\PHUDVH ODPEGD '1$5HSDLU $PVW





ODPEGD'1$ SRO\PHUDVHPX DQG WHUPLQDO GHR[\ULERQXFOHRWLG\O WUDQVIHUDVH -RXUQDO RIPROHFXODU ELRORJ\






 %UDLWKZDLWH (. HW DO  '1$ SRO\PHUDVH ODPEGD SURWHFWV PRXVH ¿EUREODVWV DJDLQVW R[LGDWLYH '1$
GDPDJHDQGLVUHFUXLWHGWRVLWHVRI'1$GDPDJHUHSDLU-%LRO&KHP
 %UDLWKZDLWH(. HW DO '1$SRO\PHUDVH ODPEGDPHGLDWHV DEDFNXSEDVH H[FLVLRQ UHSDLU DFWLYLW\ LQ
H[WUDFWVRIPRXVHHPEU\RQLF¿EUREODVWV-%LRO&KHP
 &UHVSDQ(+XEVFKHU8	0DJD*(UURUIUHHE\SDVVRIK\GUR[\DGHQLQHE\KXPDQ'1$SRO\PHUDVH




 1DJDVDZD . HW DO  ,GHQWL¿FDWLRQ DQG FKDUDFWHUL]DWLRQ RI KXPDQ '1$ SRO\PHUDVH EHWD  D '1$
SRO\PHUDVHEHWDUHODWHGHQ]\PH-%LRO&KHP





 %HUWRFFL % HW DO  &XWWLQJ HGJH '1$ SRO\PHUDVHV PX DQG ODPEGD DUH GLVSHQVDEOH IRU ,J JHQH
K\SHUPXWDWLRQ-,PPXQRO








the  hMYH  adenine  glycosylase  associated  with  colorectal  cancer:  complementation  assays  with  hMYH  variants  
DQGSUHVWHDG\VWDWHNLQHWLFVRIWKHFRUUHVSRQGLQJPXWDWHG(FROLHQ]\PHV-0RO%LRO
 3RSH0$	'DYLG66 '1$GDPDJH UHFRJQLWLRQ DQG UHSDLU E\ WKHPXULQH0XW<KRPRORJXH'1$
5HSDLU$PVW






































































loss  of  DNA  repair  capacity  in  the  neural  retina.  Neurobiol  Aging.
 :DQJ$//XNDV7-<XDQ0	1HXIHOG$+,QFUHDVHGPLWRFKRQGULDO'1$GDPDJHDQGGRZQUHJXODWLRQ
RI'1$UHSDLUHQ]\PHVLQDJHGURGHQWUHWLQDOSLJPHQWHSLWKHOLXPDQGFKRURLG0RO9LV
 +LUDQR 6 HW DO  0XWDWRU SKHQRW\SH RI 087<+QXOO PRXVH HPEU\RQLF VWHP FHOOV - %LRO &KHP









 6LHEHU20 HW DO 0\K GH¿FLHQF\ HQKDQFHV LQWHVWLQDO WXPRULJHQHVLV LQPXOWLSOH LQWHVWLQDO QHRSODVLD
$SF0LQPLFH&DQFHU5HV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






 .XER\DPD$HWDO 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
 &ODXVRQ&/6D[RZVN\77	'RHWVFK3: 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'\QDPLFÀH[LELOLW\RI'1$ UHSDLU SDWKZD\V LQJURZWK
DUUHVWHG(VFKHULFKLDFROL'1$UHSDLU





















 $PRURVR$HWDO 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ODPEGDDQGSUROLIHUDWLQJFHOOQXFOHDUDQWLJHQ3ODQW&HOO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
 0RODWRUH 6 HW DO  087<+ PXWDWLRQV DVVRFLDWHG ZLWK IDPLOLDO DGHQRPDWRXV SRO\SRVLV IXQFWLRQDO
FKDUDFWHUL]DWLRQE\DPDPPDOLDQFHOOEDVHGDVVD\+XP0XWDW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
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